archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,2.8267e-05,0.37482,0.39329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,4.5779e-05,0.26399,0.29881,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0017696,0.23345,0.1917,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,0.16968,0.15484,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,0.15438,0.091879,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,0.088582,0.13856,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,7.3279e-05,1.2977,1.1402,1,1
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,8.9327e-05,1.287,1.1871,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,3.4805e-05,1.1916,1.0999,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.00013188,1.1747,1.0656,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,7.8298e-05,1.159,1.1428,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,7.7514e-06,1.083,1.0356,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.3909e-05,1.046,0.9597,1,1
2,GO HYPERSENSITIVITY,7.8298e-05,1.0243,0.93678,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00023283,1.0124,0.96197,1,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00020554,1.0119,0.84857,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.2428e-05,0.97628,0.92789,1,1
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.8524e-05,0.96856,1.0559,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,0.00011593,0.96459,0.88041,1,1
2,GO T CELL TOLERANCE INDUCTION,0.00023283,0.95887,0.89075,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,1.2035e-05,0.9572,0.96923,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,7.8298e-05,0.95685,0.83528,1,1
2,GO TOLERANCE INDUCTION,0.00017019,0.9471,0.89109,1,1
2,GO OPSONIZATION,5.337e-06,0.94565,0.88961,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00012367,0.9452,0.9179,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.3279e-05,0.94221,0.90396,1,1
2,GO DENDRITIC CELL MIGRATION,5.6086e-05,0.93513,0.80324,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00013188,0.9317,0.89542,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.6059e-05,0.93087,0.9363,1,1
2,GO SYNAPSE PRUNING,5.2428e-05,0.9221,0.95271,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.636e-05,0.90568,0.85932,1,1
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,2.636e-05,0.90358,0.85003,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.4576e-05,0.90011,0.86687,1,1
2,GO EOSINOPHIL MIGRATION,3.4805e-05,0.9,0.87883,1,1
2,GO EOSINOPHIL CHEMOTAXIS,3.9936e-05,0.8976,0.86568,1,1
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00014989,0.89221,0.84231,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,9.6689e-06,0.89063,0.8873,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00017019,0.88867,0.88421,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,3.7287e-05,0.88822,0.83099,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.248e-05,0.88753,0.88222,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,3.4805e-05,0.88663,0.88537,1,1
2,GO CYTOLYSIS,1.4947e-05,0.88616,0.93974,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,4.5779e-05,0.87797,0.87968,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00010866,0.87696,0.83059,1,1
2,GO LEUKOCYTE AGGREGATION,3.7287e-05,0.87645,0.89437,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.5377e-05,0.87568,0.77195,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00035748,0.87566,0.83325,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00014989,0.86873,0.7787,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.8997e-05,0.86615,0.78162,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,8.9843e-06,0.86317,0.92816,1,1
2,GO COMPLEMENT ACTIVATION,5.337e-06,0.86255,0.90822,1,1
2,GO NEGATIVE T CELL SELECTION,0.00019306,0.85332,0.85676,1,1
2,GO CHEMOKINE SECRETION,1.0403e-05,0.85202,0.87274,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.2763e-05,0.85091,0.84371,1,1
2,GO CYCLOOXYGENASE PATHWAY,1.2939e-05,0.84586,0.84636,1,1
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.8267e-05,0.84528,0.80707,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.8565e-05,0.84032,0.79787,1,1
2,GO IMMUNOGLOBULIN SECRETION,4.2763e-05,0.83883,0.64261,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,7.8298e-05,0.83651,0.74601,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,5.2428e-05,0.83452,0.77682,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,7.3279e-05,0.83446,0.76737,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2907e-05,0.83402,0.79781,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.2907e-05,0.83288,0.83981,1,1
2,GO INTERLEUKIN 10 PRODUCTION,4.2763e-05,0.83252,0.71145,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,9.5377e-05,0.83075,0.80437,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.0304e-05,0.83029,0.75036,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,5.9985e-05,0.82733,0.83291,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,1.3909e-05,0.82223,0.77197,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,7.8298e-05,0.82036,0.72003,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.0304e-05,0.81714,0.8178,1,1
2,GO MONOCYTE CHEMOTAXIS,1.1191e-05,0.8164,0.84889,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.248e-05,0.81453,0.85885,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.2763e-05,0.81423,0.76586,1,1
2,GO NEUTROPHIL CHEMOTAXIS,5.337e-06,0.81202,0.78418,1,1
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,1.9888e-05,0.81185,0.90688,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00010181,0.80958,0.74716,1,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,4.5891e-06,0.80557,0.85055,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.4805e-05,0.79997,0.75663,1,1
2,GO CELLULAR DEFENSE RESPONSE,7.3279e-05,0.79976,0.73841,1,1
2,GO RESPONSE TO CHEMOKINE,4.2763e-05,0.79839,0.74721,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,5.9985e-05,0.79617,0.70145,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,7.1973e-06,0.79002,0.80884,1,1
2,GO LYMPHOCYTE MIGRATION,4.2763e-05,0.78846,0.72825,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00017019,0.78757,0.76447,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,3.4805e-05,0.78736,0.76355,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.00023283,0.78686,0.7716,1,1
2,GO RESPONSE TO PROTOZOAN,8.9327e-05,0.78541,0.71381,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.00028019,0.78024,0.72177,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00017019,0.77702,0.72062,1,1
2,GO DETECTION OF OTHER ORGANISM,9.5377e-05,0.77691,0.72456,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.9936e-05,0.77681,0.72478,1,1
2,GO NEUTROPHIL MIGRATION,1.1191e-05,0.77603,0.72828,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,5.2428e-05,0.77505,0.72055,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.0304e-05,0.77422,0.73673,1,1
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00015974,0.77056,0.6649,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,9.5377e-05,0.76955,0.67776,1,1
2,GO INTERLEUKIN 12 PRODUCTION,6.4139e-05,0.7685,0.70573,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,7.8298e-05,0.76442,0.69279,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00015974,0.76273,0.728,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.6086e-05,0.76058,0.6966,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00028019,0.76034,0.70512,1,1
2,GO T CELL MIGRATION,8.3641e-05,0.76019,0.70352,1,1
2,GO MONONUCLEAR CELL MIGRATION,1.1191e-05,0.75978,0.75591,1,1
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,7.3279e-05,0.75919,0.7573,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.7287e-05,0.75802,0.75095,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.9936e-05,0.7574,0.73623,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00011593,0.75674,0.66833,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.00033648,0.75625,0.64676,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.00015974,0.75462,0.67951,1,1
2,GO GLIAL CELL ACTIVATION,3.4805e-05,0.7537,0.74148,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,4.8997e-05,0.75301,0.74085,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00020554,0.7521,0.7025,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,0.74866,0.683,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,3.248e-05,0.747,0.71068,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00021879,0.74485,0.71871,1,1
2,GO INTERLEUKIN 4 PRODUCTION,2.8267e-05,0.73984,0.72922,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,6.4139e-05,0.73948,0.68019,1,1
2,GO INTERLEUKIN 2 PRODUCTION,3.9936e-05,0.73937,0.67056,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,5.6086e-05,0.73935,0.73128,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00014062,0.73834,0.69395,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.6086e-05,0.73691,0.66961,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,3.0304e-05,0.73662,0.78681,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,6.6813e-06,0.73662,0.85863,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00019306,0.7365,0.6777,1,1
2,GO POSITIVE T CELL SELECTION,0.00020554,0.73612,0.69005,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,1.4947e-05,0.73519,0.7305,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9888e-05,0.73499,0.68283,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,0.00023283,0.73493,0.68786,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.9888e-05,0.73488,0.78188,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00014989,0.73337,0.68839,1,1
2,GO GRANULOCYTE CHEMOTAXIS,6.2007e-06,0.73296,0.72387,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,8.3641e-05,0.73105,0.6418,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.00011593,0.73056,0.63097,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,2.2907e-05,0.73046,0.69905,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00010181,0.7303,0.67699,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00021879,0.73019,0.63624,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,1.8524e-05,0.72745,0.73961,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00023283,0.72725,0.64257,1,1
2,GO B CELL PROLIFERATION,0.00014062,0.7268,0.68632,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.2763e-05,0.72642,0.63573,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010181,0.72578,0.69085,1,1
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,5.9985e-05,0.72336,0.82128,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,8.3461e-06,0.7228,0.76478,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,8.9327e-05,0.72213,0.7149,1,1
2,GO NEUROINFLAMMATORY RESPONSE,2.8267e-05,0.72135,0.6974,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010181,0.72051,0.68299,1,1
2,GO GRANULOCYTE MIGRATION,1.0403e-05,0.7204,0.68468,1,1
2,GO RESPONSE TO INTERLEUKIN 18,0.00031664,0.71849,0.62905,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.00019306,0.71763,0.71052,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.9888e-05,0.71714,0.7112,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,7.3279e-05,0.71692,0.63481,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.1973e-06,0.71613,0.83012,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.5779e-05,0.71585,0.69805,1,1
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,2.636e-05,0.71568,0.75713,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00015974,0.71539,0.67173,1,1
2,GO THYMIC T CELL SELECTION,0.00033648,0.71527,0.66355,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010866,0.7135,0.65285,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,2.636e-05,0.71278,0.67286,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.4805e-05,0.71253,0.66714,1,1
2,GO REGULATION OF CELL KILLING,3.4805e-05,0.71231,0.6776,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,4.2763e-05,0.71191,0.63357,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00020554,0.70849,0.65885,1,1
2,GO T CELL CYTOKINE PRODUCTION,6.4139e-05,0.70838,0.63363,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,7.1973e-06,0.70607,0.87971,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,7.3279e-05,0.70606,0.70741,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8298e-05,0.70535,0.60554,1,1
2,GO T CELL EXTRAVASATION,8.9327e-05,0.70425,0.64401,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00054254,0.70407,0.61282,1,1
2,GO DETECTION OF BIOTIC STIMULUS,3.4805e-05,0.70333,0.65511,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.3909e-05,0.7027,0.7697,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00020554,0.70213,0.6826,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00017019,0.70131,0.63727,1,1
2,GO INTERLEUKIN 13 PRODUCTION,2.4576e-05,0.70115,0.7434,1,1
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019306,0.69991,0.65257,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,4.5779e-05,0.6994,0.72981,1,1
2,GO REGULATION OF PLATELET ACTIVATION,2.636e-05,0.69854,0.65279,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00019306,0.69829,0.66165,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,4.2763e-05,0.69498,0.66243,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00014062,0.69374,0.66847,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,4.5779e-05,0.69305,0.6824,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,3.7287e-05,0.69245,0.70348,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00015974,0.69227,0.63136,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.00012367,0.69133,0.60307,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00013188,0.69071,0.63204,1,1
2,GO TYPE 2 IMMUNE RESPONSE,7.8298e-05,0.69067,0.69213,1,1
2,GO INTERFERON GAMMA PRODUCTION,5.2428e-05,0.69047,0.67455,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.4576e-05,0.68945,0.64917,1,1
2,GO MACROPHAGE PROLIFERATION,2.1347e-05,0.687,0.80935,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.4947e-05,0.68647,0.66268,1,1
2,GO RESPONSE TO INTERFERON GAMMA,4.2763e-05,0.68603,0.66653,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.3909e-05,0.68587,0.6924,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2763e-05,0.68581,0.63756,1,1
2,GO INTERLEUKIN 1 PRODUCTION,2.2907e-05,0.68536,0.67395,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010866,0.68532,0.63143,1,1
2,GO T CELL SELECTION,0.00019306,0.68513,0.64668,1,1
2,GO HUMORAL IMMUNE RESPONSE,4.9495e-06,0.68349,0.70316,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.4576e-05,0.68302,0.66712,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.00010181,0.68118,0.66051,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00014062,0.67848,0.59546,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.00017019,0.6781,0.69328,1,1
2,GO T CELL MEDIATED IMMUNITY,2.8267e-05,0.67676,0.61524,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.00017019,0.67553,0.64306,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00017019,0.67376,0.60935,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.8997e-05,0.6727,0.64636,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.00011593,0.67102,0.63377,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2428e-05,0.67066,0.64202,1,1
2,GO PROTEIN ACTIVATION CASCADE,7.1973e-06,0.67041,0.72533,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00017019,0.67009,0.59759,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.2428e-05,0.66832,0.61942,1,1
2,GO REGULATION OF MYOBLAST FUSION,8.9843e-06,0.66781,0.7537,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.00020554,0.66696,0.80502,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.9985e-05,0.66579,0.58612,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00015974,0.66461,0.6342,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,5.2428e-05,0.66449,0.66298,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.00051151,0.6639,0.64823,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.3279e-05,0.66361,0.59237,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.1191e-05,0.66295,0.63702,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00010181,0.66249,0.58906,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.8267e-05,0.66223,0.60997,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.5779e-05,0.66078,0.6037,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.00042807,0.6602,0.60444,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,0.65962,0.60459,1,1
2,GO CELLULAR EXTRAVASATION,4.5779e-05,0.65926,0.60925,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00017019,0.65894,0.60434,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011593,0.65832,0.65029,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00029789,0.65815,0.65446,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.8997e-05,0.65478,0.61818,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00021879,0.65402,0.65362,1,1
2,GO RESPONSE TO INTERFERON ALPHA,4.8997e-05,0.65242,0.68335,1,1
2,GO INTEGRIN ACTIVATION,9.5377e-05,0.65227,0.63922,1,1
2,GO RESPONSE TO INTERFERON BETA,6.4139e-05,0.65095,0.59771,1,1
2,GO FIBRINOLYSIS,1.3909e-05,0.64901,0.68348,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.8267e-05,0.64833,0.60331,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,6.4139e-05,0.64646,0.58415,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,0.00014062,0.6464,0.61274,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.8997e-05,0.64507,0.59135,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.8267e-05,0.64446,0.70232,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,8.3641e-05,0.64262,0.58448,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,7.7514e-06,0.64202,0.61947,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,5.6086e-05,0.64175,0.6061,1,1
2,GO INTERLEUKIN 5 PRODUCTION,0.00010866,0.6414,0.65764,1,1
2,GO LEUKOCYTE CHEMOTAXIS,9.6689e-06,0.6411,0.63749,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,4.5779e-05,0.63939,0.72002,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.9327e-05,0.63691,0.58878,1,1
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00026348,0.63636,0.59219,1,1
2,GO ACUTE PHASE RESPONSE,1.9888e-05,0.63582,0.57257,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00021879,0.63575,0.60943,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00012367,0.63365,0.56167,1,1
2,GO PHAGOCYTOSIS RECOGNITION,1.6059e-05,0.6331,0.67198,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00014989,0.6321,0.58094,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.9888e-05,0.63007,0.6577,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.9888e-05,0.62942,0.60835,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00010181,0.62929,0.6022,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00015974,0.62789,0.61289,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00011593,0.62744,0.61591,1,1
2,GO REGULATION OF T CELL MIGRATION,0.00017019,0.62738,0.56801,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.4805e-05,0.62712,0.67925,1,1
2,GO CELL KILLING,3.4805e-05,0.6254,0.60747,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.1347e-05,0.62274,0.61106,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.00019306,0.62222,0.59149,1,1
2,GO REGULATION OF CELLULAR EXTRAVASATION,4.2763e-05,0.62211,0.64333,1,1
2,GO B CELL MEDIATED IMMUNITY,4.5779e-05,0.62064,0.63015,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.2763e-05,0.61958,0.62152,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00011593,0.61947,0.58818,1,1
2,GO PLASMINOGEN ACTIVATION,1.2939e-05,0.619,0.67323,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00014989,0.6187,0.64384,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2428e-05,0.61752,0.57182,1,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,8.3641e-05,0.61744,0.66446,1,1
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00017019,0.61633,0.61137,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00023283,0.61577,0.59598,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00020554,0.61558,0.62666,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.8298e-05,0.61539,0.58852,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,3.248e-05,0.61459,0.6293,1,1
2,GO LEUKOCYTE PROLIFERATION,5.2428e-05,0.61457,0.5817,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,5.2428e-05,0.61407,0.56208,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.248e-05,0.6135,0.6075,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00028019,0.61342,0.63535,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.00045436,0.61327,0.54638,1,1
2,GO MACROPHAGE ACTIVATION,3.7287e-05,0.6123,0.64129,1,1
2,GO ETHANOL METABOLIC PROCESS,4.2763e-05,0.61216,0.6194,1,1
2,GO REGULATION OF MEMBRANE INVAGINATION,5.6086e-05,0.61129,0.6773,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.8267e-05,0.6098,0.6171,1,1
2,GO CYTOKINE METABOLIC PROCESS,3.4805e-05,0.60913,0.59448,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.0304e-05,0.60906,0.57149,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.4805e-05,0.60847,0.6272,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00031664,0.60826,0.57009,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,3.9936e-05,0.60722,0.62203,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.4805e-05,0.60672,0.55895,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,5.6086e-05,0.60524,0.58575,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,5.6086e-05,0.6047,0.6192,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00028019,0.60444,0.55445,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,5.2428e-05,0.60421,0.56534,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,2.2907e-05,0.60421,0.68613,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.6034,0.59645,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.248e-05,0.60309,0.56347,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,5.6086e-05,0.60292,0.62595,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.00010181,0.60176,0.58644,1,1
2,GO APOPTOTIC CELL CLEARANCE,5.9985e-05,0.60121,0.61235,1,1
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00014989,0.60061,0.5208,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,1.2035e-05,0.59991,0.62554,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,4.5779e-05,0.59972,0.61308,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.2428e-05,0.59938,0.545,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,3.248e-05,0.59916,0.55673,1,1
2,GO INTERLEUKIN 8 PRODUCTION,4.5779e-05,0.59861,0.57793,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.2428e-05,0.59627,0.5355,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00029789,0.59615,0.54838,1,1
2,GO T CELL PROLIFERATION,5.9985e-05,0.59555,0.58341,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.4805e-05,0.59533,0.58693,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,1.2939e-05,0.59477,0.61487,1,1
2,GO REGULATION OF PHAGOCYTOSIS,4.2763e-05,0.59461,0.61123,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.4805e-05,0.59453,0.55593,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,0.59422,0.57112,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00064645,0.59268,0.5658,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9936e-05,0.59184,0.54727,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00021879,0.59067,0.56186,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.59067,0.55974,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,6.6813e-06,0.58979,0.65117,1,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,4.8997e-05,0.58965,0.67424,1,1
2,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,0.58953,0.53971,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.00014989,0.58896,0.56785,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00023283,0.58895,0.53918,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.0304e-05,0.58756,0.5514,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,2.636e-05,0.58711,0.63701,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,2.4576e-05,0.58537,0.54234,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00051151,0.58531,0.71798,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00010866,0.58504,0.54557,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,2.8267e-05,0.58461,0.58179,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,3.0304e-05,0.58342,0.58358,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,8.3641e-05,0.58308,0.54789,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00020554,0.58193,0.58406,1,1
2,GO ASTROCYTE ACTIVATION,2.4576e-05,0.58173,0.56864,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00028019,0.58136,0.54955,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.9985e-05,0.58107,0.61096,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.00010181,0.57974,0.55377,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2007e-06,0.57962,0.6025,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.2428e-05,0.57891,0.60735,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.00020554,0.57852,0.5569,1,1
2,GO CYTOKINE SECRETION,3.248e-05,0.57802,0.53803,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.57754,0.55928,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.8997e-05,0.57743,0.5967,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,8.3461e-06,0.57559,0.57105,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00018128,0.57454,0.53238,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.2035e-05,0.57346,0.55064,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,7.3279e-05,0.57333,0.54457,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00014989,0.57167,0.55615,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,6.4139e-05,0.57119,0.55079,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00021879,0.57045,0.56065,1,1
2,GO MACROPHAGE MIGRATION,1.6059e-05,0.56981,0.61994,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,2.1347e-05,0.56961,0.54259,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,7.8298e-05,0.56936,0.55884,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,2.1347e-05,0.56877,0.57122,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00017019,0.56869,0.56049,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00029789,0.56726,0.57611,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.9985e-05,0.56682,0.58692,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00028019,0.56557,0.53755,1,1
2,GO LYMPH NODE DEVELOPMENT,0.00013188,0.56408,0.56576,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.8267e-05,0.56373,0.59899,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00031664,0.56175,0.54606,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.9327e-05,0.56173,0.56897,1,1
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.5377e-05,0.5615,0.595,1,1
2,GO REGULATION OF T CELL ACTIVATION,9.5377e-05,0.56145,0.53513,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.248e-05,0.56128,0.57567,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,3.7287e-05,0.5607,0.59038,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010181,0.55987,0.56475,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00018128,0.55743,0.59504,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.5779e-05,0.5574,0.55872,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00014062,0.55597,0.52556,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00064645,0.55596,0.52699,1,1
2,GO ETHANOL OXIDATION,0.00020554,0.55519,0.63144,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,6.2007e-06,0.55333,0.59942,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00020554,0.55324,0.58933,1,1
2,GO MAST CELL ACTIVATION,0.00010181,0.55323,0.50543,1,1
2,GO MACROPHAGE CHEMOTAXIS,1.4947e-05,0.55277,0.60357,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00010181,0.55183,0.52895,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00013188,0.55174,0.54183,1,1
2,GO CELL CHEMOTAXIS,1.7249e-05,0.55056,0.55709,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.5377e-05,0.55002,0.50816,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0010209,0.55001,0.48292,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.00020554,0.54962,0.55501,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,3.4805e-05,0.54944,0.62038,1,1
2,GO AMYLOID BETA CLEARANCE,7.3279e-05,0.54899,0.54512,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00018128,0.54842,0.55355,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.4947e-05,0.5478,0.6436,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.9888e-05,0.5472,0.59201,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.8997e-05,0.54638,0.55586,1,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.7287e-05,0.54621,0.57834,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.8524e-05,0.54572,0.49745,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,7.7514e-06,0.54516,0.55515,1,1
2,GO REGULATION OF CELL ACTIVATION,6.8565e-05,0.54493,0.51153,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.9327e-05,0.54351,0.50754,1,1
2,GO T CELL APOPTOTIC PROCESS,7.3279e-05,0.54236,0.5342,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,8.9327e-05,0.54191,0.59579,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.4139e-05,0.54094,0.49208,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00019306,0.54091,0.51999,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00012367,0.54077,0.5528,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.4947e-05,0.54018,0.61849,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,6.4139e-05,0.53914,0.53561,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.53905,0.53615,1,1
2,GO REGULATION OF PLATELET AGGREGATION,7.3279e-05,0.53895,0.49978,1,1
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00023283,0.53872,0.55113,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.636e-05,0.53839,0.55352,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.4139e-05,0.53796,0.54303,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,2.8267e-05,0.53724,0.51657,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.3909e-05,0.53708,0.56049,1,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00017019,0.53673,0.53984,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4139e-05,0.53645,0.51025,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.9936e-05,0.53604,0.59757,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,4.5779e-05,0.53566,0.56753,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.5779e-05,0.53523,0.52249,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00012367,0.5346,0.54881,1,1
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,7.8298e-05,0.53432,0.49812,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.3279e-05,0.53356,0.52204,1,1
2,GO CHEMOKINE PRODUCTION,1.8524e-05,0.53308,0.55731,1,1
2,GO RESPIRATORY BURST,0.00013188,0.53273,0.5565,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,8.9327e-05,0.53071,0.52521,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,7.1973e-06,0.52916,0.56136,1,1
2,GO PEPTIDE CROSS LINKING,0.00020554,0.5289,0.51864,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00026348,0.52878,0.47941,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00012367,0.52877,0.54496,1,1
2,GO T CELL ACTIVATION,7.8298e-05,0.52811,0.51499,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,8.9327e-05,0.52728,0.54626,1,1
2,GO LEUKOCYTE MIGRATION,2.2907e-05,0.526,0.54942,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,9.5377e-05,0.52561,0.51077,1,1
2,GO GLYCINE TRANSPORT,0.008797,0.52275,0.33933,1,1
2,GO NAD BIOSYNTHETIC PROCESS,3.0304e-05,0.52233,0.49802,1,1
2,GO MEMBRANE RAFT ORGANIZATION,4.5779e-05,0.52139,0.55733,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7287e-05,0.51996,0.52818,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00054254,0.51952,0.55398,1,1
2,GO RESPONSE TO FUNGUS,1.2035e-05,0.51899,0.54838,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.4947e-05,0.5174,0.53867,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,5.2428e-05,0.51729,0.52109,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.00021879,0.51689,0.50263,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,3.9936e-05,0.51653,0.54582,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,7.3279e-05,0.51631,0.54242,1,1
2,GO SEROTONIN SECRETION,0.00010866,0.51629,0.50686,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,7.7514e-06,0.51629,0.64698,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,1.3909e-05,0.51517,0.56106,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.00012367,0.51495,0.48875,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,8.3641e-05,0.51427,0.5196,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.3641e-05,0.5137,0.50827,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,3.7287e-05,0.51319,0.50255,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0038653,0.51313,0.40978,1,1
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,5.2428e-05,0.51252,0.51797,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00013188,0.51242,0.5185,1,1
2,GO T CELL DIFFERENTIATION,0.00021879,0.50915,0.49199,1,1
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0003797,0.509,0.59838,1,1
2,GO SUPEROXIDE ANION GENERATION,5.6086e-05,0.50857,0.49548,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00040321,0.50789,0.48359,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00010866,0.5076,0.52581,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00029789,0.50676,0.54144,1,1
2,GO BLEB ASSEMBLY,0.00048214,0.50645,0.52374,1,1
2,GO NATURAL KILLER CELL ACTIVATION,6.8565e-05,0.50498,0.53231,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00028019,0.50368,0.5002,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,2.8267e-05,0.50331,0.52489,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00045436,0.50297,0.45309,1,1
2,GO RESPONSE TO BACTERIUM,1.2939e-05,0.50229,0.52363,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.6086e-05,0.50107,0.50071,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00072571,0.5002,0.47375,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00045436,0.49991,0.4416,1,1
2,GO NEGATIVE REGULATION OF COAGULATION,2.1347e-05,0.49977,0.54544,1,1
2,GO T CELL LINEAGE COMMITMENT,0.00020554,0.49934,0.51221,1,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.9888e-05,0.49922,0.47599,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00012367,0.49913,0.46294,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.2907e-05,0.49818,0.50177,1,1
2,GO REGULATION OF IMMUNE RESPONSE,5.6086e-05,0.49795,0.48148,1,1
2,GO INFLAMMATORY RESPONSE,2.2907e-05,0.49779,0.51262,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00011593,0.4975,0.47865,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00013188,0.49725,0.51186,1,1
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00031664,0.49575,0.46338,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00015974,0.49381,0.42549,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.00010181,0.49176,0.47181,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00011593,0.4909,0.48917,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0016767,0.48927,0.47364,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,3.4805e-05,0.48923,0.4797,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00029789,0.48921,0.58777,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.4947e-05,0.4879,0.53733,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,0.48773,0.52209,1,1
2,GO REGULATION OF CELL CELL ADHESION,7.3279e-05,0.48692,0.47867,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00033648,0.48592,0.53995,1,1
2,GO MACROPHAGE DIFFERENTIATION,0.00026348,0.48584,0.48689,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00015974,0.48519,0.50637,1,1
2,GO HETEROTYPIC CELL CELL ADHESION,2.2907e-05,0.48443,0.49644,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00014062,0.48415,0.4709,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.9985e-05,0.4836,0.47966,1,1
2,GO INNATE IMMUNE RESPONSE,3.4805e-05,0.48281,0.4768,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.48232,0.49972,1,1
2,GO PHAGOCYTOSIS,5.2428e-05,0.48199,0.51502,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,4.2763e-05,0.48154,0.46077,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00023283,0.48136,0.46377,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,6.8565e-05,0.47994,0.49427,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.00019306,0.47959,0.46408,1,1
2,GO ZYMOGEN ACTIVATION,5.7533e-06,0.4795,0.52937,1,1
2,GO REGULATION OF COAGULATION,1.7249e-05,0.47924,0.51941,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,3.248e-05,0.47923,0.47962,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.2428e-05,0.47904,0.46873,1,1
2,GO ACTIVATED T CELL PROLIFERATION,7.8298e-05,0.47739,0.45231,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.248e-05,0.47631,0.47455,1,1
2,GO FOAM CELL DIFFERENTIATION,5.2428e-05,0.476,0.49213,1,1
2,GO MYOBLAST FUSION,3.9936e-05,0.47488,0.50128,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0012758,0.47418,0.44292,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00018128,0.47364,0.4464,1,1
2,GO RESPONSE TO TUMOR CELL,0.00017019,0.47348,0.4722,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.2428e-05,0.47344,0.45081,1,1
2,GO ZYMOGEN INHIBITION,2.636e-05,0.47323,0.55431,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.0010209,0.47313,0.51965,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00020554,0.47242,0.47559,1,1
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,6.4139e-05,0.47223,0.44636,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.8524e-05,0.47154,0.48796,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00040321,0.47108,0.49563,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.9985e-05,0.47053,0.50033,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00021879,0.47025,0.4428,1,1
2,GO LYMPHOCYTE ACTIVATION,0.00011593,0.46945,0.47517,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.0304e-05,0.46922,0.45669,1,1
2,GO WATER TRANSPORT,5.6086e-05,0.46903,0.56277,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,1.4947e-05,0.46848,0.49785,1,1
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.4805e-05,0.46804,0.56271,1,1
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.5377e-05,0.46798,0.48647,1,1
2,GO LIPOXYGENASE PATHWAY,0.00010181,0.4679,0.51939,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,7.3279e-05,0.46784,0.43706,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.9985e-05,0.46687,0.45472,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00086166,0.46579,0.40304,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,6.8565e-05,0.46427,0.45906,1,1
2,GO MULTI ORGANISM CELLULAR PROCESS,6.8565e-05,0.46298,0.53477,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00026348,0.46183,0.47356,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,3.248e-05,0.46039,0.46649,1,1
2,GO REGULATION OF AMYLOID BETA CLEARANCE,6.4139e-05,0.45953,0.51971,1,1
2,GO HEMIDESMOSOME ASSEMBLY,0.024086,0.45883,0.46391,1,1
2,GO OSTEOCLAST DIFFERENTIATION,4.2763e-05,0.45881,0.45213,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.00018128,0.45879,0.44706,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,7.3279e-05,0.45847,0.45032,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00040321,0.45838,0.52942,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,5.2428e-05,0.45735,0.44892,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,7.7514e-06,0.45653,0.46955,1,1
2,GO OSTEOCLAST DEVELOPMENT,0.00014062,0.45639,0.5386,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,1.9888e-05,0.45583,0.52714,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0403e-05,0.45519,0.50496,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.9985e-05,0.45468,0.44226,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00024771,0.45388,0.48886,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.8298e-05,0.45374,0.48916,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00013188,0.45354,0.47933,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00031664,0.45353,0.43056,1,1
2,GO VAGINA DEVELOPMENT,0.00096503,0.45326,0.41483,1,1
2,GO RESPONSE TO PROSTAGLANDIN,0.00014062,0.45284,0.44552,1,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00010866,0.45234,0.43933,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00010181,0.45195,0.42195,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00014989,0.44954,0.49935,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,4.2539e-06,0.4486,0.49585,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.2428e-05,0.44849,0.47882,1,1
2,GO ETHANOL CATABOLIC PROCESS,4.5779e-05,0.4484,0.55633,1,1
2,GO B CELL ACTIVATION,0.00017019,0.44685,0.47191,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00010181,0.44652,0.47217,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,3.7287e-05,0.44627,0.54152,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00064645,0.44618,0.49948,1,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,4.5779e-05,0.44579,0.45643,1,1
2,GO RESPONSE TO INTERLEUKIN 6,3.4805e-05,0.44543,0.47903,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,3.0304e-05,0.44338,0.46417,1,1
2,GO IMMUNOGLOBULIN PRODUCTION,0.00013188,0.44302,0.45704,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00035748,0.44293,0.49253,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.44226,0.46221,1,1
2,GO CYTOKINE PRODUCTION,3.7287e-05,0.44097,0.44861,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00012367,0.44078,0.45898,1,1
2,GO SYNCYTIUM FORMATION,3.9936e-05,0.44064,0.46503,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00035748,0.44057,0.43618,1,1
2,GO DEFENSE RESPONSE,3.248e-05,0.44041,0.43516,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,7.3279e-05,0.43997,0.47304,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00068502,0.4399,0.39112,1,1
2,GO FEVER GENERATION,0.00051151,0.43966,0.38902,1,1
2,GO TRANSCYTOSIS,5.9985e-05,0.43924,0.47776,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00010181,0.43918,0.51963,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,3.0304e-05,0.43892,0.42912,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00060992,0.43881,0.48759,1,1
2,GO IMMUNE EFFECTOR PROCESS,3.9936e-05,0.43809,0.44884,1,1
2,GO CHOLESTEROL STORAGE,0.00013188,0.43756,0.49315,1,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.2907e-05,0.43732,0.51114,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00040321,0.43674,0.45046,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00054254,0.4367,0.4494,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00045436,0.43666,0.58741,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7287e-05,0.43658,0.45917,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00013188,0.43649,0.44701,1,1
2,GO BONE RESORPTION,5.6086e-05,0.43648,0.46066,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00068502,0.43637,0.40976,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0019699,0.43489,0.43303,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.00010866,0.43419,0.44591,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,2.8267e-05,0.4336,0.45482,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.4805e-05,0.43344,0.44868,1,1
2,GO POSITIVE REGULATION OF COAGULATION,3.0304e-05,0.43343,0.49263,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.43299,0.46522,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00026348,0.43257,0.45824,1,1
2,GO FLUID TRANSPORT,0.00011593,0.42969,0.48433,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00010181,0.42948,0.49888,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,6.8565e-05,0.42908,0.51463,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.9985e-05,0.42903,0.43412,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00091199,0.42877,0.50381,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00051151,0.42776,0.44851,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.3641e-05,0.4277,0.46514,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00014989,0.42743,0.55673,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00012367,0.42736,0.4599,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.8565e-05,0.42712,0.42284,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00035748,0.42656,0.43523,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00064645,0.42601,0.40521,1,1
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0054671,0.42573,0.40102,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,2.636e-05,0.42389,0.45361,1,1
2,GO CELL ADHESION MOLECULE PRODUCTION,0.00042807,0.42368,0.47119,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0025648,0.42365,0.35765,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,8.9327e-05,0.42284,0.44709,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019306,0.42259,0.43098,1,1
2,GO REGULATION OF FIBRINOLYSIS,0.00021879,0.42189,0.52048,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.00019306,0.42187,0.43807,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.8267e-05,0.42179,0.42866,1,1
2,GO B CELL HOMEOSTASIS,0.00054254,0.42107,0.41121,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,4.8997e-05,0.42094,0.54422,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00051151,0.42077,0.45334,1,1
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0044907,0.42033,0.41359,1,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0024341,0.41979,0.43068,1,1
2,GO REGULATION OF CHEMOTAXIS,5.2428e-05,0.41977,0.44016,1,1
2,GO ENTRY INTO HOST,5.9985e-05,0.4197,0.43031,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00020554,0.41948,0.43493,1,1
2,GO VASCULAR WOUND HEALING,0.00026348,0.41915,0.47915,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00010181,0.41861,0.45952,1,1
2,GO TRABECULA FORMATION,0.00024771,0.41841,0.43004,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.00012367,0.41831,0.53537,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00018128,0.41795,0.40931,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00014989,0.41731,0.4623,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.9327e-05,0.41685,0.39381,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00076864,0.41674,0.45371,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,7.3279e-05,0.4166,0.45946,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,5.2428e-05,0.4165,0.44888,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00096503,0.41579,0.41295,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00035748,0.41555,0.40843,1,1
2,GO MUCUS SECRETION,0.00010181,0.41455,0.45955,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00015974,0.41436,0.42607,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013188,0.4141,0.43838,1,1
2,GO REGULATION OF BONE REMODELING,0.00014062,0.41395,0.41759,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00023283,0.41362,0.5646,1,1
2,GO RESPONSE TO INTERLEUKIN 1,2.8267e-05,0.41361,0.37087,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00010181,0.41347,0.45764,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,6.4139e-05,0.41268,0.43847,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.00035748,0.41211,0.45057,1,1
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00086166,0.41183,0.42107,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0023095,0.41147,0.37706,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00018128,0.41145,0.44494,1,1
2,GO PROSTANOID METABOLIC PROCESS,4.5779e-05,0.41078,0.41993,1,1
2,GO PLATELET DEGRANULATION,1.6059e-05,0.41072,0.50437,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,4.8997e-05,0.40984,0.43844,1,1
2,GO LIVER MORPHOGENESIS,0.00017019,0.4098,0.39989,1,1
2,GO XENOBIOTIC CATABOLIC PROCESS,0.025096,0.40977,0.25421,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00021879,0.40955,0.46094,1,1
2,GO REGULATION OF TISSUE REMODELING,5.6086e-05,0.40828,0.43192,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6059e-05,0.40815,0.48033,1,1
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00028019,0.40735,0.4257,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,5.9985e-05,0.40664,0.46074,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0024341,0.40655,0.56303,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00021879,0.40647,0.43475,1,1
2,GO AMYLOID FIBRIL FORMATION,6.8565e-05,0.40604,0.4398,1,1
2,GO GAP JUNCTION ASSEMBLY,0.00054254,0.40566,0.50168,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00024771,0.40491,0.42116,1,1
2,GO CELL ACTIVATION,4.8997e-05,0.40382,0.42459,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.40379,0.44505,1,1
2,GO MEMBRANE INVAGINATION,0.00013188,0.40374,0.46741,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00068502,0.40162,0.44526,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0003797,0.40138,0.43446,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00091199,0.40136,0.36454,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,7.8298e-05,0.40022,0.43921,1,1
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0024341,0.39987,0.40129,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.8565e-05,0.39984,0.47976,1,1
2,GO PROTEIN TRIMERIZATION,0.00015974,0.39948,0.43632,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00023283,0.39884,0.44064,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.7249e-05,0.39814,0.46631,1,1
2,GO POSITIVE CHEMOTAXIS,2.636e-05,0.39712,0.42933,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00014062,0.39691,0.41429,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0021907,0.39685,0.41417,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,2.8267e-05,0.39667,0.41371,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00035748,0.39606,0.39475,1,1
2,GO B CELL DIFFERENTIATION,0.00033648,0.39509,0.43578,1,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00019306,0.39451,0.4353,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00019306,0.39363,0.40337,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00010866,0.39356,0.39003,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.00029789,0.39283,0.38913,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00040321,0.39245,0.40832,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.3279e-05,0.39236,0.41976,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0023095,0.39229,0.44379,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00012367,0.39166,0.51749,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00010866,0.39139,0.39339,1,1
2,GO REGULATION OF STEROL TRANSPORT,7.8298e-05,0.38989,0.3895,1,1
2,GO PROSTAGLANDIN TRANSPORT,7.8298e-05,0.38906,0.43826,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.9936e-05,0.38812,0.4073,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.00057531,0.38663,0.40954,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00024771,0.38653,0.44803,1,1
2,GO RESPONSE TO FLUID SHEAR STRESS,0.00024771,0.38652,0.45582,1,1
2,GO RESPONSE TO ANGIOTENSIN,3.9936e-05,0.38579,0.38796,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.0011418,0.3853,0.40622,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00048214,0.38524,0.40228,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0013481,0.38515,0.31732,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,5.6086e-05,0.38491,0.4454,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00040321,0.38469,0.42541,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.0020776,0.38452,0.41996,1,1
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.00015974,0.38393,0.42085,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00024771,0.38362,0.4337,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,5.9985e-05,0.38361,0.44632,1,1
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0040644,0.38328,0.37597,1,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,7.3279e-05,0.38284,0.46578,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00019306,0.38229,0.40722,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00031664,0.38229,0.3908,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00031664,0.38184,0.43777,1,1
2,GO RESPONSE TO VIRUS,0.00024771,0.38112,0.38926,1,1
2,GO ERK1 AND ERK2 CASCADE,5.2428e-05,0.38074,0.42405,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0019699,0.37963,0.46207,1,1
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.012106,0.37902,0.44574,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.0010209,0.37808,0.37466,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00023283,0.3775,0.41745,1,1
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.00013188,0.3775,0.32374,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0013481,0.37741,0.37689,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00051151,0.37663,0.47018,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0014241,0.37555,0.38056,1,1
2,GO CELLULAR RESPONSE TO DSRNA,0.00010866,0.37547,0.41555,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00013188,0.37525,0.35686,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00018128,0.37521,0.41038,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.00028019,0.37515,0.41292,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,6.8565e-05,0.3749,0.46371,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.0028457,0.37488,0.39225,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,6.4139e-05,0.37424,0.4716,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,5.9985e-05,0.37304,0.37157,1,1
2,GO REGULATION OF DEFENSE RESPONSE,5.9985e-05,0.3726,0.38505,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00040321,0.37257,0.37189,1,1
2,GO REGULATION OF LIPASE ACTIVITY,0.00015974,0.37253,0.3675,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00026348,0.37218,0.32032,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00033648,0.37216,0.34798,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00020554,0.37206,0.46274,1,1
2,GO RESPONSE TO CYTOKINE,7.3279e-05,0.3718,0.37611,1,1
2,GO COLLAGEN METABOLIC PROCESS,0.0010209,0.36988,0.42393,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.7287e-05,0.36956,0.42532,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00081392,0.36933,0.41768,1,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00021879,0.3691,0.40037,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.8298e-05,0.36845,0.4183,1,1
2,GO HYALURONAN CATABOLIC PROCESS,2.2907e-05,0.3683,0.50051,1,1
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00018128,0.36761,0.46546,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020554,0.36754,0.43466,1,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.00014989,0.36729,0.38373,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.8997e-05,0.36583,0.37948,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.00035748,0.36543,0.35994,1,1
2,GO STEROL HOMEOSTASIS,5.2428e-05,0.36537,0.38703,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0031545,0.36532,0.3892,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00064645,0.36529,0.43061,1,1
2,GO REGULATION OF WOUND HEALING,6.4139e-05,0.36521,0.41177,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00064645,0.36512,0.39382,1,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0063209,0.36456,0.39047,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00028019,0.36426,0.35446,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0003797,0.3642,0.42516,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,9.5377e-05,0.36415,0.43964,1,1
2,GO RESPONSE TO MINERALOCORTICOID,0.0016767,0.36335,0.30371,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.00028019,0.36266,0.47521,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.00081392,0.36236,0.39231,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00028019,0.36211,0.35899,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0015041,0.36208,0.43466,1,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.4805e-05,0.36176,0.48198,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00033648,0.36167,0.36332,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,6.4139e-05,0.36138,0.37755,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.00057531,0.36129,0.36668,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.00028019,0.36078,0.39951,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010181,0.36014,0.39657,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.248e-05,0.35994,0.38239,1,1
2,GO RENAL ABSORPTION,6.8565e-05,0.35979,0.49146,1,1
2,GO BONE CELL DEVELOPMENT,0.0010798,0.35919,0.37679,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.3279e-05,0.35904,0.37752,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00021879,0.35886,0.40163,1,1
2,GO PROSTAGLANDIN SECRETION,0.00031664,0.35885,0.40924,1,1
2,GO PLATELET ACTIVATION,0.00031664,0.3588,0.38683,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.35763,0.40888,1,1
2,GO REGULATION OF LYSOSOMAL LUMEN PH,3.4805e-05,0.35736,0.38331,1,1
2,GO SEQUESTERING OF METAL ION,0.00057531,0.35715,0.29692,1,1
2,GO CELLULAR RESPONSE TO IRON ION,0.0096484,0.35589,0.28779,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.00021879,0.35588,0.43135,1,1
2,GO CHOLESTEROL EFFLUX,0.00048214,0.35579,0.32547,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00031664,0.35549,0.41413,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00015974,0.35498,0.43692,1,1
2,GO P38MAPK CASCADE,0.00010866,0.35384,0.39066,1,1
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00040321,0.35352,0.35999,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0025648,0.35333,0.2991,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00023283,0.3532,0.40486,1,1
2,GO RESPONSE TO MANGANESE ION,3.4805e-05,0.35314,0.37089,1,1
2,GO BLOOD VESSEL REMODELING,0.0011418,0.35294,0.42416,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00033648,0.35283,0.319,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00014062,0.35253,0.37872,1,1
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00028019,0.352,0.35009,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,8.3641e-05,0.35187,0.38225,1,1
2,GO REGULATION OF CELL FATE SPECIFICATION,0.00010181,0.3515,0.44451,1,1
2,GO DIET INDUCED THERMOGENESIS,0.0020776,0.35072,0.32708,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00051151,0.35008,0.45808,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.00012367,0.34996,0.3983,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00020554,0.34966,0.36154,1,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00015974,0.34955,0.49063,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.015776,0.34949,0.28931,1,1
2,GO RESPONSE TO THYROID HORMONE,0.00011593,0.34949,0.36356,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,6.4139e-05,0.34939,0.36937,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0021907,0.34901,0.34873,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00015974,0.34875,0.40728,1,1
2,GO RESPONSE TO PROGESTERONE,0.0003797,0.34873,0.35257,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00045436,0.34787,0.36294,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00040321,0.34697,0.41775,1,1
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00024771,0.34695,0.40376,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00015974,0.34667,0.43347,1,1
2,GO PINOCYTOSIS,0.00068502,0.34639,0.36188,1,1
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0047188,0.34501,0.37221,1,1
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00024771,0.34483,0.45087,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,5.2428e-05,0.34477,0.33505,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00021879,0.34468,0.38089,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00014062,0.34455,0.38286,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.9985e-05,0.34337,0.40466,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00015974,0.34182,0.40325,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00072571,0.34181,0.45393,1,1
2,GO RESPONSE TO VITAMIN D,0.0013481,0.34165,0.36363,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00023283,0.34147,0.36493,1,1
2,GO HYALURONAN METABOLIC PROCESS,6.4139e-05,0.34094,0.42532,1,1
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0019699,0.34079,0.44488,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00024771,0.34072,0.43315,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00026348,0.34064,0.40799,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,7.3279e-05,0.34037,0.39534,1,1
2,GO RESPONSE TO DSRNA,0.00017019,0.34035,0.32911,1,1
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00048214,0.33988,0.39425,1,1
2,GO BONE REMODELING,0.00013188,0.33987,0.3964,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,7.3279e-05,0.33936,0.45048,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,0.33898,0.39957,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00029789,0.33896,0.3735,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00026348,0.33895,0.37127,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00051151,0.33851,0.37674,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00018128,0.3384,0.36471,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,3.4805e-05,0.3384,0.37709,1,1
2,GO SEQUESTERING OF CALCIUM ION,0.00033648,0.33817,0.34158,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,4.8997e-05,0.33785,0.34383,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.2428e-05,0.33671,0.35509,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0076456,0.33664,0.27476,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014989,0.33566,0.37064,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00017019,0.33408,0.36181,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00029789,0.33377,0.41822,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0012758,0.33365,0.37529,1,1
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0025648,0.33353,0.40982,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.33316,0.42513,1,1
2,GO TISSUE REMODELING,6.4139e-05,0.33301,0.42713,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0040644,0.33255,0.31168,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0010798,0.33238,0.3484,1,1
2,GO HEART TRABECULA FORMATION,0.0020776,0.33205,0.3425,1,1
2,GO REGULATION OF CELL ADHESION,0.00012367,0.33196,0.40264,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00018128,0.33162,0.40757,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.9327e-05,0.33151,0.37113,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0019699,0.33082,0.40863,1,1
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00017019,0.33079,0.42586,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0016767,0.33049,0.42204,1,1
2,GO PLATELET AGGREGATION,0.00040321,0.33049,0.4007,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00020554,0.32997,0.36072,1,1
2,GO RETINAL METABOLIC PROCESS,0.00033648,0.32964,0.42576,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0042727,0.32936,0.37701,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00029789,0.3283,0.39018,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0013481,0.32786,0.40964,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00010866,0.32785,0.38597,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00091199,0.32771,0.35735,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026348,0.32724,0.35,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,0.00014989,0.3268,0.36003,1,1
2,GO SEROTONIN TRANSPORT,0.0025648,0.32654,0.32364,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00010866,0.32632,0.35244,1,1
2,GO LUNG MORPHOGENESIS,0.00086166,0.32625,0.35567,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00024771,0.32596,0.40356,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00060992,0.32549,0.40005,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00011593,0.32535,0.37027,1,1
2,GO REGULATION OF PROTEIN MATURATION,5.2428e-05,0.32532,0.35076,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,8.3641e-05,0.32521,0.40515,1,1
2,GO PULMONARY VALVE DEVELOPMENT,0.008797,0.32452,0.34395,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.0031545,0.32376,0.31168,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00014989,0.32358,0.316,1,1
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0019699,0.32357,0.2759,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.6086e-05,0.3233,0.35835,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010181,0.32318,0.3405,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00057531,0.32165,0.32276,1,1
2,GO SOMATIC STEM CELL DIVISION,0.024086,0.32162,0.33024,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0034935,0.32149,0.31143,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00029789,0.32104,0.34759,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0003797,0.32095,0.49168,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00018128,0.32077,0.36471,1,1
2,GO STORE OPERATED CALCIUM ENTRY,0.00332,0.32061,0.32753,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.3279e-05,0.32051,0.36316,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00064645,0.31986,0.41601,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0013481,0.31942,0.401,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.00064645,0.31917,0.33354,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0014241,0.31892,0.35763,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00010866,0.31887,0.34055,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.00068502,0.31866,0.34274,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.9985e-05,0.31857,0.38476,1,1
2,GO REGULATION OF CELL FATE COMMITMENT,0.00010866,0.31827,0.3617,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00068502,0.31689,0.33025,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00014989,0.31679,0.38208,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.31663,0.33998,1,1
2,GO CELLULAR RESPONSE TO VITAMIN,0.0024341,0.31608,0.33837,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00014989,0.316,0.37787,1,1
2,GO SEQUESTERING OF TRIGLYCERIDE,0.00081392,0.31578,0.32698,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00024771,0.31576,0.36367,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00086166,0.31544,0.33914,1,1
2,GO ARGININE METABOLIC PROCESS,0.00010866,0.31525,0.34023,1,1
2,GO INTERACTION WITH SYMBIONT,5.9985e-05,0.31469,0.32683,1,1
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00026348,0.31449,0.31691,1,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,9.5377e-05,0.31414,0.33382,1,1
2,GO TRABECULA MORPHOGENESIS,0.0012071,0.31406,0.34473,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00011593,0.31381,0.36099,1,1
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00051151,0.31339,0.39567,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021907,0.31338,0.28936,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0010209,0.31322,0.35109,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0024341,0.31286,0.34498,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0029965,0.3128,0.28917,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00023283,0.31246,0.30345,1,1
2,GO REGULATION OF VASOCONSTRICTION,0.00035748,0.31206,0.3916,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0017696,0.31203,0.31841,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0092139,0.31193,0.4005,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.7287e-05,0.31179,0.33396,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00091199,0.31177,0.39517,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00057531,0.31173,0.4341,1,1
2,GO REGULATION OF ODONTOGENESIS,0.0020776,0.31162,0.34837,1,1
2,GO REGULATION OF LIPID STORAGE,0.00033648,0.3109,0.34317,1,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0057394,0.31041,0.31537,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0010798,0.30988,0.2916,1,1
2,GO CARDIOBLAST DIFFERENTIATION,0.0020776,0.30966,0.32364,1,1
2,GO SULFATION,0.00096503,0.30958,0.36671,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00011593,0.30904,0.37781,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00048214,0.30902,0.30739,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00024771,0.30889,0.32214,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.4805e-05,0.30868,0.36396,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0031545,0.30823,0.38536,1,1
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.00023283,0.30812,0.39355,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.00014062,0.30803,0.3401,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0010209,0.30692,0.30453,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8298e-05,0.3063,0.32205,1,1
2,GO HEAT GENERATION,0.0018673,0.30588,0.30451,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.00023283,0.30585,0.27181,1,1
2,GO ICOSANOID METABOLIC PROCESS,4.2763e-05,0.30564,0.36407,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0031545,0.30531,0.27161,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0028457,0.30514,0.35418,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00021879,0.30479,0.31991,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,5.6086e-05,0.30462,0.349,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.00031664,0.30446,0.37277,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,3.9936e-05,0.304,0.32723,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00014989,0.30355,0.36522,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00021879,0.30352,0.36594,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00028019,0.30331,0.3599,1,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.0021907,0.30329,0.43209,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00060992,0.30317,0.38595,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0024341,0.30314,0.37008,1,1
2,GO OVULATION,0.00091199,0.30312,0.36289,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00057531,0.30307,0.30168,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00020554,0.30301,0.31956,1,1
2,GO CARTILAGE MORPHOGENESIS,0.0034935,0.3028,0.30362,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00014989,0.30261,0.30998,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00076864,0.30254,0.34091,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0080134,0.30235,0.24778,1,1
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00017019,0.30171,0.31497,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0031545,0.30089,0.29159,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00060992,0.30089,0.31131,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,8.3641e-05,0.30068,0.3286,1,1
2,GO COPPER ION TRANSPORT,0.00029789,0.30052,0.33064,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0010798,0.30041,0.35801,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0060238,0.30023,0.2823,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.00096503,0.30019,0.31916,1,1
2,GO RESPONSE TO SALT STRESS,0.0025648,0.30019,0.2675,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00086166,0.30009,0.34134,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00020554,0.29964,0.36121,1,1
2,GO ENDOCARDIAL CUSHION FORMATION,0.0021907,0.29926,0.35495,1,1
2,GO REGULATION OF ICOSANOID SECRETION,0.00017019,0.29891,0.33041,1,1
2,GO COAGULATION,0.00014989,0.29891,0.35483,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,9.5377e-05,0.2988,0.36619,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.014457,0.29876,0.28042,1,1
2,GO NECROTIC CELL DEATH,0.00020554,0.29862,0.31732,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00019306,0.29846,0.34421,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0003797,0.29845,0.38707,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0038653,0.29837,0.27268,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0023095,0.29825,0.30366,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0063209,0.2981,0.27531,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.00086166,0.29778,0.32882,1,1
2,GO LYSOSOME LOCALIZATION,0.00068502,0.29774,0.30712,1,1
2,GO PROTEIN NITROSYLATION,0.00040321,0.29767,0.32015,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00026348,0.29628,0.34723,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00091199,0.29615,0.35743,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00031664,0.29596,0.34075,1,1
2,GO PEPTIDE CATABOLIC PROCESS,0.00014989,0.29586,0.38089,1,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00010181,0.29563,0.35253,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.29551,0.36008,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00028019,0.29534,0.29586,1,1
2,GO RETINOL METABOLIC PROCESS,0.00042807,0.29531,0.3147,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0057394,0.29518,0.33345,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0016767,0.29446,0.29933,1,1
2,GO DECIDUALIZATION,0.0015041,0.29445,0.37915,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018128,0.29436,0.35164,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00096503,0.29425,0.32245,1,1
2,GO RESPONSE TO LIPID,9.5377e-05,0.29417,0.298,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00086166,0.29404,0.25234,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0034935,0.29398,0.38649,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0040644,0.29385,0.33809,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013481,0.29312,0.34263,1,1
2,GO GLIAL CELL PROLIFERATION,0.0010798,0.2931,0.32931,1,1
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00096503,0.29295,0.37375,1,1
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00014062,0.29291,0.39416,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00076864,0.29192,0.3146,1,1
2,GO REGULATION OF VASCULOGENESIS,0.0021907,0.29156,0.35124,1,1
2,GO POSITIVE REGULATION OF OSSIFICATION,0.00035748,0.29134,0.33602,1,1
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0063209,0.29129,0.28399,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00017019,0.29096,0.32042,1,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0010798,0.29081,0.35579,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00081392,0.29063,0.31622,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00014062,0.29062,0.35525,1,1
2,GO RESPONSE TO EPINEPHRINE,0.033245,0.29036,0.23642,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00035748,0.29023,0.3206,1,1
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.0052065,0.29015,0.36398,1,1
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00042807,0.29012,0.32934,1,1
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.013235,0.29011,0.31324,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.00040321,0.29002,0.34975,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0054671,0.28984,0.38407,1,1
2,GO PYROPTOSIS,0.0031545,0.2897,0.31789,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00091199,0.28955,0.30978,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.00048214,0.28932,0.30377,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.00023283,0.28929,0.27611,1,1
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0083971,0.28831,0.25994,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00013188,0.28821,0.36406,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0054671,0.2877,0.32545,1,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.0052065,0.28694,0.32514,1,1
2,GO GLIAL CELL MIGRATION,0.0060238,0.28685,0.2652,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00033648,0.28571,0.31588,1,1
2,GO REGULATION OF RECEPTOR BINDING,0.0028457,0.28569,0.31416,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.00026348,0.28568,0.36372,1,1
2,GO PROTEIN AUTOPROCESSING,0.00020554,0.28462,0.30108,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.00014062,0.28444,0.34584,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0024341,0.28365,0.29171,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.043559,0.28313,0.20622,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00054254,0.28231,0.37698,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00035748,0.28198,0.35681,1,1
2,GO AORTIC VALVE DEVELOPMENT,0.0083971,0.28185,0.35698,1,1
2,GO SALIVA SECRETION,0.0034935,0.28132,0.31468,1,1
2,GO POLYOL TRANSPORT,0.0038653,0.2807,0.33558,1,1
2,GO RESPONSE TO CORTICOSTEROID,9.5377e-05,0.2802,0.31683,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0021907,0.27986,0.2594,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.033245,0.27973,0.25854,1,1
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.00018128,0.27943,0.30054,1,1
2,GO EXOCYTOSIS,6.8565e-05,0.2791,0.30091,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.0080134,0.27908,0.30014,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00068502,0.27874,0.33743,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.00011593,0.27872,0.29209,1,1
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0040644,0.27865,0.30395,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00040321,0.27856,0.35321,1,1
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.02951,0.27824,0.2399,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0031545,0.27776,0.35238,1,1
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0024341,0.27763,0.31354,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00060992,0.27754,0.30493,1,1
2,GO BICARBONATE TRANSPORT,0.0076456,0.27739,0.22116,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00019306,0.27712,0.30503,1,1
2,GO BRONCHUS DEVELOPMENT,0.0027019,0.27643,0.39365,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00068502,0.27637,0.33604,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00064645,0.27607,0.28103,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.037377,0.27592,0.29372,1,1
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0003797,0.27522,0.30864,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00019306,0.27429,0.31628,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.00035748,0.27378,0.29669,1,1
2,GO RESPONSE TO PARATHYROID HORMONE,0.011063,0.27375,0.22294,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00033648,0.27342,0.31714,1,1
2,GO REGULATION OF FATTY ACID TRANSPORT,0.00024771,0.27325,0.32397,1,1
2,GO MYELOID CELL DEVELOPMENT,0.00096503,0.27253,0.32014,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0018673,0.27251,0.28995,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.0025648,0.2722,0.30254,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0011418,0.27148,0.27295,1,1
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0027019,0.27101,0.26614,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0076456,0.27098,0.24674,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.00332,0.27086,0.38433,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.00054254,0.27074,0.33303,1,1
2,GO PLASMA MEMBRANE FUSION,0.00028019,0.27073,0.36801,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.00091199,0.27061,0.28063,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00072571,0.27043,0.35037,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00024771,0.27018,0.30026,1,1
2,GO WOUND HEALING,0.00033648,0.27007,0.3378,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0016767,0.27003,0.32329,1,1
2,GO NEURON REMODELING,0.010101,0.26996,0.3001,1,1
2,GO REGULATION OF CELL SHAPE,0.00054254,0.26967,0.31421,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00068502,0.26945,0.34079,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.00013188,0.26929,0.31181,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0020776,0.2692,0.36181,1,1
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00096503,0.26914,0.33826,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.00019306,0.26882,0.32145,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00096503,0.26869,0.36004,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.054439,0.26823,0.21245,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0014241,0.26811,0.30873,1,1
2,GO MYOBLAST PROLIFERATION,0.0024341,0.26779,0.2748,1,1
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.00040321,0.26762,0.2979,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0031545,0.26719,0.29126,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00048214,0.26714,0.29665,1,1
2,GO RESPONSE TO ATP,0.0012071,0.2671,0.28905,1,1
2,GO MUSCLE CELL PROLIFERATION,0.00029789,0.26695,0.33183,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0016767,0.26692,0.35612,1,1
2,GO GLAND MORPHOGENESIS,0.0018673,0.26674,0.33097,1,1
2,GO RESPONSE TO RETINOIC ACID,0.00018128,0.26651,0.30909,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,7.8298e-05,0.26648,0.29232,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00040321,0.26623,0.29,1,1
2,GO CELL SUBSTRATE ADHESION,0.0018673,0.26538,0.34319,1,1
2,GO HEAD MORPHOGENESIS,0.011063,0.26535,0.25739,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00096503,0.26518,0.29686,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015104,0.26513,0.31332,1,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00017019,0.26511,0.28159,1,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0014241,0.2649,0.32257,1,1
2,GO DRUG METABOLIC PROCESS,0.00060992,0.26474,0.28994,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00057531,0.26472,0.26074,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0083971,0.26461,0.27328,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00081392,0.26454,0.27354,1,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0036751,0.26427,0.28504,1,1
2,GO INTERACTION WITH HOST,0.00015974,0.26406,0.28885,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.023112,0.26402,0.26038,1,1
2,GO TAXIS,0.00029789,0.26399,0.30388,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00051151,0.26379,0.29459,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0044907,0.26307,0.25007,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0023095,0.263,0.34832,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00020554,0.26298,0.28199,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00042807,0.26291,0.31629,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0063209,0.26259,0.27073,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,4.8997e-05,0.26245,0.31394,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0021907,0.26168,0.30626,1,1
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00072571,0.26113,0.33771,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0020776,0.26103,0.25146,1,1
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.00010866,0.26096,0.29071,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0010209,0.26084,0.3197,1,1
2,GO SALIVARY GLAND DEVELOPMENT,0.0029965,0.2608,0.34675,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00054254,0.26079,0.26858,1,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.043559,0.26018,0.22262,1,1
2,GO BONE MINERALIZATION,0.00020554,0.26017,0.32618,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00068502,0.25993,0.28073,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00024771,0.2594,0.3087,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.0031545,0.25934,0.26619,1,1
2,GO REGULATION OF PINOCYTOSIS,0.0049572,0.25922,0.28688,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00051151,0.2589,0.2876,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0011418,0.25881,0.26465,1,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.037377,0.25881,0.29324,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.00068502,0.25849,0.31865,1,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.013235,0.25848,0.21578,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00068502,0.2583,0.30211,1,1
2,GO RESPONSE TO INACTIVITY,0.017954,0.25829,0.22542,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.00072571,0.25823,0.3537,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.00051151,0.25796,0.30602,1,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0034935,0.25777,0.26703,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023095,0.2577,0.29143,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0025648,0.25766,0.25375,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0027019,0.25761,0.29238,1,1
2,GO RUFFLE ORGANIZATION,0.00014062,0.25725,0.33344,1,1
2,GO PROTEIN PROCESSING,2.8267e-05,0.25721,0.30839,1,1
2,GO RELAXATION OF CARDIAC MUSCLE,0.011574,0.2572,0.26703,1,1
2,GO EXPLORATION BEHAVIOR,0.0083971,0.25699,0.256,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00011593,0.25644,0.28959,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,2.2907e-05,0.25641,0.30508,1,1
2,GO SECRETION BY TISSUE,0.0016767,0.25615,0.24681,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0018673,0.25604,0.28144,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0036751,0.25594,0.25349,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,0.0017696,0.2558,0.25336,1,1
2,GO RESPONSE TO UV B,0.00051151,0.25547,0.29955,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0044907,0.25504,0.22818,1,1
2,GO TISSUE MIGRATION,0.0013481,0.25494,0.31878,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00028019,0.25486,0.29706,1,1
2,GO ENGULFMENT OF APOPTOTIC CELL,0.0040644,0.25474,0.29701,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014062,0.25462,0.30125,1,1
2,GO ZINC ION HOMEOSTASIS,0.022172,0.25356,0.21575,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00076864,0.25326,0.2984,1,1
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.050584,0.25303,0.19128,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0066311,0.25288,0.36191,1,1
2,GO ENDOTHELIAL CELL PROLIFERATION,0.00096503,0.25266,0.3107,1,1
2,GO RESPONSE TO CAMP,0.00040321,0.25264,0.30299,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00026348,0.25258,0.36318,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0057394,0.25253,0.32717,1,1
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0012071,0.25229,0.32611,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.0044907,0.2521,0.30902,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0083971,0.25196,0.26102,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00013188,0.25195,0.30489,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.0013481,0.25181,0.25232,1,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.01266,0.25139,0.27416,1,1
2,GO BIOMINERALIZATION,0.0010209,0.2511,0.28275,1,1
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.010572,0.25096,0.28172,1,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0017696,0.25065,0.25551,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.00057531,0.25054,0.35538,1,1
2,GO TRACHEA MORPHOGENESIS,0.0014241,0.25015,0.38855,1,1
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.010572,0.25008,0.2892,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00026348,0.25006,0.27327,1,1
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0034935,0.24999,0.31964,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.00086166,0.24974,0.2665,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.00081392,0.24933,0.25703,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.052482,0.24922,0.16407,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.015776,0.24881,0.25854,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.019548,0.24833,0.24876,1,1
2,GO LIPID STORAGE,0.00019306,0.2482,0.29538,1,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.0011418,0.24795,0.25552,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.013235,0.24717,0.26736,1,1
2,GO DORSAL AORTA DEVELOPMENT,0.037377,0.24706,0.24186,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00064645,0.24698,0.29726,1,1
2,GO STEROID HORMONE SECRETION,0.023112,0.24663,0.23528,1,1
2,GO RENAL FILTRATION,0.013834,0.24662,0.32933,1,1
2,GO CELLULAR ION HOMEOSTASIS,0.00015974,0.24651,0.25772,1,1
2,GO REPLACEMENT OSSIFICATION,0.013235,0.24622,0.2747,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0014241,0.2462,0.28318,1,1
2,GO SPROUTING ANGIOGENESIS,0.0052065,0.24564,0.30718,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00068502,0.24561,0.25389,1,1
2,GO CELL CELL ADHESION,0.00048214,0.24516,0.30149,1,1
2,GO HEART INDUCTION,0.021265,0.24513,0.28939,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.012106,0.24481,0.23978,1,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.038848,0.24475,0.24517,1,1
2,GO EMBRYO IMPLANTATION,0.00042807,0.24459,0.33294,1,1
2,GO RESPONSE TO WOUNDING,0.00042807,0.24442,0.31091,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00014062,0.24425,0.26477,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.0038653,0.2441,0.32514,1,1
2,GO RELAXATION OF MUSCLE,0.007293,0.24398,0.24004,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,3.4805e-05,0.24381,0.26217,1,1
2,GO HEART TRABECULA MORPHOGENESIS,0.0028457,0.24368,0.31155,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0063209,0.24331,0.28953,1,1
2,GO IRON ION HOMEOSTASIS,5.2428e-05,0.24318,0.30301,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0038653,0.24287,0.34344,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00060992,0.24268,0.31104,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.010101,0.24266,0.23421,1,1
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,9.5377e-05,0.24249,0.27409,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0018673,0.24221,0.2471,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,6.4139e-05,0.24184,0.26379,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0040644,0.2418,0.30177,1,1
2,GO RESPONSE TO FATTY ACID,0.00068502,0.24134,0.26933,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0010798,0.24109,0.25457,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0029965,0.24098,0.22127,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0049572,0.24029,0.26567,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0044907,0.24023,0.28022,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00014062,0.24001,0.28702,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00023283,0.23988,0.25126,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.011574,0.23985,0.22795,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0013481,0.23961,0.28144,1,1
2,GO MYOTUBE DIFFERENTIATION,0.0034935,0.23952,0.25484,1,1
2,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.0092139,0.23931,0.31257,1,1
2,GO STEROL TRANSPORT,0.0003797,0.23906,0.2894,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00031664,0.23882,0.30098,1,1
2,GO VASCULOGENESIS,0.0060238,0.23878,0.31187,1,1
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.048745,0.2386,0.35081,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00015974,0.23833,0.28564,1,1
2,GO METAL ION HOMEOSTASIS,0.00012367,0.23821,0.27779,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00051151,0.23813,0.26947,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0036751,0.23801,0.33724,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.01266,0.23791,0.24923,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0047188,0.23762,0.26325,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0044907,0.2375,0.26497,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0011418,0.23733,0.30885,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.00057531,0.23716,0.31563,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0025648,0.23712,0.26185,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0020776,0.2369,0.37376,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.011574,0.23586,0.23156,1,1
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0019699,0.23565,0.40366,1,1
2,GO REGULATION OF OSSIFICATION,0.00072571,0.23559,0.29444,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.00026348,0.23556,0.25054,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0016767,0.23502,0.25088,1,1
2,GO AMINOGLYCAN METABOLIC PROCESS,0.0023095,0.2349,0.28473,1,1
2,GO REGULATION OF ANION TRANSPORT,0.0020776,0.2343,0.2437,1,1
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0076456,0.23394,0.25362,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0047188,0.23388,0.33056,1,1
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0023095,0.23363,0.27804,1,1
2,GO TISSUE REGENERATION,0.0013481,0.23314,0.22944,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0018673,0.23277,0.33132,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.007293,0.23276,0.25904,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0024341,0.23223,0.27058,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.00035748,0.23196,0.28346,1,1
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00086166,0.23157,0.32801,1,1
2,GO INTERFERON BETA PRODUCTION,0.0019699,0.23135,0.31579,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0054671,0.23133,0.26189,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0024341,0.23129,0.32655,1,1
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00018128,0.23122,0.28552,1,1
2,GO DETOXIFICATION,3.7287e-05,0.23119,0.27014,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00042807,0.23112,0.30905,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0019699,0.23104,0.23705,1,1
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.00096503,0.23041,0.24389,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.033245,0.2304,0.22858,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00033648,0.2304,0.25936,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0003797,0.23035,0.26508,1,1
2,GO MITOCHONDRIAL DEPOLARIZATION,0.00031664,0.23005,0.29986,1,1
2,GO ANIMAL ORGAN REGENERATION,8.3641e-05,0.22968,0.26943,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013481,0.22863,0.22505,1,1
2,GO HEPARIN METABOLIC PROCESS,0.0083971,0.22819,0.2881,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.030713,0.22808,0.2078,1,1
2,GO ENDOCRINE PROCESS,0.00096503,0.22806,0.30215,1,1
2,GO ORGAN INDUCTION,0.0036751,0.22779,0.2464,1,1
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.010572,0.22777,0.25616,1,1
2,GO TRACHEA DEVELOPMENT,0.0036751,0.22682,0.32096,1,1
2,GO ION HOMEOSTASIS,0.00023283,0.2268,0.25094,1,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.010101,0.2266,0.24121,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00096503,0.22629,0.2524,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.0038653,0.22624,0.2525,1,1
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00031664,0.22615,0.28538,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,9.5377e-05,0.22601,0.25246,1,1
2,GO VASCULATURE DEVELOPMENT,0.0010209,0.22589,0.33217,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0013481,0.22584,0.25595,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00028019,0.22574,0.23737,1,1
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0036751,0.22553,0.28509,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.00031664,0.2253,0.27529,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.00031664,0.22478,0.27057,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0021907,0.22467,0.25226,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00072571,0.22447,0.29293,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.00054254,0.22446,0.27686,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0024341,0.2244,0.2299,1,1
2,GO BASEMENT MEMBRANE ORGANIZATION,0.0060238,0.22387,0.31775,1,1
2,GO REGULATION OF MAPK CASCADE,0.00040321,0.22379,0.27676,1,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.023112,0.2237,0.23357,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0011418,0.22355,0.246,1,1
2,GO RESPONSE TO ESTROGEN,0.00029789,0.22336,0.29706,1,1
2,GO RESPONSE TO KETONE,0.00054254,0.22333,0.24643,1,1
2,GO KERATINOCYTE MIGRATION,0.0063209,0.22301,0.26564,1,1
2,GO TERPENOID METABOLIC PROCESS,0.0021907,0.22285,0.21555,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0027019,0.22248,0.27262,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00057531,0.22202,0.27142,1,1
2,GO RESPONSE TO HYPEROXIA,0.00017019,0.22183,0.32553,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00081392,0.22156,0.25572,1,1
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0021907,0.22155,0.26034,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.011574,0.22114,0.24409,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0029965,0.22111,0.2104,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.0029965,0.22106,0.2724,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.010101,0.22102,0.24498,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0172,0.22089,0.21559,1,1
2,GO MESENCHYME MORPHOGENESIS,0.0027019,0.22089,0.31499,1,1
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.016475,0.22061,0.23156,1,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0092139,0.22057,0.29308,1,1
2,GO REGULATION OF TUBE SIZE,0.0015041,0.22044,0.27225,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.010572,0.22016,0.28484,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0042727,0.22,0.25152,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.0012758,0.21981,0.24121,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0013481,0.21981,0.28212,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0012758,0.2197,0.27981,1,1
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024086,0.21964,0.23094,1,1
2,GO CHONDROCYTE PROLIFERATION,0.041938,0.21914,0.24205,1,1
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0019699,0.21913,0.26524,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.00060992,0.21883,0.24386,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00060992,0.21859,0.24698,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0036751,0.21839,0.19271,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0040644,0.21837,0.26817,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0060238,0.21824,0.23178,1,1
2,GO FATTY ACID TRANSPORT,0.00020554,0.21727,0.26923,1,1
2,GO ESTROUS CYCLE,0.025096,0.21725,0.26396,1,1
2,GO ODONTOGENESIS,0.017954,0.21677,0.21828,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0019699,0.2159,0.27404,1,1
2,GO VIRAL GENOME REPLICATION,0.00068502,0.21557,0.28086,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.0066311,0.21512,0.22162,1,1
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.013834,0.21472,0.23757,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.015776,0.21466,0.22965,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.007293,0.21447,0.28898,1,1
2,GO SECRETION,0.00028019,0.21428,0.2516,1,1
2,GO DENDRITE SELF AVOIDANCE,0.040368,0.21397,0.20657,1,1
2,GO RESPONSE TO ALCOHOL,0.00060992,0.21379,0.23572,1,1
2,GO REGULATION OF EXCRETION,0.018736,0.2136,0.24001,1,1
2,GO MYELIN MAINTENANCE,0.0172,0.21344,0.25659,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00024771,0.21321,0.27279,1,1
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.046961,0.21291,0.27073,1,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.030713,0.21283,0.21966,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0034935,0.21277,0.30044,1,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.00057531,0.21266,0.25011,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.01266,0.21254,0.25736,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00021879,0.21237,0.25672,1,1
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0019699,0.21225,0.28129,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0012758,0.21206,0.30156,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00028019,0.21179,0.27375,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.02951,0.21177,0.20143,1,1
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0010798,0.21117,0.26359,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.013834,0.21116,0.25281,1,1
2,GO VASODILATION,0.00076864,0.21094,0.26398,1,1
2,GO FIBROBLAST PROLIFERATION,0.0016767,0.21065,0.25136,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0076456,0.21055,0.2483,1,1
2,GO WATER HOMEOSTASIS,0.010572,0.21051,0.22456,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00024771,0.21042,0.24604,1,1
2,GO REGULATION OF MYELINATION,0.011574,0.21038,0.22742,1,1
2,GO VIRAL LIFE CYCLE,0.00028019,0.21019,0.26948,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00011593,0.21012,0.25935,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.0012071,0.21003,0.2379,1,1
2,GO REGULATION OF GASTRULATION,0.0027019,0.20992,0.27625,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00064645,0.20991,0.20901,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0040644,0.20971,0.24822,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00057531,0.20926,0.25828,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0040644,0.20916,0.26646,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0010209,0.20898,0.24683,1,1
2,GO GENITALIA MORPHOGENESIS,0.025096,0.20898,0.26033,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.015104,0.20895,0.21155,1,1
2,GO ENDOTHELIUM DEVELOPMENT,0.0060238,0.20881,0.29579,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00086166,0.2087,0.28477,1,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.0066311,0.20842,0.26943,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.0021907,0.20819,0.20188,1,1
2,GO INACTIVATION OF MAPK ACTIVITY,0.0027019,0.20787,0.26355,1,1
2,GO BIOLOGICAL ADHESION,0.0012071,0.20768,0.29605,1,1
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.0028457,0.20763,0.30202,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042807,0.20753,0.23184,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0052065,0.20711,0.25338,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0024341,0.20703,0.24084,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.00076864,0.20697,0.20845,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.007293,0.20679,0.28978,1,1
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0040644,0.20634,0.24472,1,1
2,GO HEART VALVE DEVELOPMENT,0.01266,0.20631,0.29142,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00068502,0.20623,0.29277,1,1
2,GO REGULATION OF TRANSPOSITION,0.01266,0.20539,0.19895,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.00015974,0.20496,0.24514,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00014062,0.2048,0.25646,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0083971,0.20428,0.22892,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.019548,0.20425,0.24478,1,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0038653,0.20422,0.23901,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00051151,0.20415,0.25888,1,1
2,GO MANGANESE ION TRANSPORT,0.0042727,0.2041,0.27104,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0027019,0.20407,0.29685,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00051151,0.20353,0.2391,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.014457,0.20307,0.27101,1,1
2,GO LIPID CATABOLIC PROCESS,0.0003797,0.20297,0.22443,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00072571,0.20292,0.25764,1,1
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0044907,0.20291,0.25838,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0042727,0.20279,0.27643,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00010866,0.20267,0.24561,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0044907,0.20257,0.2251,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0044907,0.20236,0.28228,1,1
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0049572,0.20153,0.22259,1,1
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.013235,0.20139,0.20727,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,1.8524e-05,0.20138,0.24402,1,1
2,GO LIPID HOMEOSTASIS,0.0012758,0.20116,0.24253,1,1
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0021907,0.20115,0.21557,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0023095,0.20085,0.24423,1,1
2,GO COPPER ION HOMEOSTASIS,0.0012758,0.20074,0.21747,1,1
2,GO TUBE MORPHOGENESIS,0.00332,0.20048,0.2737,1,1
2,GO EPITHELIAL CELL PROLIFERATION,0.00072571,0.20004,0.26918,1,1
2,GO BONE MATURATION,0.0172,0.19917,0.25323,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0063209,0.19902,0.24776,1,1
2,GO TISSUE HOMEOSTASIS,0.00045436,0.19885,0.26605,1,1
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0063209,0.19881,0.24638,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0015882,0.19806,0.21597,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00015974,0.19796,0.23544,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.00332,0.19786,0.23341,1,1
2,GO OSSIFICATION,0.0024341,0.1978,0.2434,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00072571,0.19768,0.27256,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00096503,0.19757,0.23392,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0044907,0.19754,0.22061,1,1
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.00048214,0.19705,0.22647,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0024341,0.19698,0.22112,1,1
2,GO PROTEIN MATURATION,0.00011593,0.19655,0.23557,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00051151,0.19609,0.22517,1,1
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0080134,0.19605,0.27775,1,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.0015041,0.19597,0.24128,1,1
2,GO CELL MOTILITY,0.00068502,0.19567,0.26325,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.010101,0.19556,0.25463,1,1
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0052065,0.19553,0.22507,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.010101,0.1955,0.23711,1,1
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0029965,0.19549,0.23798,1,1
2,GO PROTEIN DEMANNOSYLATION,0.025096,0.19538,0.23569,1,1
2,GO RENAL SYSTEM PROCESS,0.0036751,0.19528,0.25937,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011574,0.19522,0.26364,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.0042727,0.19445,0.22752,1,1
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00051151,0.1942,0.29975,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00029789,0.19383,0.2492,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0016767,0.19375,0.24769,1,1
2,GO HYPOTONIC RESPONSE,0.022172,0.19367,0.21289,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.015104,0.19344,0.24378,1,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00024771,0.19332,0.25213,1,1
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00054254,0.19329,0.22618,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0027019,0.19291,0.24092,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.019548,0.19283,0.16244,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0172,0.19263,0.19493,1,1
2,GO REGULATION OF ENDOCRINE PROCESS,0.013834,0.19252,0.22633,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,8.9327e-05,0.19237,0.22947,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.026142,0.19232,0.26333,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00081392,0.19215,0.23821,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00054254,0.192,0.26761,1,1
2,GO DIGESTION,0.015776,0.19194,0.18198,1,1
2,GO SIALYLATION,0.040368,0.19194,0.23383,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.00072571,0.19138,0.22954,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00091199,0.19094,0.22859,1,1
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.010101,0.19046,0.24626,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.011063,0.19032,0.24668,1,1
2,GO HEART FORMATION,0.0083971,0.18983,0.2188,1,1
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.018736,0.18972,0.24343,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00057531,0.1897,0.22371,1,1
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0052065,0.18961,0.23011,1,1
2,GO PROTEIN KINASE A SIGNALING,0.028348,0.18959,0.16992,1,1
2,GO RIG I SIGNALING PATHWAY,0.010572,0.18948,0.20086,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00017019,0.18935,0.23343,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.018736,0.18862,0.20676,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0096484,0.18832,0.21527,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0021907,0.18821,0.25717,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00068502,0.18821,0.23849,1,1
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0040644,0.18789,0.17649,1,1
2,GO RENAL WATER HOMEOSTASIS,0.010101,0.18767,0.267,1,1
2,GO REGULATION OF PROTEOLYSIS,0.00031664,0.1872,0.22824,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0015882,0.18719,0.22503,1,1
2,GO ERBB SIGNALING PATHWAY,0.011063,0.18698,0.2123,1,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.008797,0.18639,0.23418,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0031545,0.18635,0.1762,1,1
2,GO REGULATION OF PEPTIDE SECRETION,0.00072571,0.18614,0.23444,1,1
2,GO POSITIVE REGULATION OF SECRETION,0.00064645,0.18587,0.22439,1,1
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0040644,0.18584,0.25037,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0052065,0.18554,0.17437,1,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0010798,0.18547,0.23904,1,1
2,GO TRANSPOSITION,0.020391,0.18543,0.19315,1,1
2,GO VITAMIN TRANSPORT,0.00091199,0.18536,0.22791,1,1
2,GO MAINTENANCE OF LOCATION,0.00060992,0.18529,0.2371,1,1
2,GO BILE ACID METABOLIC PROCESS,0.0031545,0.18506,0.19446,1,1
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0054671,0.18434,0.25183,1,1
2,GO PHAGOSOME MATURATION,0.0052065,0.1842,0.20654,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.0014241,0.18419,0.22178,1,1
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0040644,0.18415,0.21093,1,1
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.015104,0.18373,0.25909,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.00332,0.1837,0.21019,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.034576,0.18364,0.17592,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.018736,0.1836,0.19633,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0044907,0.18324,0.23741,1,1
2,GO ENDOCYTOSIS,0.0012071,0.18258,0.25519,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.020391,0.18256,0.17114,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0021907,0.18256,0.22646,1,1
2,GO OSTEOBLAST DIFFERENTIATION,0.0038653,0.18252,0.23131,1,1
2,GO SLEEP,0.006955,0.18247,0.19476,1,1
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0040644,0.18239,0.23064,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.0015041,0.18186,0.24634,1,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0017696,0.18179,0.19464,1,1
2,GO CELL VOLUME HOMEOSTASIS,0.011063,0.18147,0.24407,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.00060992,0.18088,0.23513,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.014457,0.18008,0.20156,1,1
2,GO CELL RECOGNITION,0.0024341,0.18006,0.21806,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.006955,0.18004,0.23454,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0066311,0.17956,0.24305,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0027019,0.1792,0.22986,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0052065,0.17913,0.23416,1,1
2,GO CHEMICAL HOMEOSTASIS,0.00051151,0.1788,0.22576,1,1
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.008797,0.17858,0.24006,1,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.0036751,0.17852,0.19795,1,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.040368,0.17821,0.16304,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00332,0.1782,0.22283,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0036751,0.17814,0.20918,1,1
2,GO CIRCULATORY SYSTEM PROCESS,0.0063209,0.1779,0.21106,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0018673,0.17783,0.21542,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.00091199,0.17752,0.20799,1,1
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011063,0.17749,0.2003,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0017696,0.17719,0.21504,1,1
2,GO RESPONSE TO STEROID HORMONE,0.0031545,0.17703,0.21412,1,1
2,GO AMYLOID BETA FORMATION,0.0060238,0.17699,0.23371,1,1
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00096503,0.17698,0.22057,1,1
2,GO REGULATION OF HEAT GENERATION,0.020391,0.17625,0.24127,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0172,0.17596,0.24586,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0060238,0.17582,0.21059,1,1
2,GO NEPHRON TUBULE FORMATION,0.019548,0.17553,0.20924,1,1
2,GO AMELOGENESIS,0.035953,0.17551,0.1881,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.0092139,0.17541,0.15312,1,1
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0040644,0.17517,0.30584,1,1
2,GO RESPONSE TO PH,0.014457,0.17489,0.21211,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.00057531,0.17456,0.21377,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00057531,0.174,0.25664,1,1
2,GO BONE DEVELOPMENT,0.0092139,0.17326,0.25153,1,1
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0018673,0.17313,0.24267,1,1
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.020391,0.17293,0.16661,1,1
2,GO FAT CELL DIFFERENTIATION,0.0047188,0.17214,0.23275,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0034935,0.17208,0.17855,1,1
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0015882,0.17189,0.20686,1,1
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.050584,0.17187,0.2067,1,1
2,GO TUBE DEVELOPMENT,0.0060238,0.1718,0.24019,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.035953,0.17108,0.21811,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.0012071,0.17094,0.22345,1,1
2,GO BONE MORPHOGENESIS,0.0172,0.17051,0.24136,1,1
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.025096,0.17019,0.18918,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00048214,0.17006,0.23687,1,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0092139,0.16991,0.16194,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00072571,0.1698,0.21726,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.020391,0.16909,0.24255,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.0012758,0.16903,0.20859,1,1
2,GO POSITIVE REGULATION OF SIGNALING,0.0013481,0.169,0.21532,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0092139,0.16868,0.23192,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.006955,0.16839,0.21013,1,1
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.0063209,0.16823,0.29707,1,1
2,GO RESPONSE TO COPPER ION,0.038848,0.16798,0.17482,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.0036751,0.16781,0.18305,1,1
2,GO LIVER REGENERATION,0.0012071,0.1676,0.22232,1,1
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0010798,0.16712,0.21404,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0038653,0.16711,0.21545,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0066311,0.1671,0.20421,1,1
2,GO ANIMAL ORGAN MATURATION,0.0172,0.16668,0.24611,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.045233,0.16665,0.22091,1,1
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.013834,0.16661,0.18991,1,1
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0066311,0.16654,0.30508,1,1
2,GO RUFFLE ASSEMBLY,0.00076864,0.16653,0.24396,1,1
2,GO FORMATION OF PRIMARY GERM LAYER,0.0038653,0.16613,0.27968,1,1
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.018736,0.16549,0.16685,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0083971,0.16537,0.22363,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0080134,0.16531,0.23232,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00332,0.16522,0.20814,1,1
2,GO JNK CASCADE,0.0054671,0.16384,0.2265,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0057394,0.16356,0.1891,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.022172,0.16351,0.19741,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0060238,0.16347,0.22261,1,1
2,GO ENDOCRINE HORMONE SECRETION,0.012106,0.16321,0.21921,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.020391,0.16316,0.21246,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0036751,0.16314,0.2318,1,1
2,GO PHAGOSOME ACIDIFICATION,0.024086,0.16293,0.13898,1,1
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.010101,0.16268,0.2034,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.0021907,0.16264,0.2029,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0027019,0.16259,0.21608,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0029965,0.16199,0.18365,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.00076864,0.16188,0.22417,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.020391,0.16173,0.2015,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00020554,0.16147,0.24296,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0052065,0.16144,0.19624,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0063209,0.1613,0.18514,1,1
2,GO REGULATION OF ORGAN GROWTH,0.011063,0.16126,0.19298,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0036751,0.16109,0.20626,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.030713,0.15995,0.16503,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.0015882,0.15983,0.20766,1,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0080134,0.15928,0.20488,1,1
2,GO REGULATION OF MUSCLE CONTRACTION,0.014457,0.15924,0.17877,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.0012071,0.15855,0.23109,1,1
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.010572,0.1585,0.1906,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.0057394,0.1582,0.22034,1,1
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.018736,0.15799,0.23795,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.025096,0.15795,0.18198,1,1
2,GO PEPTIDE SECRETION,0.0027019,0.15792,0.21136,1,1
2,GO RESPONSE TO ESTRADIOL,0.0023095,0.15764,0.21479,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.01266,0.1575,0.1747,1,1
2,GO CALCIUM ION IMPORT,0.038848,0.15747,0.14941,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.035953,0.15694,0.15392,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0036751,0.1568,0.20861,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.007293,0.15646,0.17739,1,1
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.023112,0.15645,0.18293,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.040368,0.15642,0.15359,1,1
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0044907,0.15602,0.2144,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0054671,0.15563,0.20214,1,1
2,GO MUSCLE FILAMENT SLIDING,0.015104,0.15561,0.16145,1,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0054671,0.15551,0.20515,1,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.030713,0.15505,0.1468,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0040644,0.15427,0.18954,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.024086,0.15407,0.1828,1,1
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0054671,0.15406,0.19999,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0025648,0.15371,0.20576,1,1
2,GO RESPONSE TO CALCIUM ION,0.010101,0.15352,0.17439,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.013235,0.15305,0.20092,1,1
2,GO HORMONE METABOLIC PROCESS,0.0024341,0.15264,0.20653,1,1
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0066311,0.15249,0.2035,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.024086,0.15247,0.18828,1,1
2,GO RESPONSE TO CADMIUM ION,0.018736,0.15226,0.16963,1,1
2,GO LUNG EPITHELIUM DEVELOPMENT,0.025096,0.15198,0.2095,1,1
2,GO ORGANIC CATION TRANSPORT,0.043559,0.15155,0.17781,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0018673,0.15131,0.21417,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015041,0.15106,0.15087,1,1
2,GO PLACENTA DEVELOPMENT,0.0096484,0.15013,0.1996,1,1
2,GO ETHER METABOLIC PROCESS,0.008797,0.15007,0.17366,1,1
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.011574,0.14965,0.15331,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0027019,0.14935,0.19407,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.026142,0.14929,0.1578,1,1
2,GO REGULATION OF CELL DEATH,0.0012071,0.14922,0.20227,1,1
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0027019,0.14774,0.18168,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00096503,0.14744,0.22232,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0016767,0.1472,0.21154,1,1
2,GO HEME METABOLIC PROCESS,0.0040644,0.14683,0.16095,1,1
2,GO REGULATION OF HEART MORPHOGENESIS,0.046961,0.14612,0.19331,1,1
2,GO OVULATION CYCLE,0.034576,0.14611,0.19481,1,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0025648,0.14607,0.19445,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0042727,0.14603,0.18981,1,1
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.018736,0.14492,0.17324,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0003797,0.14473,0.19858,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0013481,0.14465,0.1978,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.007293,0.14404,0.18233,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0028457,0.14363,0.18947,1,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.038848,0.14326,0.16985,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0049572,0.14318,0.19576,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.015104,0.14288,0.18436,1,1
2,GO RESPONSE TO ZINC ION,0.019548,0.14262,0.17808,1,1
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.006955,0.14215,0.18386,1,1
2,GO IRON ION TRANSPORT,0.0011418,0.14152,0.20547,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.019548,0.14151,0.13101,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0054671,0.14149,0.17694,1,1
2,GO REGULATION OF SENSORY PERCEPTION,0.038848,0.14133,0.15807,1,1
2,GO REGULATION OF HEART GROWTH,0.01266,0.14125,0.18732,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.0020776,0.14098,0.17925,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0080134,0.14091,0.19627,1,1
2,GO BODY FLUID SECRETION,0.013235,0.14088,0.17153,1,1
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.007293,0.14085,0.18242,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0024341,0.1406,0.2057,1,1
2,GO RESPONSE TO HORMONE,0.0042727,0.14028,0.19063,1,1
2,GO REGENERATION,0.0021907,0.14019,0.20708,1,1
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.035953,0.14014,0.14546,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017954,0.13946,0.16413,1,1
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0080134,0.1394,0.17614,1,1
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.026142,0.13927,0.16622,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.030713,0.13856,0.14125,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0080134,0.13838,0.17621,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010572,0.13826,0.16845,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0040644,0.13824,0.18832,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.016475,0.13817,0.26864,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.031957,0.13796,0.15855,1,1
2,GO CARBOHYDRATE TRANSPORT,0.0172,0.13672,0.16614,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.0036751,0.136,0.17352,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.022172,0.13562,0.25473,1,1
2,GO GASTRULATION,0.015776,0.1355,0.21485,1,1
2,GO TEMPERATURE HOMEOSTASIS,0.013235,0.1338,0.17349,1,1
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0044907,0.13281,0.17836,1,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.02951,0.13267,0.15047,1,1
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.027226,0.13163,0.14098,1,1
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.014457,0.13115,0.20231,1,1
2,GO REGULATION OF PROTEIN BINDING,0.023112,0.13108,0.17613,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0011418,0.131,0.1853,1,1
2,GO MUSCLE SYSTEM PROCESS,0.02951,0.13054,0.16694,1,1
2,GO ACTIN MEDIATED CELL CONTRACTION,0.048745,0.1303,0.15125,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.052482,0.13023,0.15939,1,1
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.015776,0.13011,0.17649,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.008797,0.12971,0.20316,1,1
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0042727,0.12951,0.18908,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0023095,0.12932,0.19143,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015104,0.12913,0.17067,1,1
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.008797,0.12902,0.19233,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0049572,0.12891,0.20656,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0063209,0.12859,0.16426,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0021907,0.12829,0.17683,1,1
2,GO MUSCLE CONTRACTION,0.052482,0.12827,0.15495,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0038653,0.12808,0.19979,1,1
2,GO CELLULAR HOMEOSTASIS,0.00091199,0.1277,0.20095,1,1
2,GO ANATOMICAL STRUCTURE MATURATION,0.037377,0.12567,0.15397,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00048214,0.12504,0.18533,1,1
2,GO REGULATION OF PHOSPHORYLATION,0.0060238,0.12464,0.18601,1,1
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0044907,0.12457,0.20168,1,1
2,GO NEGATIVE REGULATION OF SIGNALING,0.011574,0.12439,0.17009,1,1
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.024086,0.12388,0.13869,1,1
2,GO SYMBIOTIC PROCESS,0.0023095,0.12376,0.15886,1,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.023112,0.12314,0.2144,1,1
2,GO RESPONSE TO ETHANOL,0.0015041,0.12262,0.1874,1,1
2,GO HOMEOSTATIC PROCESS,0.0034935,0.12261,0.18668,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.013235,0.12237,0.1576,1,1
2,GO RESPONSE TO PEPTIDE,0.0083971,0.12209,0.17744,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0076456,0.12047,0.17734,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.025096,0.12044,0.1929,1,1
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0083971,0.11978,0.17768,1,1
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.021265,0.11977,0.15769,1,1
2,GO REGULATION OF ION TRANSPORT,0.033245,0.11771,0.1418,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0019699,0.11679,0.1592,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION,0.023112,0.11622,0.17274,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.011574,0.11622,0.17508,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.041938,0.11562,0.10415,1,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.030713,0.11499,0.16129,1,1
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.025096,0.11489,0.16249,1,1
2,GO SMOOTH MUSCLE CONTRACTION,0.02951,0.11379,0.19341,1,1
2,GO AMINE METABOLIC PROCESS,0.0066311,0.11351,0.14104,1,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.046961,0.11319,0.13805,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.034576,0.11157,0.1643,1,1
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.011574,0.11156,0.15559,1,1
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.031957,0.11065,0.13104,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.040368,0.10984,0.12676,1,1
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0172,0.10978,0.15687,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.10944,0.15865,1,1
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.013235,0.10926,0.17471,1,1
2,GO NEURON DEATH,0.054439,0.10918,0.14282,1,1
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0025648,0.10876,0.17909,1,1
2,GO REGULATION OF PEPTIDE TRANSPORT,0.01266,0.10859,0.16764,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.034576,0.10719,0.14705,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0044907,0.1071,0.15566,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.016475,0.10679,0.14092,1,1
2,GO RNA DECAPPING,0.050584,0.10665,0.16739,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.028348,0.10622,0.16239,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0023095,0.10528,0.18138,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0076456,0.1052,0.18373,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0028457,0.10511,0.15614,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.038848,0.10509,0.15491,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0063209,0.10473,0.18968,1,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.031957,0.10201,0.13599,1,1
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.021265,0.10184,0.16397,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.006955,0.10161,0.15228,1,1
2,GO CARDIOCYTE DIFFERENTIATION,0.027226,0.098261,0.17357,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.0080134,0.097133,0.18331,1,1
2,GO KETONE BIOSYNTHETIC PROCESS,0.020391,0.095709,0.15324,1,1
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033245,0.093158,0.17147,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.040368,0.093072,0.12945,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.043559,0.092476,0.095079,1,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.033245,0.090535,0.15332,1,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025096,0.090239,0.16973,1,1
2,GO PROTEIN DESTABILIZATION,0.019548,0.080523,0.16204,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.026142,0.078228,0.11872,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.054439,0.076876,0.12698,1,1
2,GO REGULATION OF ERAD PATHWAY,0.040368,0.067204,0.15846,1,1
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.0049572,0.91171,0.76767,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0038653,0.8531,0.70413,1,1
3,GO CHRONIC INFLAMMATORY RESPONSE,0.0012758,0.84183,0.69167,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00072571,0.83746,0.6421,1,1
3,GO TOLERANCE INDUCTION,0.010101,0.83538,0.62472,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0013481,0.82604,0.75201,1,1
3,GO T CELL TOLERANCE INDUCTION,0.0063209,0.82403,0.68378,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.01266,0.81714,0.63473,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0020776,0.80923,0.62339,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0014241,0.80661,0.65096,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00076864,0.79379,0.66391,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.007293,0.79013,0.61347,1,1
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.013834,0.78283,0.54315,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0042727,0.76613,0.66245,1,1
3,GO T CELL CHEMOTAXIS,0.0015041,0.75891,0.61403,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0044907,0.75436,0.6027,1,1
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00054254,0.7346,0.75376,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0054671,0.73062,0.61186,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0014241,0.71583,0.57861,1,1
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0016767,0.71034,0.57287,1,1
3,GO SYNAPSE PRUNING,0.00332,0.70452,0.72554,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,0.0044907,0.70193,0.54838,1,1
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00057531,0.69942,0.74723,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00076864,0.69913,0.6145,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.9936e-05,0.68555,0.68228,1,1
3,GO T HELPER 2 CELL DIFFERENTIATION,0.00040321,0.68407,0.64795,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0047188,0.68405,0.60179,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0023095,0.67967,0.58767,1,1
3,GO T HELPER 1 CELL DIFFERENTIATION,0.00029789,0.67112,0.68545,1,1
3,GO RESPONSE TO CHEMOKINE,0.0027019,0.66759,0.48821,1,1
3,GO REGULATION OF T CELL CHEMOTAXIS,0.00096503,0.66378,0.57337,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0023095,0.66077,0.58885,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00081392,0.65966,0.58581,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0040644,0.65835,0.53103,1,1
3,GO ETHANOL OXIDATION,2.636e-05,0.65455,0.78647,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0014241,0.64854,0.57765,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.008797,0.64668,0.50727,1,1
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00081392,0.64549,0.62149,1,1
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.012106,0.64509,0.54952,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0023095,0.63869,0.50346,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.0019699,0.63787,0.50208,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,0.63767,0.59136,1,1
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00015974,0.63464,0.63676,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.015104,0.62676,0.57821,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0047188,0.62621,0.5731,1,1
3,GO DENDRITIC CELL MIGRATION,0.010572,0.62367,0.52591,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0028457,0.62173,0.5828,1,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00068502,0.61936,0.61378,1,1
3,GO RESPONSE TO PROTOZOAN,0.0028457,0.61758,0.54639,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0025648,0.61161,0.44773,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.010101,0.61138,0.48969,1,1
3,GO INTERLEUKIN 2 PRODUCTION,0.00081392,0.60862,0.54465,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0054671,0.60422,0.48672,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015882,0.60414,0.48617,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0015041,0.6014,0.52546,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.011574,0.59977,0.52761,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0047188,0.59885,0.48978,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.013834,0.59827,0.46308,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0029965,0.59551,0.46625,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.01266,0.59516,0.47194,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0054671,0.59507,0.47006,1,1
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0011418,0.58969,0.6452,1,1
3,GO RESPONSE TO TYPE I INTERFERON,0.0052065,0.58807,0.42928,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,0.0019699,0.58727,0.54889,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.00060992,0.58687,0.5718,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0015041,0.5861,0.52696,1,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.01266,0.58447,0.53679,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0083971,0.58381,0.43272,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010209,0.5838,0.5074,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0016767,0.58084,0.56662,1,1
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0096484,0.57999,0.47267,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0054671,0.57972,0.4435,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00023283,0.57956,0.51713,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0044907,0.57931,0.52757,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.0080134,0.57905,0.45382,1,1
3,GO NEGATIVE T CELL SELECTION,0.007293,0.57864,0.58396,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0025648,0.57773,0.58246,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0020776,0.57615,0.47657,1,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0012071,0.5757,0.53936,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0015882,0.57561,0.54046,1,1
3,GO CELLULAR DEFENSE RESPONSE,0.010101,0.57358,0.46927,1,1
3,GO INTERLEUKIN 10 PRODUCTION,0.0038653,0.57071,0.51159,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,0.57026,0.48787,1,1
3,GO POSITIVE T CELL SELECTION,0.022172,0.56977,0.42402,1,1
3,GO ETHANOL METABOLIC PROCESS,7.3279e-05,0.56957,0.57141,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00332,0.56879,0.497,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0018673,0.56843,0.5032,1,1
3,GO T CELL EXTRAVASATION,0.0040644,0.56487,0.45928,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00010866,0.56475,0.52253,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0029965,0.56333,0.46222,1,1
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0015882,0.56319,0.52445,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0011418,0.56296,0.53909,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.016475,0.56142,0.465,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.008797,0.56036,0.50301,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0049572,0.55994,0.43925,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0014241,0.55871,0.4986,1,1
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00029789,0.55665,0.52537,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.010572,0.55448,0.47823,1,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.3279e-05,0.55447,0.58013,1,1
3,GO NEUTROPHIL MIGRATION,0.0054671,0.5539,0.43985,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.0049572,0.55359,0.46704,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.011574,0.55339,0.44795,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0012071,0.55302,0.51917,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.008797,0.55274,0.58397,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0018673,0.55205,0.50575,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0015882,0.55024,0.51833,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.0020776,0.55023,0.569,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00068502,0.54907,0.49584,1,1
3,GO NEUTROPHIL EXTRAVASATION,0.0016767,0.54806,0.47606,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,6.2007e-06,0.54677,0.58132,1,1
3,GO CHEMOKINE SECRETION,0.0049572,0.54596,0.45903,1,1
3,GO HEMIDESMOSOME ASSEMBLY,0.035953,0.5459,0.37685,1,1
3,GO REGULATION OF CELL KILLING,0.0049572,0.54316,0.44638,1,1
3,GO INTERLEUKIN 8 PRODUCTION,0.00060992,0.54248,0.47236,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,0.54177,0.44002,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0034935,0.53831,0.4711,1,1
3,GO COMPLEMENT ACTIVATION,0.006955,0.53681,0.45917,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.016475,0.53674,0.4155,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0023095,0.53533,0.4781,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00051151,0.53179,0.47508,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00021879,0.53102,0.47846,1,1
3,GO OPSONIZATION,0.019548,0.53056,0.35673,1,1
3,GO THYMIC T CELL SELECTION,0.030713,0.53012,0.38884,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.015104,0.52963,0.46449,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00332,0.52824,0.40589,1,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0025648,0.52515,0.48793,1,1
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00024771,0.52499,0.5708,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.021265,0.52437,0.40977,1,1
3,GO T CELL MEDIATED IMMUNITY,0.0029965,0.52432,0.44528,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.01266,0.52421,0.44546,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0076456,0.52308,0.45577,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0018673,0.52242,0.46368,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.0023095,0.52093,0.52739,1,1
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0010209,0.52088,0.47072,1,1
3,GO RESPONSE TO INTERFERON BETA,0.0014241,0.52026,0.47554,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0052065,0.51884,0.43545,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0066311,0.51875,0.41557,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0063209,0.51841,0.48034,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.0063209,0.51579,0.45167,1,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0036751,0.51521,0.41717,1,1
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.013235,0.515,0.41159,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0018673,0.51476,0.48366,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00019306,0.51234,0.53336,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0015882,0.51151,0.51969,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00040321,0.51015,0.45705,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0054671,0.50982,0.44463,1,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.01266,0.50945,0.40986,1,1
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.0015882,0.50913,0.51546,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0023095,0.50912,0.51115,1,1
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00091199,0.5089,0.48919,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.017954,0.50867,0.40984,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0031545,0.50765,0.45254,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.0025648,0.50536,0.47038,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00023283,0.50469,0.53245,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.008797,0.50231,0.34818,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0034935,0.50211,0.40252,1,1
3,GO T CELL APOPTOTIC PROCESS,0.00096503,0.50206,0.43645,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.008797,0.50178,0.44295,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0019699,0.50132,0.46923,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0027019,0.50014,0.44673,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.0063209,0.49895,0.43457,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00068502,0.49876,0.45997,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,0.49726,0.41977,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0018673,0.49687,0.47772,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0092139,0.49676,0.40681,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0027019,0.49503,0.44943,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.49498,0.44094,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0036751,0.49302,0.4311,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0044907,0.49289,0.47278,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0027019,0.49223,0.41896,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0047188,0.49079,0.46469,1,1
3,GO CYTOKINE METABOLIC PROCESS,0.0025648,0.49043,0.4087,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0015041,0.49026,0.45852,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0096484,0.48904,0.41271,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0029965,0.48862,0.43392,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0092139,0.4885,0.46611,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.022172,0.48571,0.4104,1,1
3,GO NAD BIOSYNTHETIC PROCESS,0.0010209,0.48485,0.38438,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,3.9936e-05,0.48473,0.46627,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0063209,0.48371,0.36806,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0066311,0.48355,0.40275,1,1
3,GO CELL AGGREGATION,0.0025648,0.48271,0.3565,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00045436,0.48196,0.49001,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0096484,0.48087,0.37927,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.015104,0.48032,0.3816,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0021907,0.47714,0.47226,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0049572,0.47693,0.4341,1,1
3,GO T CELL SELECTION,0.021265,0.47654,0.39333,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0063209,0.47545,0.42685,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0083971,0.4751,0.37051,1,1
3,GO B CELL PROLIFERATION,0.0096484,0.4749,0.41659,1,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.0057394,0.4747,0.3999,1,1
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.013834,0.47462,0.39831,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0028457,0.47453,0.4794,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0080134,0.47441,0.39224,1,1
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.023112,0.47413,0.43174,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0060238,0.47364,0.3978,1,1
3,GO MITRAL VALVE DEVELOPMENT,0.0014241,0.47337,0.42387,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0049572,0.46989,0.4402,1,1
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00014989,0.4688,0.53988,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0040644,0.46841,0.40237,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0096484,0.46777,0.40271,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0083971,0.46725,0.41052,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0063209,0.46598,0.40779,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029965,0.46555,0.42625,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.01266,0.4653,0.3978,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.01266,0.46329,0.39843,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0036751,0.45969,0.47538,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.020391,0.45912,0.39606,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.0092139,0.45831,0.4194,1,1
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0066311,0.45825,0.40945,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0042727,0.45758,0.40071,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0013481,0.45597,0.39257,1,1
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.015104,0.45584,0.39237,1,1
3,GO MACROPHAGE ACTIVATION,0.0066311,0.45579,0.41125,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00051151,0.45575,0.46505,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.0038653,0.45514,0.4167,1,1
3,GO MACROPHAGE MIGRATION,0.0021907,0.45192,0.42474,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0010798,0.45101,0.40069,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0049572,0.45004,0.40301,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0063209,0.44997,0.36988,1,1
3,GO T CELL PROLIFERATION,0.0080134,0.44946,0.39502,1,1
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00011593,0.4489,0.41067,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0052065,0.44874,0.41107,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0017696,0.44813,0.39716,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0036751,0.44782,0.40767,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.006955,0.44625,0.35148,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0036751,0.44563,0.39247,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0083971,0.44538,0.4012,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00060992,0.44463,0.40225,1,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0025648,0.44368,0.38203,1,1
3,GO PROTEIN ACTIVATION CASCADE,0.0034935,0.44362,0.37698,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0038653,0.4434,0.30011,1,1
3,GO CYTIDINE TO URIDINE EDITING,0.0036751,0.44283,0.42818,1,1
3,GO BLEB ASSEMBLY,0.0029965,0.44212,0.4573,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.019548,0.44162,0.38306,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0042727,0.44062,0.44594,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0080134,0.44016,0.47109,1,1
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00014989,0.43751,0.41172,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.0080134,0.43621,0.38937,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.046961,0.43601,0.31854,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.007293,0.43579,0.39326,1,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00076864,0.43505,0.45091,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0044907,0.43427,0.38287,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0096484,0.43388,0.35364,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0063209,0.43366,0.37338,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.0017696,0.43326,0.35418,1,1
3,GO REGULATION OF T CELL MIGRATION,0.0024341,0.43206,0.43909,1,1
3,GO I KAPPAB PHOSPHORYLATION,0.00086166,0.43205,0.41742,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0049572,0.432,0.36082,1,1
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.016475,0.43187,0.42724,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0083971,0.4316,0.37362,1,1
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00057531,0.43138,0.53344,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0057394,0.43014,0.38924,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0021907,0.42967,0.42109,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031545,0.42632,0.37582,1,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00020554,0.4254,0.44951,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0080134,0.42446,0.38594,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0066311,0.42399,0.38988,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0066311,0.42329,0.39057,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0019699,0.42304,0.36676,1,1
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00040321,0.42255,0.47473,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.007293,0.42192,0.33138,1,1
3,GO PHAGOCYTOSIS RECOGNITION,0.0031545,0.42117,0.41904,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0096484,0.42082,0.39464,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00048214,0.42065,0.47816,1,1
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00035748,0.42043,0.45796,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.015104,0.42008,0.40846,1,1
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00096503,0.41912,0.35928,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00096503,0.41841,0.38758,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0066311,0.41841,0.37591,1,1
3,GO BONE TRABECULA MORPHOGENESIS,0.007293,0.41807,0.45685,1,1
3,GO MYOBLAST MIGRATION,0.00060992,0.41794,0.4273,1,1
3,GO AMINE CATABOLIC PROCESS,0.0023095,0.41781,0.32127,1,1
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00064645,0.41751,0.44214,1,1
3,GO ASTROCYTE ACTIVATION,0.0054671,0.41558,0.38458,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0063209,0.41513,0.39845,1,1
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.018736,0.41474,0.39523,1,1
3,GO MACROPHAGE CHEMOTAXIS,0.0023095,0.4143,0.41122,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.010572,0.41382,0.35207,1,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00031664,0.41379,0.40043,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.011063,0.41362,0.34811,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0025648,0.41322,0.31139,1,1
3,GO ACUTE PHASE RESPONSE,0.0019699,0.4125,0.37562,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024341,0.41187,0.44668,1,1
3,GO REGULATION OF PHAGOCYTOSIS,0.006955,0.41175,0.38739,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00068502,0.41152,0.39461,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.0080134,0.4115,0.37488,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0083971,0.41098,0.36827,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.010101,0.40942,0.43766,1,1
3,GO LEUKOCYTE PROLIFERATION,0.0096484,0.40923,0.3738,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.020391,0.40864,0.35558,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0042727,0.40829,0.35254,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.0019699,0.40794,0.39674,1,1
3,GO B CELL MEDIATED IMMUNITY,0.008797,0.40775,0.41686,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0042727,0.40752,0.368,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.012106,0.4074,0.35219,1,1
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.0015882,0.40686,0.44222,1,1
3,GO T CELL ACTIVATION,0.008797,0.40596,0.35982,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.033245,0.40507,0.34428,1,1
3,GO FEVER GENERATION,0.0038653,0.40448,0.31193,1,1
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00021879,0.40416,0.39024,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.011063,0.40309,0.35313,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0016767,0.40249,0.36458,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0029965,0.40217,0.40401,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.017954,0.40188,0.39028,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0036751,0.40184,0.42243,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0092139,0.40175,0.40326,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00096503,0.40102,0.49943,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.0027019,0.40079,0.48226,1,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0049572,0.40026,0.39439,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0052065,0.39998,0.38509,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,1.9888e-05,0.3994,0.38992,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1347e-05,0.39893,0.42875,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0080134,0.39874,0.36147,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0052065,0.3982,0.37981,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0044907,0.398,0.3845,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0047188,0.39797,0.3768,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0023095,0.3967,0.41362,1,1
3,GO NEUTROPHIL HOMEOSTASIS,0.00031664,0.39631,0.46271,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0020776,0.39581,0.39634,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0020776,0.39563,0.4035,1,1
3,GO PEPTIDE CROSS LINKING,0.0092139,0.39512,0.35238,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.0044907,0.39475,0.33372,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0023095,0.39416,0.39486,1,1
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011063,0.39376,0.35612,1,1
3,GO SOMATIC STEM CELL DIVISION,0.0049572,0.39372,0.38806,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0021907,0.39359,0.36626,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.00031664,0.39357,0.45684,1,1
3,GO CELLULAR EXTRAVASATION,0.0083971,0.39339,0.37487,1,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0042727,0.39179,0.4218,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00072571,0.39084,0.34357,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0023095,0.39051,0.32127,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00332,0.38895,0.35935,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.0038653,0.38841,0.36847,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0047188,0.38838,0.37658,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0060238,0.38742,0.29965,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0060238,0.38709,0.3787,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,0.0010798,0.38694,0.33647,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.006955,0.38674,0.35716,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0083971,0.38646,0.33984,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.010101,0.38602,0.37528,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.00051151,0.38468,0.3955,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0047188,0.38449,0.28038,1,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.034576,0.3841,0.27261,1,1
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0016767,0.38393,0.4324,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0013481,0.38386,0.38203,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0080134,0.38384,0.32797,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0031545,0.38382,0.37029,1,1
3,GO FIBRINOLYSIS,0.0047188,0.38323,0.38345,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0015041,0.38269,0.36624,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.011063,0.3816,0.31182,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0066311,0.38127,0.38385,1,1
3,GO PLASMINOGEN ACTIVATION,0.013834,0.38107,0.32116,1,1
3,GO HUMORAL IMMUNE RESPONSE,0.015104,0.37933,0.34464,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0020776,0.37895,0.39027,1,1
3,GO INNATE IMMUNE RESPONSE,0.0047188,0.37857,0.34594,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0049572,0.37836,0.35607,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.013834,0.37787,0.33516,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0015882,0.37779,0.36892,1,1
3,GO ETHANOL CATABOLIC PROCESS,0.0012758,0.37729,0.29901,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.020391,0.37688,0.27159,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.028348,0.37556,0.26875,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00332,0.37552,0.42307,1,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0042727,0.37219,0.34344,1,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.007293,0.3721,0.34582,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0047188,0.37143,0.3556,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00086166,0.37058,0.35901,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0031545,0.37045,0.3913,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0029965,0.36929,0.38277,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00051151,0.36804,0.34967,1,1
3,GO CHEMOKINE PRODUCTION,0.0019699,0.36762,0.36979,1,1
3,GO RESPONSE TO VIRUS,0.0021907,0.3659,0.32748,1,1
3,GO OSTEOCLAST DEVELOPMENT,0.0034935,0.36587,0.39897,1,1
3,GO MYELOID CELL APOPTOTIC PROCESS,0.00091199,0.3653,0.35513,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.0014241,0.36493,0.32665,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.0057394,0.3628,0.32496,1,1
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0021907,0.36269,0.4734,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0047188,0.36199,0.33278,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0012071,0.36144,0.40849,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.035953,0.36139,0.3343,1,1
3,GO CHONDROCYTE PROLIFERATION,0.0014241,0.36135,0.39671,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.0028457,0.36119,0.29637,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00033648,0.36103,0.35931,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0044907,0.36061,0.31829,1,1
3,GO T CELL DIFFERENTIATION,0.006955,0.36041,0.3628,1,1
3,GO BIOLOGICAL PHASE,0.011574,0.35923,0.33672,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00035748,0.35863,0.38777,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0049572,0.35862,0.32975,1,1
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.00040321,0.35813,0.43356,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00086166,0.35725,0.38843,1,1
3,GO LYMPHOCYTE ACTIVATION,0.0080134,0.35635,0.326,1,1
3,GO T CELL LINEAGE COMMITMENT,0.025096,0.35632,0.30844,1,1
3,GO PROSTATE GLAND GROWTH,0.0011418,0.35601,0.38682,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0025648,0.35589,0.36284,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0083971,0.35539,0.33349,1,1
3,GO RETINOL METABOLIC PROCESS,4.5779e-05,0.35533,0.34771,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0040644,0.35508,0.28536,1,1
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0023095,0.35503,0.32544,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0047188,0.35475,0.30814,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00096503,0.35446,0.35096,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,0.0060238,0.35433,0.31998,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0029965,0.35424,0.32692,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0049572,0.352,0.3542,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00064645,0.3519,0.39535,1,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.011063,0.35186,0.29262,1,1
3,GO CELLULAR RESPONSE TO X RAY,0.0019699,0.35179,0.37477,1,1
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0031545,0.35154,0.37254,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,0.0042727,0.35149,0.33874,1,1
3,GO SEQUESTERING OF METAL ION,0.014457,0.35128,0.33423,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0018673,0.35096,0.35708,1,1
3,GO ZYMOGEN INHIBITION,0.0015882,0.35084,0.40271,1,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0023095,0.35076,0.33558,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.0060238,0.35065,0.33066,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0040644,0.35001,0.34347,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0052065,0.34996,0.29526,1,1
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00017019,0.34953,0.43701,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0012071,0.34923,0.36942,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0038653,0.3482,0.35099,1,1
3,GO TONGUE DEVELOPMENT,0.0038653,0.34816,0.25883,1,1
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.007293,0.34738,0.41405,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.025096,0.34726,0.26483,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0036751,0.34719,0.28447,1,1
3,GO FLUID TRANSPORT,0.00332,0.34711,0.33971,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.017954,0.3468,0.40008,1,1
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.024086,0.34642,0.31418,1,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,6.4139e-05,0.34577,0.35558,1,1
3,GO HYPOTONIC RESPONSE,0.00332,0.34561,0.32863,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0011418,0.34556,0.36019,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.006955,0.34463,0.34095,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0029965,0.34461,0.34641,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.0057394,0.34454,0.34593,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.008797,0.34448,0.31062,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0044907,0.34448,0.32899,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0038653,0.34434,0.32339,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00332,0.34398,0.24977,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0080134,0.34356,0.28731,1,1
3,GO SKELETAL MUSCLE TISSUE REGENERATION,5.9985e-05,0.34335,0.35902,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.010572,0.34309,0.32977,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0092139,0.34217,0.35809,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0066311,0.34194,0.30891,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00023283,0.34141,0.35121,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.012106,0.34093,0.37709,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00033648,0.34073,0.3356,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0015882,0.34036,0.45196,1,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00035748,0.33977,0.38781,1,1
3,GO PINOCYTOSIS,0.0034935,0.33954,0.32586,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0052065,0.33948,0.30264,1,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0031545,0.33923,0.27397,1,1
3,GO RETINAL METABOLIC PROCESS,0.00060992,0.33901,0.37916,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.015104,0.33901,0.33991,1,1
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0024341,0.33875,0.36706,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.0010209,0.33863,0.32849,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0096484,0.33742,0.32495,1,1
3,GO COLLAGEN CATABOLIC PROCESS,0.0038653,0.33733,0.37085,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.013834,0.3373,0.24389,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.0080134,0.33713,0.34654,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0028457,0.33652,0.32366,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.010101,0.3365,0.34786,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00332,0.33607,0.33426,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0029965,0.33593,0.38403,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0063209,0.33547,0.52859,1,1
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0019699,0.33508,0.30011,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.013235,0.3348,0.29712,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.014457,0.33408,0.43127,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00091199,0.33397,0.38723,1,1
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.022172,0.33389,0.25581,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0057394,0.33308,0.31735,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025648,0.33278,0.33134,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0034935,0.33136,0.30245,1,1
3,GO EPIDERMIS MORPHOGENESIS,0.0015041,0.33125,0.35108,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.048745,0.33054,0.29365,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0060238,0.33043,0.32418,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.0172,0.33032,0.22071,1,1
3,GO LEFT RIGHT AXIS SPECIFICATION,0.011063,0.33005,0.25156,1,1
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0031545,0.32965,0.32035,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.0057394,0.32944,0.33098,1,1
3,GO SERTOLI CELL DEVELOPMENT,0.00091199,0.32941,0.34388,1,1
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00035748,0.32894,0.36076,1,1
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.0028457,0.32889,0.31751,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0052065,0.32855,0.32169,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0076456,0.32848,0.28159,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.007293,0.32809,0.32284,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0076456,0.328,0.25893,1,1
3,GO REGULATION OF STEM CELL DIVISION,0.012106,0.32652,0.30683,1,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0034935,0.326,0.26645,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0036751,0.3259,0.29545,1,1
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00332,0.32409,0.35388,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0015882,0.32395,0.33115,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0031545,0.32331,0.30505,1,1
3,GO ASTROCYTE DEVELOPMENT,0.0021907,0.3233,0.36,1,1
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00332,0.32293,0.31215,1,1
3,GO RESPONSE TO BACTERIUM,0.0060238,0.32238,0.3175,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0019699,0.32173,0.34416,1,1
3,GO B CELL ACTIVATION,0.011063,0.3215,0.31256,1,1
3,GO INTERACTION WITH SYMBIONT,7.3279e-05,0.32093,0.32605,1,1
3,GO REGULATION OF LIPASE ACTIVITY,0.0010209,0.31962,0.2953,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0060238,0.31938,0.3186,1,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.016475,0.31911,0.29381,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00051151,0.31902,0.34602,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.013235,0.31875,0.27408,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0036751,0.31869,0.29881,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00096503,0.3185,0.39359,1,1
3,GO RESPONSE TO INTERLEUKIN 1,0.00064645,0.31797,0.30228,1,1
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0018673,0.31786,0.3958,1,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0020776,0.31777,0.30963,1,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.011574,0.31769,0.39888,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0038653,0.31768,0.32367,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.010572,0.31741,0.31479,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.0076456,0.31676,0.32124,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0063209,0.31644,0.33312,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.0018673,0.31608,0.33238,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0080134,0.31607,0.2921,1,1
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0036751,0.31563,0.35429,1,1
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00091199,0.31505,0.3502,1,1
3,GO CYTOKINE PRODUCTION,0.0042727,0.31477,0.31579,1,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0036751,0.31462,0.35254,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00031664,0.31409,0.37543,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.010101,0.31326,0.31819,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0054671,0.31304,0.35785,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0063209,0.31294,0.31559,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.0096484,0.31232,0.28851,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.014457,0.31165,0.26271,1,1
3,GO HEPATOCYTE DIFFERENTIATION,0.00072571,0.31161,0.31314,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0047188,0.31158,0.34246,1,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.006955,0.31149,0.32747,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0025648,0.31056,0.26492,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0063209,0.30978,0.34084,1,1
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0038653,0.30975,0.295,1,1
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0019699,0.30962,0.33603,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.022172,0.30954,0.33546,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0044907,0.30916,0.31209,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0076456,0.30869,0.27112,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0010209,0.30842,0.32096,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.015776,0.30752,0.29156,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00068502,0.30713,0.29863,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.0049572,0.30644,0.29558,1,1
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0015882,0.30621,0.36129,1,1
3,GO O GLYCAN PROCESSING,0.012106,0.30591,0.22787,1,1
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.007293,0.30571,0.34394,1,1
3,GO MUSCLE CELL FATE COMMITMENT,0.00024771,0.30552,0.36306,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0044907,0.30488,0.25729,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0038653,0.30473,0.27989,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0063209,0.30459,0.34003,1,1
3,GO IMMUNE EFFECTOR PROCESS,0.0057394,0.3037,0.30616,1,1
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0060238,0.30347,0.33337,1,1
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.013235,0.30328,0.3986,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00057531,0.30268,0.26576,1,1
3,GO NIK NF KAPPAB SIGNALING,0.00081392,0.30213,0.27633,1,1
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0027019,0.30208,0.40765,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.0057394,0.30199,0.3362,1,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00029789,0.30145,0.35511,1,1
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0034935,0.30087,0.28596,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.014457,0.30064,0.22324,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0063209,0.30055,0.29373,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.00028019,0.30029,0.36664,1,1
3,GO RIG I SIGNALING PATHWAY,0.00064645,0.3,0.28623,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0054671,0.2999,0.32566,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0017696,0.29938,0.29839,1,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.00051151,0.29873,0.29331,1,1
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.040368,0.29854,0.27813,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.021265,0.29833,0.24131,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.046961,0.29788,0.24114,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0021907,0.29739,0.45007,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.0096484,0.29732,0.31708,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.0036751,0.29693,0.30884,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0017696,0.2966,0.29383,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00060992,0.29645,0.28534,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0054671,0.29477,0.32607,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0080134,0.29451,0.19932,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0044907,0.29383,0.2822,1,1
3,GO REGULATION OF ODONTOGENESIS,0.0066311,0.29374,0.26492,1,1
3,GO LYMPHANGIOGENESIS,0.0036751,0.29308,0.34685,1,1
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00068502,0.29271,0.31465,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0036751,0.29224,0.34095,1,1
3,GO ENTRY INTO HOST,0.0063209,0.2919,0.30561,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.022172,0.29121,0.28008,1,1
3,GO PRIMARY MIRNA PROCESSING,0.00015974,0.29098,0.42004,1,1
3,GO ACTIN FILAMENT SEVERING,0.0076456,0.29034,0.36112,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.0092139,0.28935,0.29605,1,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.01266,0.28896,0.30717,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.013834,0.28894,0.28159,1,1
3,GO B CELL DIFFERENTIATION,0.006955,0.28888,0.31428,1,1
3,GO DEFENSE RESPONSE,0.0066311,0.28887,0.28908,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0042727,0.28879,0.36875,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.015104,0.2882,0.2741,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0021907,0.28789,0.3575,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.28784,0.25633,1,1
3,GO PODOSOME ASSEMBLY,0.0066311,0.28768,0.33428,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.007293,0.28764,0.31547,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0031545,0.2874,0.31364,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0010798,0.28679,0.28431,1,1
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.027226,0.2865,0.29373,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0034935,0.28636,0.30843,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0036751,0.28612,0.26421,1,1
3,GO VAGINA DEVELOPMENT,0.033245,0.28606,0.23545,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0031545,0.28586,0.31409,1,1
3,GO LYMPH VESSEL DEVELOPMENT,0.0083971,0.28545,0.32629,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.014457,0.28535,0.29493,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0019699,0.28504,0.28435,1,1
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0015041,0.28477,0.32233,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0012758,0.28475,0.33607,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0027019,0.28418,0.35313,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00081392,0.28401,0.28565,1,1
3,GO SKIN MORPHOGENESIS,0.033245,0.28393,0.30455,1,1
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0076456,0.28375,0.32442,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.0031545,0.28352,0.25818,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.031957,0.28343,0.3003,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0016767,0.28291,0.31971,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.043559,0.28277,0.26946,1,1
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.045233,0.28233,0.22827,1,1
3,GO RENAL ABSORPTION,0.0049572,0.28229,0.33453,1,1
3,GO GLIAL CELL PROLIFERATION,0.0015041,0.28227,0.31737,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0057394,0.2818,0.26119,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.007293,0.2814,0.28055,1,1
3,GO GAP JUNCTION ASSEMBLY,0.038848,0.28096,0.30167,1,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.015776,0.28035,0.27792,1,1
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.008797,0.27971,0.34463,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00086166,0.27968,0.27383,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.006955,0.27829,0.28316,1,1
3,GO REGULATION OF DEFENSE RESPONSE,0.0049572,0.27822,0.27206,1,1
3,GO HYALURONAN CATABOLIC PROCESS,0.0024341,0.27764,0.32305,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0034935,0.27755,0.29129,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0015041,0.27575,0.30153,1,1
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0054671,0.2753,0.32145,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.028348,0.27492,0.26373,1,1
3,GO CELL ADHESION MOLECULE PRODUCTION,0.0096484,0.27471,0.33432,1,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.043559,0.27414,0.28499,1,1
3,GO BONE CELL DEVELOPMENT,0.013235,0.2736,0.29689,1,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00332,0.27336,0.29687,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0054671,0.27334,0.28032,1,1
3,GO DNA DEAMINATION,0.0066311,0.27319,0.32329,1,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0014241,0.27303,0.32694,1,1
3,GO COLLAGEN FIBRIL ORGANIZATION,0.017954,0.27279,0.39531,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.0018673,0.27273,0.30027,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0057394,0.27267,0.30871,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00332,0.27265,0.28738,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.0057394,0.27264,0.30604,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0066311,0.27241,0.27736,1,1
3,GO DIET INDUCED THERMOGENESIS,0.025096,0.27232,0.22518,1,1
3,GO TONGUE MORPHOGENESIS,0.033245,0.27228,0.22213,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.024086,0.27227,0.25779,1,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0010798,0.27184,0.30099,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0044907,0.27176,0.21875,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0020776,0.27165,0.31109,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.041938,0.27164,0.22048,1,1
3,GO SUPEROXIDE ANION GENERATION,0.027226,0.27146,0.26155,1,1
3,GO RESPONSE TO MANGANESE ION,0.0023095,0.27092,0.26647,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0063209,0.27018,0.30429,1,1
3,GO TERPENOID METABOLIC PROCESS,0.00024771,0.26987,0.2624,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0096484,0.26974,0.27334,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0013481,0.26867,0.32508,1,1
3,GO RESPONSE TO CYTOKINE,0.0038653,0.26856,0.27881,1,1
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00332,0.26831,0.33115,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.027226,0.26796,0.25404,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.0021907,0.26792,0.28442,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.012106,0.26751,0.25868,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0011418,0.26731,0.3151,1,1
3,GO REGULATION OF DNA METHYLATION,0.0042727,0.26728,0.24863,1,1
3,GO TRACHEA DEVELOPMENT,0.0060238,0.26716,0.30743,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0036751,0.26707,0.3062,1,1
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.016475,0.26671,0.23247,1,1
3,GO ENDODERMAL CELL DIFFERENTIATION,0.0083971,0.26662,0.41194,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.0096484,0.26563,0.2648,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0024341,0.26554,0.30483,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0020776,0.26533,0.29053,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.013834,0.26533,0.24561,1,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.030713,0.26511,0.21742,1,1
3,GO PYROPTOSIS,0.008797,0.26503,0.31001,1,1
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0038653,0.26455,0.26876,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00018128,0.26417,0.28824,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00045436,0.26382,0.31409,1,1
3,GO TRABECULA FORMATION,0.050584,0.26375,0.2381,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011574,0.26371,0.23277,1,1
3,GO HIPPO SIGNALING,0.017954,0.26359,0.27417,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0028457,0.26351,0.3283,1,1
3,GO GLOMERULUS DEVELOPMENT,0.014457,0.26224,0.29811,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0014241,0.26199,0.29315,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0042727,0.2619,0.28662,1,1
3,GO RESPONSE TO X RAY,0.00081392,0.26173,0.3136,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.012106,0.26155,0.26003,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0018673,0.26149,0.27403,1,1
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.034576,0.26137,0.30887,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.014457,0.26126,0.24481,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.025096,0.26125,0.26084,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0025648,0.26109,0.31903,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.012106,0.26103,0.27276,1,1
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0042727,0.26053,0.25257,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.034576,0.2605,0.32903,1,1
3,GO PROTEIN NITROSYLATION,0.0066311,0.26039,0.2663,1,1
3,GO MAMMARY GLAND MORPHOGENESIS,0.0038653,0.26034,0.31454,1,1
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.017954,0.26007,0.28119,1,1
3,GO REGULATION OF PROTEIN MATURATION,0.0021907,0.25961,0.25631,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0060238,0.25934,0.2362,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.008797,0.25917,0.27271,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.007293,0.25862,0.31908,1,1
3,GO INTERFERON BETA PRODUCTION,0.00332,0.25823,0.30888,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.023112,0.25744,0.27712,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,0.026142,0.25738,0.16692,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0076456,0.25714,0.28631,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,0.028348,0.25701,0.30351,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0052065,0.257,0.25776,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.018736,0.25694,0.26706,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0027019,0.25605,0.2804,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.012106,0.25604,0.25945,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0066311,0.25589,0.27081,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0020776,0.25558,0.23242,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0025648,0.25549,0.29639,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0054671,0.25517,0.33158,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.011574,0.25515,0.3555,1,1
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0019699,0.25479,0.31588,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.046961,0.25441,0.22252,1,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.00024771,0.25383,0.30507,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.013834,0.25334,0.25533,1,1
3,GO B CELL APOPTOTIC PROCESS,0.0063209,0.25322,0.25884,1,1
3,GO ARTERY MORPHOGENESIS,0.0021907,0.25319,0.3412,1,1
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0049572,0.25315,0.28075,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.020391,0.25292,0.31176,1,1
3,GO RESPONSE TO DSRNA,0.0044907,0.2527,0.23867,1,1
3,GO STEM CELL DIVISION,0.015776,0.25247,0.26777,1,1
3,GO RESPONSE TO GROWTH HORMONE,0.00081392,0.25238,0.27083,1,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.00076864,0.25191,0.31171,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.0016767,0.2519,0.27401,1,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0012758,0.25188,0.35531,1,1
3,GO DECIDUALIZATION,0.015104,0.25173,0.28028,1,1
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0049572,0.25165,0.24703,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0040644,0.25092,0.26146,1,1
3,GO MYELOID CELL DEVELOPMENT,0.0036751,0.25089,0.28508,1,1
3,GO REGULATION OF CELL FATE COMMITMENT,0.007293,0.25031,0.25756,1,1
3,GO ARTERY DEVELOPMENT,0.0024341,0.25021,0.34436,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.0052065,0.25004,0.26986,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0044907,0.24981,0.26386,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.011063,0.24976,0.27372,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.045233,0.24967,0.22744,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00086166,0.24962,0.27236,1,1
3,GO BRONCHUS DEVELOPMENT,0.035953,0.24894,0.24926,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0096484,0.24879,0.28897,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00021879,0.24869,0.2304,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0016767,0.24715,0.25978,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.0036751,0.24698,0.29542,1,1
3,GO TROPHOBLAST CELL MIGRATION,0.00076864,0.24675,0.31043,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.023112,0.24662,0.23501,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0010798,0.24655,0.22882,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.011574,0.24643,0.25908,1,1
3,GO ODONTOGENESIS,0.007293,0.24606,0.23509,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0042727,0.246,0.26866,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.024086,0.24598,0.1907,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0049572,0.24589,0.27313,1,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.008797,0.24576,0.29696,1,1
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.011063,0.24575,0.23997,1,1
3,GO EPIBOLY,0.0047188,0.2455,0.28631,1,1
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0172,0.24549,0.29822,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.018736,0.24539,0.21154,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.016475,0.24538,0.24628,1,1
3,GO REGULATION OF CALCIUM ION IMPORT,0.006955,0.24537,0.26958,1,1
3,GO PANCREATIC JUICE SECRETION,0.037377,0.24519,0.22206,1,1
3,GO B CELL HOMEOSTASIS,0.012106,0.24473,0.31137,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0052065,0.24447,0.25379,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0096484,0.24415,0.26562,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.035953,0.24384,0.27745,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0016767,0.24363,0.31372,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.028348,0.24305,0.18853,1,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.031957,0.24302,0.23489,1,1
3,GO FIBROBLAST ACTIVATION,0.014457,0.24247,0.26354,1,1
3,GO MRNA TRANSCRIPTION,0.0047188,0.24245,0.28687,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0060238,0.24228,0.30362,1,1
3,GO RESPONSE TO INTERLEUKIN 12,0.0076456,0.24228,0.21627,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0018673,0.24221,0.25276,1,1
3,GO PROSTATE GLAND DEVELOPMENT,0.006955,0.24191,0.28191,1,1
3,GO CHROMATIN DISASSEMBLY,0.020391,0.24155,0.21188,1,1
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0054671,0.24115,0.28685,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.010101,0.2411,0.25364,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0057394,0.24072,0.22894,1,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022172,0.2407,0.27706,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0060238,0.24069,0.24787,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.015776,0.24036,0.24036,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.019548,0.23982,0.20509,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0063209,0.23977,0.25472,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023112,0.23976,0.25551,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.021265,0.23907,0.19335,1,1
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0063209,0.23894,0.26019,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0023095,0.2388,0.26548,1,1
3,GO ZYMOGEN ACTIVATION,0.015776,0.23849,0.25341,1,1
3,GO ENDODERM FORMATION,0.0047188,0.23799,0.37419,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0080134,0.2379,0.32901,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0029965,0.23754,0.2676,1,1
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.011574,0.23751,0.2084,1,1
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00023283,0.23686,0.24053,1,1
3,GO MESODERMAL CELL DIFFERENTIATION,0.0013481,0.23655,0.29512,1,1
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.034576,0.23631,0.24139,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0017696,0.23599,0.29225,1,1
3,GO RESPONSE TO UV C,0.01266,0.23559,0.21021,1,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0042727,0.23539,0.31635,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0025648,0.23524,0.24694,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.0020776,0.2351,0.24724,1,1
3,GO KERATINOCYTE MIGRATION,0.034576,0.2348,0.22613,1,1
3,GO VIRAL GENOME REPLICATION,0.0023095,0.23426,0.2643,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.026142,0.23411,0.26465,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.015104,0.23395,0.21808,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.010572,0.23367,0.25488,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.021265,0.23327,0.23783,1,1
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.013235,0.23323,0.2336,1,1
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010572,0.23288,0.28135,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0083971,0.23237,0.2331,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.0083971,0.23185,0.23363,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0038653,0.23142,0.35891,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0018673,0.23125,0.24182,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.015776,0.23117,0.24554,1,1
3,GO SYNCYTIUM FORMATION,0.0054671,0.23081,0.31667,1,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0018673,0.23078,0.29264,1,1
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.043559,0.23077,0.21134,1,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.013834,0.23063,0.31176,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0034935,0.2303,0.29634,1,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0096484,0.23017,0.34002,1,1
3,GO TISSUE REGENERATION,0.0060238,0.23012,0.20364,1,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.0083971,0.22981,0.2962,1,1
3,GO BLOOD VESSEL MORPHOGENESIS,0.0096484,0.22979,0.26285,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.014457,0.22952,0.19766,1,1
3,GO ARGININE METABOLIC PROCESS,0.019548,0.22884,0.18111,1,1
3,GO STEROL HOMEOSTASIS,0.0060238,0.22882,0.24756,1,1
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0015041,0.22873,0.22905,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0092139,0.22843,0.236,1,1
3,GO DRUG METABOLIC PROCESS,0.0080134,0.22839,0.1741,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.00051151,0.22827,0.25885,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00048214,0.22811,0.2436,1,1
3,GO MANGANESE ION TRANSPORT,0.0063209,0.22785,0.20962,1,1
3,GO NOTOCHORD DEVELOPMENT,0.027226,0.22734,0.23076,1,1
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.040368,0.22719,0.22572,1,1
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.025096,0.2267,0.23114,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.031957,0.22652,0.24671,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0052065,0.22625,0.28665,1,1
3,GO ASTROCYTE DIFFERENTIATION,0.0083971,0.2261,0.25601,1,1
3,GO OVULATION,0.008797,0.22599,0.24793,1,1
3,GO RESPONSE TO VITAMIN A,0.0034935,0.22597,0.24136,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0083971,0.2259,0.26135,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0024341,0.22581,0.25496,1,1
3,GO ERYTHROCYTE MATURATION,0.0042727,0.22506,0.27974,1,1
3,GO AORTA DEVELOPMENT,0.0023095,0.22485,0.34212,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.017954,0.22461,0.26188,1,1
3,GO AORTA MORPHOGENESIS,0.00332,0.2246,0.37241,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0063209,0.22429,0.22572,1,1
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0052065,0.22401,0.22114,1,1
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0080134,0.22396,0.24151,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0020776,0.2239,0.24789,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.016475,0.22363,0.22711,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0036751,0.22359,0.26576,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.007293,0.22308,0.22889,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00332,0.223,0.22115,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.013235,0.22294,0.2722,1,1
3,GO VASCULATURE DEVELOPMENT,0.0066311,0.22293,0.26035,1,1
3,GO REGULATION OF PINOCYTOSIS,0.025096,0.22275,0.24285,1,1
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.013235,0.22274,0.28903,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0080134,0.22271,0.24641,1,1
3,GO LUNG MORPHOGENESIS,0.025096,0.22258,0.22165,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0076456,0.22252,0.20139,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02951,0.2224,0.23313,1,1
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.034576,0.22195,0.2362,1,1
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.015104,0.22187,0.27343,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00332,0.22155,0.22431,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.011063,0.22151,0.24569,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0063209,0.22129,0.20079,1,1
3,GO PROTEIN TRIMERIZATION,0.027226,0.22103,0.27217,1,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.012106,0.22095,0.26049,1,1
3,GO BLASTODERM SEGMENTATION,0.00091199,0.22016,0.28007,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.013834,0.21989,0.26727,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.021265,0.21925,0.2373,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.017954,0.21916,0.23217,1,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.013834,0.21843,0.27057,1,1
3,GO RESPONSE TO IONIZING RADIATION,0.00033648,0.21816,0.23928,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.018736,0.21784,0.21912,1,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.035953,0.21779,0.25142,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.010101,0.21742,0.26791,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.02951,0.21704,0.17979,1,1
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0049572,0.21694,0.33192,1,1
3,GO LIVER REGENERATION,0.00045436,0.21683,0.24307,1,1
3,GO SPROUTING ANGIOGENESIS,0.010101,0.21647,0.27795,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.054439,0.21633,0.1463,1,1
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.0076456,0.21547,0.21875,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.010572,0.21546,0.18553,1,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025648,0.21526,0.25949,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0066311,0.21458,0.26846,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0023095,0.21439,0.26758,1,1
3,GO COCHLEA MORPHOGENESIS,0.013834,0.21401,0.20925,1,1
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011063,0.21329,0.25512,1,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.0036751,0.21322,0.28078,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.010101,0.21321,0.212,1,1
3,GO REGULATION OF GASTRULATION,0.0024341,0.21299,0.25559,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0052065,0.21293,0.22562,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.018736,0.21229,0.22262,1,1
3,GO REGULATION OF CELL SHAPE,0.0092139,0.21198,0.24912,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.0021907,0.21168,0.24382,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.022172,0.21155,0.30358,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0040644,0.21105,0.19673,1,1
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0052065,0.21065,0.24237,1,1
3,GO SECRETION BY TISSUE,0.033245,0.21014,0.15833,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.008797,0.20975,0.25186,1,1
3,GO DRUG CATABOLIC PROCESS,0.045233,0.2096,0.15866,1,1
3,GO MATERNAL PLACENTA DEVELOPMENT,0.01266,0.20939,0.23769,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.0054671,0.20908,0.20273,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0040644,0.20864,0.22136,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.052482,0.20853,0.2434,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0052065,0.2079,0.25472,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.013834,0.20764,0.17395,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0023095,0.20759,0.20443,1,1
3,GO REGULATION OF CELL ADHESION,0.0172,0.20754,0.26383,1,1
3,GO VIRAL LIFE CYCLE,0.0020776,0.2075,0.24006,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.011063,0.20736,0.2236,1,1
3,GO TISSUE MIGRATION,0.011574,0.20732,0.23081,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.006955,0.20725,0.199,1,1
3,GO P38MAPK CASCADE,0.013834,0.20724,0.25829,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.026142,0.2072,0.22161,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0092139,0.20719,0.22623,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.011574,0.20704,0.17856,1,1
3,GO RESPONSE TO GAMMA RADIATION,0.00028019,0.20692,0.25203,1,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0054671,0.2067,0.22471,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0066311,0.20647,0.24625,1,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.035953,0.20624,0.23456,1,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.0020776,0.20621,0.25139,1,1
3,GO MYOBLAST FUSION,0.0080134,0.20614,0.32622,1,1
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.007293,0.20608,0.29302,1,1
3,GO FEMALE GENITALIA DEVELOPMENT,0.026142,0.20605,0.20287,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.0049572,0.20533,0.24836,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0042727,0.20503,0.26415,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0052065,0.2048,0.23711,1,1
3,GO RNA DECAPPING,0.0038653,0.20478,0.22429,1,1
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0044907,0.20478,0.2404,1,1
3,GO RESPONSE TO ESTROGEN,0.01266,0.20456,0.20647,1,1
3,GO NADPH REGENERATION,0.011063,0.20455,0.16495,1,1
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0017696,0.20448,0.31687,1,1
3,GO CELL CELL RECOGNITION,0.0024341,0.20391,0.23381,1,1
3,GO MYOBLAST DIFFERENTIATION,0.010101,0.20376,0.21475,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.040368,0.20281,0.15491,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.01266,0.20271,0.18711,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.017954,0.20244,0.29112,1,1
3,GO REGULATION OF HAIR CYCLE,0.0092139,0.20228,0.23279,1,1
3,GO CELL MATRIX ADHESION,0.037377,0.2022,0.24011,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016475,0.20208,0.21956,1,1
3,GO HEAT GENERATION,0.019548,0.2018,0.23203,1,1
3,GO EMBRYO IMPLANTATION,0.0060238,0.20177,0.26889,1,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.015776,0.2016,0.1611,1,1
3,GO GTP METABOLIC PROCESS,7.8298e-05,0.20102,0.22123,1,1
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0054671,0.20091,0.24157,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0076456,0.20085,0.25583,1,1
3,GO INTERACTION WITH HOST,0.0034935,0.20082,0.23579,1,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0052065,0.20078,0.23992,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.01266,0.20054,0.22623,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.017954,0.20005,0.23427,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.011063,0.20001,0.18597,1,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0025648,0.19999,0.18967,1,1
3,GO NEUROBLAST DIVISION,0.017954,0.19971,0.24445,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.0018673,0.19955,0.16706,1,1
3,GO NEPHRON TUBULE FORMATION,0.0092139,0.19947,0.28553,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.048745,0.19921,0.1932,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.046961,0.19916,0.21133,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0042727,0.19914,0.23228,1,1
3,GO BLASTOCYST GROWTH,0.023112,0.19912,0.15862,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.0019699,0.19889,0.21508,1,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0047188,0.19881,0.20879,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013834,0.1988,0.19273,1,1
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0012758,0.19878,0.22894,1,1
3,GO AMINO SUGAR METABOLIC PROCESS,0.0063209,0.19855,0.24911,1,1
3,GO WATER TRANSPORT,0.015104,0.19854,0.30813,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0015882,0.19841,0.28117,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.026142,0.19825,0.2017,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.034576,0.19803,0.16967,1,1
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.02951,0.19787,0.1833,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.015776,0.19725,0.19995,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0049572,0.19661,0.27837,1,1
3,GO MIRNA METABOLIC PROCESS,0.046961,0.19657,0.17228,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.024086,0.19654,0.18964,1,1
3,GO GLAND MORPHOGENESIS,0.014457,0.19649,0.25424,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.024086,0.19633,0.25226,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0096484,0.19617,0.1976,1,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0025648,0.19599,0.27201,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.024086,0.19559,0.2249,1,1
3,GO MALE GENITALIA DEVELOPMENT,0.026142,0.19554,0.22346,1,1
3,GO T CELL HOMEOSTASIS,0.027226,0.1955,0.22874,1,1
3,GO CELLULAR RESPONSE TO ATP,0.021265,0.19544,0.19239,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.026142,0.195,0.22959,1,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.030713,0.195,0.26734,1,1
3,GO ESTROUS CYCLE,0.035953,0.19494,0.26663,1,1
3,GO CELL SUBSTRATE ADHESION,0.034576,0.19475,0.24181,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.046961,0.19466,0.23311,1,1
3,GO LIVER MORPHOGENESIS,0.013235,0.19436,0.24043,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083971,0.19412,0.20006,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0083971,0.19407,0.21389,1,1
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.018736,0.19405,0.29622,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0038653,0.1938,0.21236,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.028348,0.19298,0.24214,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.007293,0.1927,0.27759,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.034576,0.19248,0.19293,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.02951,0.19242,0.18032,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.043559,0.19216,0.17511,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.015776,0.19202,0.24164,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.010101,0.19112,0.23341,1,1
3,GO MUSCLE CELL PROLIFERATION,0.0054671,0.19111,0.23828,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.015776,0.19084,0.34761,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.024086,0.19082,0.17233,1,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0076456,0.19066,0.22044,1,1
3,GO BONE DEVELOPMENT,0.010101,0.19033,0.23864,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.035953,0.19026,0.17483,1,1
3,GO MRNA MODIFICATION,0.018736,0.19023,0.19827,1,1
3,GO INNER CELL MASS CELL PROLIFERATION,0.043559,0.18984,0.15173,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0017696,0.18977,0.17625,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0024341,0.18974,0.23812,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0092139,0.18927,0.19242,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.010572,0.18918,0.23529,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.030713,0.18903,0.19732,1,1
3,GO REGULATION OF PROTEIN IMPORT,0.00057531,0.18888,0.23963,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.025096,0.18888,0.25705,1,1
3,GO RNA DESTABILIZATION,0.023112,0.18863,0.21885,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.010101,0.18857,0.24716,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.013235,0.18856,0.25496,1,1
3,GO TISSUE REMODELING,0.019548,0.18844,0.26846,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.013235,0.18822,0.20373,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.007293,0.18782,0.26405,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.043559,0.1877,0.20897,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.030713,0.18762,0.23343,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0076456,0.18758,0.22179,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.027226,0.18714,0.22309,1,1
3,GO PROTEIN DEMANNOSYLATION,0.052482,0.18707,0.19214,1,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.015776,0.1866,0.20755,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0052065,0.18649,0.27881,1,1
3,GO KERATINOCYTE PROLIFERATION,0.031957,0.18641,0.21414,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.015776,0.18632,0.21316,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.016475,0.18626,0.22033,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012106,0.1861,0.21288,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.013235,0.18599,0.18017,1,1
3,GO REGULATION OF WOUND HEALING,0.045233,0.18586,0.2042,1,1
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0036751,0.18546,0.18374,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00332,0.18512,0.25289,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.015104,0.18509,0.17373,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.00020554,0.18501,0.22757,1,1
3,GO RESPONSE TO VITAMIN,0.030713,0.18487,0.18811,1,1
3,GO ERBB SIGNALING PATHWAY,0.0047188,0.18476,0.22206,1,1
3,GO SKIN DEVELOPMENT,0.043559,0.18463,0.16407,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.011574,0.18417,0.18013,1,1
3,GO PERICARDIUM DEVELOPMENT,0.0049572,0.18399,0.32866,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041938,0.18372,0.21146,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0031545,0.18353,0.23854,1,1
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.028348,0.1835,0.19904,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.035953,0.18337,0.22771,1,1
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0044907,0.18335,0.18414,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.016475,0.18326,0.22597,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.012106,0.18279,0.25659,1,1
3,GO HEME METABOLIC PROCESS,0.00035748,0.18278,0.20563,1,1
3,GO UTP METABOLIC PROCESS,0.045233,0.18209,0.13095,1,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.010101,0.18203,0.24527,1,1
3,GO TUBE MORPHOGENESIS,0.019548,0.18198,0.21497,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.013834,0.18195,0.22435,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0060238,0.18174,0.23898,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.01266,0.18166,0.17521,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.028348,0.18162,0.21258,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.013834,0.18155,0.23595,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.040368,0.18149,0.1771,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.011574,0.1814,0.237,1,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045233,0.18139,0.21517,1,1
3,GO FIBROBLAST PROLIFERATION,0.0029965,0.18131,0.24078,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.008797,0.18125,0.29395,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.0172,0.18092,0.26746,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.038848,0.18086,0.19944,1,1
3,GO DNA METHYLATION,0.022172,0.18073,0.16103,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.011063,0.18066,0.19015,1,1
3,GO ENDODERM DEVELOPMENT,0.018736,0.18053,0.29826,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.011063,0.18053,0.17451,1,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0076456,0.18019,0.18467,1,1
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.041938,0.17985,0.19884,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.026142,0.17929,0.174,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.010101,0.17911,0.19229,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.017954,0.17899,0.16891,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.040368,0.17873,0.20641,1,1
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0038653,0.17818,0.20581,1,1
3,GO BLOOD VESSEL REMODELING,0.037377,0.1778,0.28279,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014457,0.17776,0.2266,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0028457,0.17687,0.173,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.02951,0.17686,0.21838,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0047188,0.17682,0.21536,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.010101,0.17677,0.17809,1,1
3,GO RRNA MODIFICATION,0.0025648,0.17655,0.1432,1,1
3,GO AXIS ELONGATION,0.023112,0.17621,0.25126,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.015104,0.17612,0.20391,1,1
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.043559,0.17592,0.26838,1,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.010572,0.17583,0.24992,1,1
3,GO AUTOPHAGOSOME MATURATION,0.0076456,0.17548,0.15351,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0080134,0.17539,0.23313,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.010572,0.17538,0.23465,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.025096,0.17535,0.19303,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.014457,0.17532,0.17936,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.014457,0.1752,0.16754,1,1
3,GO NEURAL TUBE FORMATION,0.052482,0.17394,0.1595,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.007293,0.17383,0.23421,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0013481,0.17317,0.20816,1,1
3,GO GENITALIA DEVELOPMENT,0.040368,0.17311,0.1896,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.030713,0.17309,0.15728,1,1
3,GO PORE COMPLEX ASSEMBLY,0.0054671,0.17298,0.19947,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.020391,0.17288,0.24879,1,1
3,GO REGULATION OF HEAT GENERATION,0.040368,0.17286,0.21436,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0018673,0.17223,0.16083,1,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.015776,0.17177,0.20593,1,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0028457,0.17162,0.21515,1,1
3,GO REGULATION OF LIPID STORAGE,0.023112,0.17158,0.22186,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0060238,0.17116,0.23358,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.015776,0.17115,0.22826,1,1
3,GO LAMELLIPODIUM ORGANIZATION,0.0049572,0.17073,0.21875,1,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0096484,0.17047,0.19809,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.01266,0.17037,0.20437,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0044907,0.17018,0.19749,1,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.013834,0.1699,0.1634,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.037377,0.16941,0.15058,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.015776,0.16929,0.20178,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.031957,0.16887,0.17394,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.033245,0.1687,0.19329,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.014457,0.16863,0.22617,1,1
3,GO PROTEIN KINASE B SIGNALING,0.019548,0.16843,0.20466,1,1
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.052482,0.16821,0.17873,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0036751,0.16786,0.24181,1,1
3,GO RUFFLE ORGANIZATION,0.016475,0.16783,0.22278,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00086166,0.16762,0.22696,1,1
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.038848,0.1675,0.16237,1,1
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0049572,0.16742,0.21197,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0076456,0.1672,0.22306,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.0015041,0.16695,0.22799,1,1
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.035953,0.16678,0.14302,1,1
3,GO GOLGI LOCALIZATION,0.0066311,0.16569,0.17936,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011063,0.16548,0.22575,1,1
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.025096,0.16538,0.29324,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.046961,0.1653,0.16562,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.040368,0.16527,0.2034,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0080134,0.16474,0.22205,1,1
3,GO RESPONSE TO ATP,0.016475,0.16447,0.19664,1,1
3,GO CELLULAR RESPONSE TO CAMP,0.018736,0.16393,0.1729,1,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.008797,0.16373,0.16736,1,1
3,GO TISSUE HOMEOSTASIS,0.020391,0.1635,0.18547,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.037377,0.16341,0.22076,1,1
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.00332,0.16333,0.20647,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.026142,0.16319,0.20775,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.040368,0.163,0.20991,1,1
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.015104,0.163,0.15712,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0066311,0.16288,0.26943,1,1
3,GO EPIDERMIS DEVELOPMENT,0.048745,0.16284,0.1569,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.035953,0.16265,0.20552,1,1
3,GO RESPONSE TO FATTY ACID,0.025096,0.1626,0.16953,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.043559,0.16244,0.229,1,1
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.030713,0.16244,0.25005,1,1
3,GO SYMBIOTIC PROCESS,0.0015041,0.16208,0.17642,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0044907,0.162,0.20519,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.013235,0.16168,0.19451,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0019699,0.16167,0.15913,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.035953,0.16113,0.19412,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.014457,0.16085,0.19768,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,0.16076,0.1792,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0172,0.16072,0.31947,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010101,0.16022,0.17514,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.035953,0.16005,0.20112,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0027019,0.15988,0.18127,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.015776,0.15957,0.1729,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.035953,0.15919,0.20021,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0049572,0.15882,0.19906,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.054439,0.1588,0.13743,1,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.040368,0.15877,0.15989,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00029789,0.15831,0.26366,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.018736,0.15812,0.15681,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.045233,0.15766,0.19334,1,1
3,GO V D J RECOMBINATION,0.022172,0.15763,0.19903,1,1
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.026142,0.15714,0.21982,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.011063,0.15701,0.20527,1,1
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.017954,0.15689,0.25089,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.010101,0.15679,0.18233,1,1
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.015104,0.15675,0.23066,1,1
3,GO REGULATION OF GENE SILENCING,0.011574,0.15661,0.16609,1,1
3,GO RRNA METHYLATION,0.0096484,0.15658,0.1471,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.033245,0.15651,0.11686,1,1
3,GO NUCLEOTIDE SALVAGE,0.033245,0.15643,0.16573,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.010101,0.1563,0.17944,1,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0083971,0.15627,0.1891,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0040644,0.15626,0.1445,1,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00332,0.15535,0.17188,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.013235,0.15517,0.18894,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.054439,0.15456,0.1985,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0172,0.15442,0.23545,1,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.038848,0.15441,0.20134,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0025648,0.15423,0.19019,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.048745,0.15414,0.1832,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.034576,0.15386,0.20222,1,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.010101,0.15328,0.17366,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.030713,0.15283,0.19764,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.026142,0.15248,0.16347,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0060238,0.15215,0.14985,1,1
3,GO MUSCLE CELL MIGRATION,0.0080134,0.15213,0.28443,1,1
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.016475,0.15192,0.22251,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0034935,0.15119,0.17489,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.008797,0.15058,0.17421,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.010572,0.1504,0.1774,1,1
3,GO STEROL METABOLIC PROCESS,0.026142,0.15034,0.15876,1,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.050584,0.15011,0.17696,1,1
3,GO FORMATION OF PRIMARY GERM LAYER,0.015104,0.1496,0.25115,1,1
3,GO SNRNA PROCESSING,0.041938,0.14931,0.15171,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.021265,0.14929,0.21581,1,1
3,GO ETHER METABOLIC PROCESS,0.0080134,0.14876,0.19557,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.054439,0.14825,0.12959,1,1
3,GO RESPONSE TO RETINOIC ACID,0.031957,0.14822,0.1838,1,1
3,GO BONE REMODELING,0.035953,0.14817,0.24521,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.016475,0.14775,0.13471,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.008797,0.14735,0.17298,1,1
3,GO CELLULAR RESPONSE TO UV,0.013235,0.1471,0.16118,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.046961,0.14693,0.21086,1,1
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.048745,0.14645,0.1878,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0010798,0.14636,0.16579,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0027019,0.14634,0.1864,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.019548,0.14611,0.27834,1,1
3,GO REGULATION OF TELOMERASE ACTIVITY,0.00332,0.14607,0.16721,1,1
3,GO BONE MORPHOGENESIS,0.028348,0.14597,0.2324,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0036751,0.14522,0.15756,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.007293,0.14499,0.23469,1,1
3,GO LIPID OXIDATION,0.041938,0.14477,0.12902,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.043559,0.14476,0.2274,1,1
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.013834,0.14465,0.15689,1,1
3,GO COPPER ION HOMEOSTASIS,0.052482,0.14418,0.1538,1,1
3,GO REGULATION OF PROTEOLYSIS,0.027226,0.14404,0.15943,1,1
3,GO WOUND HEALING,0.046961,0.14337,0.19599,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.024086,0.14336,0.16724,1,1
3,GO NCRNA CATABOLIC PROCESS,0.030713,0.14277,0.1586,1,1
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.043559,0.14275,0.12708,1,1
3,GO LIPID HOMEOSTASIS,0.021265,0.14202,0.17551,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.027226,0.14201,0.14359,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.016475,0.14198,0.18861,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.038848,0.14195,0.19294,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.041938,0.14178,0.16481,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.015776,0.14152,0.18778,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.010101,0.14123,0.14911,1,1
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.031957,0.14103,0.1941,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.011574,0.14078,0.12831,1,1
3,GO RNA INTERFERENCE,0.054439,0.14064,0.17359,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.033245,0.14046,0.11812,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.035953,0.14033,0.15928,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.024086,0.13995,0.13745,1,1
3,GO THYMUS DEVELOPMENT,0.008797,0.13984,0.17452,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0066311,0.13961,0.16903,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.028348,0.1392,0.13726,1,1
3,GO RESPONSE TO LIPID,0.028348,0.13914,0.17847,1,1
3,GO CELLULAR PIGMENTATION,0.021265,0.13902,0.16472,1,1
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.046961,0.13897,0.19564,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0092139,0.13855,0.25825,1,1
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0024341,0.13848,0.1412,1,1
3,GO CORONARY VASCULATURE DEVELOPMENT,0.02951,0.13813,0.24942,1,1
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.011574,0.13812,0.16922,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.020391,0.13785,0.25155,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.040368,0.13736,0.19924,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.037377,0.137,0.15268,1,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.013834,0.13663,0.13396,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.023112,0.13634,0.18924,1,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.023112,0.13559,0.14527,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.054439,0.13556,0.16877,1,1
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.024086,0.13539,0.13451,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.046961,0.13519,0.14167,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.014457,0.13494,0.22532,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0172,0.13452,0.16312,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.023112,0.1344,0.21413,1,1
3,GO BLASTOCYST FORMATION,0.0020776,0.13382,0.18246,1,1
3,GO RETINA HOMEOSTASIS,0.015104,0.13371,0.12309,1,1
3,GO LATERAL MESODERM DEVELOPMENT,0.054439,0.13354,0.22879,1,1
3,GO ANIMAL ORGAN REGENERATION,0.0092139,0.13351,0.1858,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.018736,0.13343,0.17503,1,1
3,GO RESPONSE TO STEROL,0.024086,0.13336,0.22045,1,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.015776,0.13269,0.14929,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.13248,0.13911,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.045233,0.13223,0.19637,1,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.052482,0.13212,0.17603,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.041938,0.13194,0.16152,1,1
3,GO FATTY ACID TRANSPORT,0.041938,0.13144,0.15739,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.043559,0.13081,0.19223,1,1
3,GO GASTRULATION,0.015776,0.13068,0.22827,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.020391,0.13026,0.15852,1,1
3,GO NCRNA PROCESSING,0.015104,0.13006,0.12725,1,1
3,GO NADP METABOLIC PROCESS,0.054439,0.12953,0.13617,1,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.028348,0.12928,0.13981,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.038848,0.12906,0.17166,1,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.023112,0.12788,0.21531,1,1
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0015882,0.12773,0.14785,1,1
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.028348,0.12763,0.2252,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027226,0.12753,0.17242,1,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.019548,0.12735,0.16318,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.015104,0.12729,0.13638,1,1
3,GO OSTEOBLAST DIFFERENTIATION,0.052482,0.12719,0.16853,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0066311,0.1269,0.17561,1,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.01266,0.12678,0.12995,1,1
3,GO GENE SILENCING,0.041938,0.12651,0.13326,1,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0080134,0.12591,0.13837,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.021265,0.12583,0.1212,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.018736,0.12559,0.15876,1,1
3,GO FIBROBLAST MIGRATION,0.028348,0.12515,0.20343,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.023112,0.12494,0.14453,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.008797,0.12461,0.18714,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.031957,0.12455,0.11145,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.050584,0.12436,0.15833,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.012106,0.12431,0.17466,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.052482,0.12351,0.14353,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.015104,0.12343,0.13017,1,1
3,GO CELLULAR RESPONSE TO RADIATION,0.01266,0.12333,0.1502,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.012106,0.12326,0.14703,1,1
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.028348,0.12303,0.14262,1,1
3,GO VIRAL TRANSLATION,0.011574,0.12274,0.16336,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.011574,0.12229,0.16427,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.016475,0.12208,0.16563,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.021265,0.12188,0.13773,1,1
3,GO MITOTIC CELL CYCLE ARREST,0.045233,0.1215,0.17817,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.015104,0.12099,0.19734,1,1
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.046961,0.12092,0.1849,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.043559,0.1209,0.17345,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.013235,0.12012,0.16883,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.011574,0.12007,0.16565,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.048745,0.11977,0.14149,1,1
3,GO MAINTENANCE OF CELL NUMBER,0.02951,0.11967,0.17332,1,1
3,GO VITAMIN METABOLIC PROCESS,0.0080134,0.11908,0.15649,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0015041,0.1185,0.17502,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.024086,0.11807,0.1428,1,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.011063,0.11771,0.13285,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.040368,0.11692,0.15302,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.054439,0.11601,0.16294,1,1
3,GO STEM CELL DIFFERENTIATION,0.027226,0.11542,0.16963,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.040368,0.11528,0.13891,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.0092139,0.11492,0.15858,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.02951,0.11448,0.16194,1,1
3,GO PLACENTA DEVELOPMENT,0.037377,0.11447,0.17474,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.010572,0.11444,0.17523,1,1
3,GO MULTI ORGANISM LOCALIZATION,0.0096484,0.11427,0.13792,1,1
3,GO SPERM EGG RECOGNITION,0.023112,0.11383,0.13627,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.028348,0.11356,0.15343,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.037377,0.11294,0.10668,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.016475,0.11289,0.13374,1,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.0040644,0.11218,0.20739,1,1
3,GO JNK CASCADE,0.052482,0.11174,0.16473,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0034935,0.11172,0.15644,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.037377,0.11136,0.15419,1,1
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.033245,0.11099,0.14647,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.037377,0.11083,0.16347,1,1
3,GO REGENERATION,0.033245,0.1104,0.15908,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.006955,0.10992,0.15775,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.054439,0.10944,0.18366,1,1
3,GO TRNA METHYLATION,0.048745,0.10923,0.13799,1,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.048745,0.10877,0.13097,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.045233,0.10835,0.12231,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033245,0.10818,0.15242,1,1
3,GO PROTEIN TETRAMERIZATION,0.017954,0.10798,0.15762,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.048745,0.10763,0.094039,1,1
3,GO REGULATION OF CELL DEATH,0.024086,0.10755,0.15188,1,1
3,GO RNA CATABOLIC PROCESS,0.0049572,0.10744,0.10662,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0036751,0.10731,0.15703,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.040368,0.10727,0.25311,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.024086,0.10719,0.16697,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.034576,0.10708,0.12864,1,1
3,GO RIBOSOME BIOGENESIS,0.020391,0.10629,0.1083,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.014457,0.10572,0.14664,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.023112,0.10373,0.15004,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.008797,0.10283,0.12666,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035953,0.10254,0.11749,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.041938,0.10247,0.13814,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.043559,0.10222,0.17427,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.02951,0.10219,0.14556,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.045233,0.10162,0.14925,1,1
3,GO REGULATION OF FIBROBLAST MIGRATION,0.050584,0.10137,0.19258,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.030713,0.10123,0.17017,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.038848,0.10069,0.14298,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0029965,0.10059,0.13805,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.035953,0.10045,0.10832,1,1
3,GO IMPORT INTO NUCLEUS,0.043559,0.10003,0.12762,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.007293,0.099915,0.15435,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.052482,0.098073,0.15643,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.016475,0.098037,0.15196,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.031957,0.097487,0.15589,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.0057394,0.09626,0.13594,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.031957,0.095641,0.15986,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.041938,0.094574,0.14322,1,1
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.043559,0.09422,0.15109,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0049572,0.092776,0.098507,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.030713,0.09277,0.1207,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.023112,0.092596,0.14502,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.050584,0.092561,0.12731,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.038848,0.092545,0.14502,1,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023112,0.092265,0.12824,1,1
3,GO VIRAL GENE EXPRESSION,0.0096484,0.092033,0.099999,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.045233,0.0917,0.14159,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.022172,0.089858,0.11649,1,1
3,GO RRNA METABOLIC PROCESS,0.043559,0.089127,0.10286,1,1
3,GO APOPTOTIC PROCESS,0.054439,0.089103,0.13317,1,1
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.052482,0.087493,0.16953,1,1
3,GO ACTIN NUCLEATION,0.043559,0.087164,0.13496,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.027226,0.086674,0.13158,1,1
3,GO MATURATION OF LSU RRNA,0.045233,0.086655,0.12247,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.021265,0.086549,0.13849,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.040368,0.085715,0.14417,1,1
3,GO LIPID METABOLIC PROCESS,0.052482,0.084313,0.1309,1,1
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.040368,0.083113,0.16235,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.080845,0.0806,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.020391,0.078433,0.14226,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0092139,0.073851,0.091068,1,1
3,GO REGULATION OF GLIOGENESIS,0.045233,0.071421,0.1573,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.027226,0.070135,0.076223,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.023112,0.069482,0.11294,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.048745,0.06642,0.11597,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.033245,0.06307,0.074914,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.034576,0.061187,0.096183,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.021265,0.060656,0.084121,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00040321,0.70811,0.60504,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00014989,0.69761,0.58521,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,7.8298e-05,0.69542,0.70655,1,1
4,GO REGULATION OF SYNAPSE MATURATION,2.636e-05,0.69329,0.6735,1,1
4,GO SYNAPTIC MEMBRANE ADHESION,0.00010866,0.67727,0.59749,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0054671,0.6618,0.49041,1,1
4,GO COMMISSURAL NEURON AXON GUIDANCE,2.2907e-05,0.65709,0.60368,1,1
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00048214,0.63061,0.54297,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.2539e-06,0.6233,0.72331,1,1
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,7.3279e-05,0.62128,0.62977,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00013188,0.61163,0.53791,1,1
4,GO RESPONSE TO POTASSIUM ION,0.0011418,0.59738,0.44234,1,1
4,GO POSITIVE REGULATION OF NEURON MIGRATION,5.9985e-05,0.58915,0.61787,1,1
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00028019,0.5875,0.55627,1,1
4,GO PREPULSE INHIBITION,9.5377e-05,0.57503,0.57759,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00020554,0.57378,0.51728,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.013235,0.5734,0.45056,1,1
4,GO SYNAPSE MATURATION,7.8298e-05,0.55784,0.59539,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00054254,0.55783,0.45075,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.00010181,0.5444,0.54077,1,1
4,GO TELENCEPHALON REGIONALIZATION,0.00026348,0.54383,0.49972,1,1
4,GO DISTAL TUBULE DEVELOPMENT,0.0042727,0.54273,0.45889,1,1
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00054254,0.53569,0.49576,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00014989,0.53229,0.51512,1,1
4,GO REGULATION OF NEURON MIGRATION,4.8997e-05,0.52481,0.54966,1,1
4,GO CELL PROLIFERATION IN HINDBRAIN,0.00021879,0.52263,0.43697,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,5.9985e-05,0.51596,0.5284,1,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.00060992,0.51378,0.5628,1,1
4,GO FOREBRAIN REGIONALIZATION,3.4805e-05,0.51261,0.55526,1,1
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0019699,0.50008,0.5539,1,1
4,GO CARDIAC VENTRICLE FORMATION,0.00045436,0.49437,0.50545,1,1
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00012367,0.49121,0.41526,1,1
4,GO VOCALIZATION BEHAVIOR,0.00035748,0.48652,0.45257,1,1
4,GO MICROTUBULE DEPOLYMERIZATION,0.00014989,0.47855,0.46884,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.0044907,0.4781,0.45363,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00035748,0.47424,0.49101,1,1
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,5.6086e-05,0.47302,0.43336,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025096,0.47042,0.35755,1,1
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0023095,0.46574,0.39276,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.00045436,0.46333,0.51353,1,1
4,GO DENDRITIC TRANSPORT,0.00051151,0.45911,0.48817,1,1
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012758,0.45704,0.38282,1,1
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00042807,0.456,0.44737,1,1
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00026348,0.45544,0.41171,1,1
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0016767,0.45537,0.39487,1,1
4,GO SPINAL CORD PATTERNING,0.00051151,0.45295,0.48665,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00014989,0.44893,0.46283,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00096503,0.44666,0.41388,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00042807,0.44646,0.42091,1,1
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00035748,0.44296,0.44362,1,1
4,GO PROTEIN LOCALIZATION TO AXON,0.00054254,0.44268,0.46204,1,1
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00029789,0.43943,0.4514,1,1
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00057531,0.43877,0.41406,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.3279e-05,0.43471,0.51609,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00021879,0.42958,0.41162,1,1
4,GO NEURONAL ION CHANNEL CLUSTERING,0.00014062,0.42886,0.47088,1,1
4,GO CARDIAC CHAMBER FORMATION,0.0025648,0.42092,0.40837,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00060992,0.41781,0.41797,1,1
4,GO CEREBELLAR CORTEX DEVELOPMENT,3.9936e-05,0.41768,0.40023,1,1
4,GO CEREBELLAR CORTEX MORPHOGENESIS,4.2763e-05,0.41019,0.42292,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.00048214,0.41009,0.35954,1,1
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0023095,0.40982,0.38219,1,1
4,GO ANATOMICAL STRUCTURE REGRESSION,0.0011418,0.4088,0.40857,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00086166,0.40825,0.35631,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0027019,0.40807,0.40193,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,9.5377e-05,0.40693,0.42517,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00060992,0.40559,0.37363,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.033245,0.40277,0.23285,1,1
4,GO NEURON FATE SPECIFICATION,0.0012071,0.40182,0.42452,1,1
4,GO DENTATE GYRUS DEVELOPMENT,0.00068502,0.40161,0.48953,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0003797,0.4016,0.40468,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031664,0.40008,0.41451,1,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0025648,0.39922,0.45385,1,1
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0057394,0.39872,0.32489,1,1
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.6086e-05,0.39854,0.47298,1,1
4,GO CELL PROLIFERATION IN FOREBRAIN,0.0013481,0.39394,0.38633,1,1
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0018673,0.39374,0.32697,1,1
4,GO GROWTH HORMONE SECRETION,0.00054254,0.39209,0.42023,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.0014241,0.39101,0.36428,1,1
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00045436,0.39089,0.41401,1,1
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00024771,0.39042,0.42004,1,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00076864,0.39034,0.34591,1,1
4,GO FORELIMB MORPHOGENESIS,0.00072571,0.38895,0.37548,1,1
4,GO NEURON CELL CELL ADHESION,0.0012071,0.38702,0.48221,1,1
4,GO HISTONE H3 K27 METHYLATION,0.0014241,0.38685,0.36844,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0027019,0.38679,0.29927,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00096503,0.38619,0.33854,1,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00064645,0.38596,0.42306,1,1
4,GO MATING BEHAVIOR,0.00051151,0.38559,0.34615,1,1
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0015041,0.38409,0.36654,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00086166,0.38384,0.37771,1,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,7.8298e-05,0.38113,0.49622,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0027019,0.37922,0.3196,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0083971,0.37915,0.48881,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0040644,0.37755,0.38633,1,1
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00042807,0.37718,0.4047,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0014241,0.37592,0.35808,1,1
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0020776,0.37579,0.35354,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0027019,0.37535,0.41355,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0003797,0.37415,0.36076,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00051151,0.37256,0.38627,1,1
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0019699,0.37149,0.39542,1,1
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.00042807,0.37117,0.50219,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00020554,0.37057,0.40787,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0013481,0.36865,0.36101,1,1
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00332,0.36854,0.37571,1,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00033648,0.36793,0.35062,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00010181,0.36732,0.40915,1,1
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0044907,0.36508,0.30593,1,1
4,GO EPITHELIAL CELL MATURATION,0.007293,0.36385,0.29058,1,1
4,GO STARTLE RESPONSE,0.00017019,0.36335,0.45381,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.2763e-05,0.36294,0.42168,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0021907,0.36266,0.33903,1,1
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00051151,0.36249,0.34308,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0076456,0.36236,0.28438,1,1
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00057531,0.36227,0.38739,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0019699,0.36126,0.41229,1,1
4,GO MEIOTIC CHROMOSOME SEPARATION,0.00072571,0.36057,0.41723,1,1
4,GO CRANIAL NERVE MORPHOGENESIS,0.012106,0.35979,0.29759,1,1
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0057394,0.35952,0.27907,1,1
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0015882,0.35867,0.31872,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00031664,0.3581,0.43926,1,1
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0017696,0.35617,0.31697,1,1
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.0017696,0.35445,0.28746,1,1
4,GO METENCEPHALON DEVELOPMENT,6.8565e-05,0.35443,0.35022,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0017696,0.35423,0.41607,1,1
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00096503,0.35419,0.36369,1,1
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0029965,0.35347,0.30535,1,1
4,GO HISTONE H3 K9 METHYLATION,0.00072571,0.35306,0.34772,1,1
4,GO NEURAL TUBE PATTERNING,0.0021907,0.353,0.28568,1,1
4,GO CORPUS CALLOSUM DEVELOPMENT,0.00060992,0.35251,0.373,1,1
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00064645,0.35202,0.33871,1,1
4,GO CEREBELLAR CORTEX FORMATION,0.00026348,0.35171,0.38723,1,1
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0012758,0.35098,0.35202,1,1
4,GO RESPONSE TO L GLUTAMATE,7.8298e-05,0.35062,0.35859,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00033648,0.35062,0.35648,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00076864,0.35041,0.35312,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00057531,0.34886,0.33235,1,1
4,GO RESPONSE TO COCAINE,0.00024771,0.34764,0.34935,1,1
4,GO NUCLEUS LOCALIZATION,0.00035748,0.34699,0.41567,1,1
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00018128,0.34625,0.37059,1,1
4,GO MAGNESIUM ION HOMEOSTASIS,0.0038653,0.34504,0.34996,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0010798,0.34194,0.35297,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00086166,0.34157,0.34631,1,1
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00096503,0.33998,0.34357,1,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0010209,0.33871,0.33337,1,1
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0012071,0.33763,0.34965,1,1
4,GO REGULATION OF SPINDLE CHECKPOINT,0.00014989,0.33636,0.34914,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.0038653,0.33441,0.31365,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00020554,0.33429,0.37891,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0063209,0.33427,0.29015,1,1
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00015974,0.33316,0.33611,1,1
4,GO ACROSOME ASSEMBLY,0.0047188,0.33291,0.29312,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0012758,0.33262,0.3096,1,1
4,GO CARTILAGE MORPHOGENESIS,0.013834,0.33217,0.30668,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00091199,0.3314,0.33471,1,1
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0015041,0.33111,0.27936,1,1
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013834,0.33064,0.28649,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00081392,0.33053,0.30579,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.00035748,0.32943,0.33309,1,1
4,GO DENDRITE MORPHOGENESIS,0.00029789,0.32889,0.35861,1,1
4,GO URETER DEVELOPMENT,0.024086,0.32827,0.39695,1,1
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.0018673,0.32744,0.34739,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0014241,0.32652,0.38694,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00026348,0.32592,0.38192,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0063209,0.32578,0.28856,1,1
4,GO RESPONSE TO NICOTINE,0.00068502,0.32547,0.34052,1,1
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00026348,0.32451,0.3157,1,1
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0013481,0.32411,0.30863,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00060992,0.32375,0.34801,1,1
4,GO INNERVATION,0.0040644,0.32308,0.45515,1,1
4,GO FACIAL NERVE MORPHOGENESIS,0.050584,0.32191,0.26078,1,1
4,GO BRAIN MORPHOGENESIS,0.00072571,0.3219,0.31469,1,1
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.0036751,0.32075,0.29271,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.015104,0.31985,0.33992,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00014062,0.31844,0.36642,1,1
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.0014241,0.31752,0.2952,1,1
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0027019,0.31696,0.29305,1,1
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0029965,0.31663,0.30344,1,1
4,GO NEURAL RETINA DEVELOPMENT,0.00042807,0.31641,0.34402,1,1
4,GO NUCLEAR MIGRATION,0.00060992,0.31598,0.41547,1,1
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00040321,0.31561,0.31275,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.011063,0.31518,0.3381,1,1
4,GO PRESYNAPSE ORGANIZATION,0.00057531,0.3151,0.35321,1,1
4,GO NEURAL CREST FORMATION,0.0083971,0.31478,0.35053,1,1
4,GO RESPONSE TO INSECTICIDE,0.0083971,0.31469,0.27655,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0080134,0.31427,0.26601,1,1
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.0010798,0.31426,0.39089,1,1
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0172,0.31422,0.28561,1,1
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00072571,0.31421,0.3705,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.0044907,0.31418,0.27644,1,1
4,GO CATECHOLAMINE UPTAKE,0.00081392,0.31404,0.36716,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.0019699,0.31377,0.36166,1,1
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0010798,0.31242,0.28334,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00086166,0.31233,0.34987,1,1
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0023095,0.31093,0.35744,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0031545,0.31026,0.34593,1,1
4,GO HEART VALVE FORMATION,0.0038653,0.30842,0.42054,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0003797,0.30817,0.34647,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.018736,0.30805,0.3396,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.0017696,0.30774,0.35926,1,1
4,GO AXONEME ASSEMBLY,0.031957,0.30728,0.22514,1,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0015041,0.30714,0.29624,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.040368,0.30636,0.27505,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.00014989,0.30584,0.3316,1,1
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0014241,0.30538,0.32007,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0060238,0.30535,0.28099,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00086166,0.30526,0.27979,1,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00048214,0.30512,0.324,1,1
4,GO SPINAL CORD DEVELOPMENT,0.00014062,0.30481,0.38779,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0016767,0.3045,0.2984,1,1
4,GO NEURON MIGRATION,7.3279e-05,0.3036,0.40087,1,1
4,GO CARNITINE SHUTTLE,0.00042807,0.3034,0.32291,1,1
4,GO MICROTUBULE BUNDLE FORMATION,0.0044907,0.3032,0.25957,1,1
4,GO RETINAL ROD CELL DIFFERENTIATION,0.022172,0.30316,0.23418,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0010209,0.30274,0.31955,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00031664,0.30238,0.3434,1,1
4,GO ADULT BEHAVIOR,0.0003797,0.3022,0.33728,1,1
4,GO THALAMUS DEVELOPMENT,0.0052065,0.30155,0.33078,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.023112,0.30103,0.25755,1,1
4,GO ASYMMETRIC CELL DIVISION,0.010101,0.30083,0.24585,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0012071,0.30038,0.3451,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0049572,0.30004,0.34709,1,1
4,GO SUCKLING BEHAVIOR,0.0066311,0.29927,0.31724,1,1
4,GO RESPONSE TO LEUCINE,0.0019699,0.29891,0.35624,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0018673,0.29783,0.28251,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00081392,0.29774,0.32505,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00096503,0.29766,0.31734,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0015041,0.29752,0.32203,1,1
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00057531,0.29745,0.33533,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0049572,0.29744,0.31566,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.015104,0.29722,0.26817,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0013481,0.29698,0.26231,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.0019699,0.29683,0.3562,1,1
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00096503,0.29641,0.32157,1,1
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0047188,0.29627,0.34325,1,1
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.025096,0.29517,0.26331,1,1
4,GO NEUROTRANSMITTER SECRETION,0.00091199,0.29435,0.32642,1,1
4,GO REGULATION OF CHROMATIN BINDING,0.00072571,0.29423,0.33113,1,1
4,GO DENDRITE DEVELOPMENT,0.00029789,0.29394,0.33372,1,1
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.006955,0.29388,0.27886,1,1
4,GO DENDRITIC SPINE DEVELOPMENT,0.00023283,0.29377,0.34665,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00068502,0.29257,0.33739,1,1
4,GO MITOTIC SISTER CHROMATID COHESION,0.00031664,0.29224,0.3285,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00048214,0.29217,0.34352,1,1
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00051151,0.29138,0.33383,1,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.011574,0.29135,0.27509,1,1
4,GO ANTEROGRADE AXONAL TRANSPORT,0.00096503,0.29122,0.3104,1,1
4,GO HIPPOCAMPUS DEVELOPMENT,6.8565e-05,0.28914,0.31494,1,1
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0003797,0.28896,0.3002,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0080134,0.28884,0.30363,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0016767,0.28828,0.27664,1,1
4,GO MICROTUBULE BASED MOVEMENT,0.00086166,0.28824,0.27037,1,1
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00051151,0.28756,0.33385,1,1
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00042807,0.28709,0.30618,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.013235,0.28642,0.30835,1,1
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.01266,0.28605,0.26314,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.00021879,0.2859,0.33741,1,1
4,GO TRANSPORT ALONG MICROTUBULE,0.00045436,0.28575,0.28475,1,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.043559,0.28545,0.25213,1,1
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.01266,0.28503,0.20093,1,1
4,GO MICROTUBULE POLYMERIZATION,0.00076864,0.28403,0.32533,1,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00086166,0.28367,0.33433,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0015041,0.2832,0.32003,1,1
4,GO G0 TO G1 TRANSITION,0.0012758,0.28283,0.2958,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00054254,0.28241,0.33033,1,1
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0021907,0.28229,0.31422,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0013481,0.28203,0.30885,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.00076864,0.28139,0.30889,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00019306,0.28112,0.3264,1,1
4,GO INTERSTRAND CROSS LINK REPAIR,0.00060992,0.28043,0.2956,1,1
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0016767,0.28017,0.43052,1,1
4,GO REGULATION OF AXONOGENESIS,0.0012071,0.27998,0.33567,1,1
4,GO RESPONSE TO FOOD,0.0012071,0.27987,0.28344,1,1
4,GO RESPONSE TO VITAMIN A,0.0083971,0.27979,0.2048,1,1
4,GO NEURON RECOGNITION,0.0057394,0.27975,0.28287,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00014062,0.2796,0.31193,1,1
4,GO HINDBRAIN MORPHOGENESIS,0.00019306,0.27843,0.31613,1,1
4,GO NEUROBLAST PROLIFERATION,0.00086166,0.27812,0.30321,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00031664,0.27774,0.29169,1,1
4,GO NEURON FATE COMMITMENT,0.0020776,0.27573,0.32454,1,1
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0047188,0.27523,0.28996,1,1
4,GO RESPONSE TO HYDROXYUREA,0.0027019,0.27504,0.27046,1,1
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0057394,0.27467,0.35868,1,1
4,GO HISTONE METHYLATION,0.00068502,0.27464,0.3065,1,1
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.025096,0.27449,0.2359,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0047188,0.27444,0.25806,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.0014241,0.27395,0.29644,1,1
4,GO LEARNING,0.00048214,0.27227,0.31788,1,1
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0017696,0.27179,0.27419,1,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0028457,0.27177,0.28302,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.026142,0.27162,0.27829,1,1
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00057531,0.27151,0.40657,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00042807,0.27086,0.31106,1,1
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0044907,0.27071,0.29502,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0011418,0.27052,0.30663,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0025648,0.27004,0.28575,1,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00064645,0.26995,0.30081,1,1
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.007293,0.26982,0.29219,1,1
4,GO CELL FATE SPECIFICATION,0.00332,0.26963,0.25928,1,1
4,GO MICROTUBULE BASED TRANSPORT,0.0012758,0.26898,0.27123,1,1
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.018736,0.26838,0.29458,1,1
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0040644,0.26685,0.3035,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0023095,0.26674,0.32159,1,1
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0014241,0.26664,0.30443,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.00060992,0.26621,0.27493,1,1
4,GO MICROTUBULE BASED PROCESS,0.00040321,0.26614,0.27165,1,1
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0016767,0.26567,0.28703,1,1
4,GO SYNAPSE ORGANIZATION,0.0012758,0.26551,0.29623,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0023095,0.26524,0.28282,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0076456,0.26436,0.30112,1,1
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.007293,0.26425,0.26315,1,1
4,GO UTERUS DEVELOPMENT,0.0047188,0.26361,0.34531,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00096503,0.26346,0.31384,1,1
4,GO PROTEIN METHYLATION,0.00068502,0.26323,0.28244,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0021907,0.26301,0.31583,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0010209,0.2624,0.29184,1,1
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.016475,0.26236,0.20929,1,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0023095,0.25973,0.23996,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00040321,0.25947,0.2652,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00029789,0.25881,0.31166,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.007293,0.25871,0.37091,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.01266,0.25832,0.22139,1,1
4,GO RECEPTOR CLUSTERING,0.0042727,0.25793,0.29709,1,1
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.052482,0.25754,0.24969,1,1
4,GO MICROTUBULE NUCLEATION,0.0036751,0.25715,0.30474,1,1
4,GO PROTEIN DEMETHYLATION,0.0015882,0.25571,0.31667,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00332,0.25557,0.32776,1,1
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.037377,0.25515,0.2477,1,1
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0017696,0.25509,0.25335,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0036751,0.25507,0.2384,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0003797,0.25501,0.32341,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0036751,0.25493,0.27603,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0047188,0.25474,0.25488,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.0014241,0.25466,0.29549,1,1
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0020776,0.25355,0.27254,1,1
4,GO MISMATCH REPAIR,0.00023283,0.25335,0.27502,1,1
4,GO HISTONE EXCHANGE,0.00064645,0.25332,0.29442,1,1
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.00068502,0.25308,0.23515,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0015882,0.25292,0.3369,1,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00031664,0.25264,0.27117,1,1
4,GO FEEDING BEHAVIOR,0.0066311,0.2525,0.21937,1,1
4,GO SYNAPTIC SIGNALING,0.0012758,0.25238,0.27937,1,1
4,GO NEURON PROJECTION GUIDANCE,0.0020776,0.25214,0.31253,1,1
4,GO AXONAL TRANSPORT,0.0011418,0.25176,0.31034,1,1
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.013834,0.25164,0.25184,1,1
4,GO EXPLORATION BEHAVIOR,0.040368,0.25161,0.20143,1,1
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00014989,0.25152,0.33033,1,1
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00060992,0.25104,0.27176,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.0044907,0.25015,0.32886,1,1
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.007293,0.24983,0.26421,1,1
4,GO HISTONE H3 K4 METHYLATION,0.00057531,0.2498,0.29841,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.00086166,0.24901,0.32839,1,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.00096503,0.2485,0.25185,1,1
4,GO CHROMATIN REMODELING,0.00064645,0.24849,0.27047,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0092139,0.24773,0.27472,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.0012758,0.24762,0.27365,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.015104,0.24718,0.20501,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,0.0017696,0.24667,0.27644,1,1
4,GO RECOMBINATIONAL REPAIR,0.00091199,0.2459,0.27227,1,1
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.024086,0.24588,0.20264,1,1
4,GO HINDBRAIN DEVELOPMENT,0.00040321,0.24539,0.27815,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING,0.00017019,0.24523,0.26542,1,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.011574,0.24518,0.22196,1,1
4,GO REGULATION OF FEEDING BEHAVIOR,0.00064645,0.24506,0.25289,1,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.040368,0.24447,0.19254,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.008797,0.24398,0.25377,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.00010181,0.24385,0.34376,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.017954,0.24342,0.23784,1,1
4,GO DNA DEPENDENT DNA REPLICATION,0.0013481,0.24325,0.26842,1,1
4,GO STRESS GRANULE ASSEMBLY,0.00051151,0.24315,0.29847,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.015776,0.24313,0.21182,1,1
4,GO LEFT RIGHT AXIS SPECIFICATION,0.0083971,0.24262,0.267,1,1
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0052065,0.24256,0.26071,1,1
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.00010181,0.24255,0.30361,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0003797,0.24244,0.2525,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0036751,0.24227,0.25121,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0015882,0.24181,0.2792,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.007293,0.24178,0.24519,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0024341,0.24169,0.28721,1,1
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0040644,0.24133,0.27408,1,1
4,GO REGULATION OF CYTOKINESIS,0.0015041,0.24095,0.26442,1,1
4,GO MYOBLAST MIGRATION,0.052482,0.23964,0.20767,1,1
4,GO ECTODERM DEVELOPMENT,0.0024341,0.2389,0.24164,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0024341,0.2389,0.2937,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0040644,0.23863,0.26013,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0013481,0.23862,0.30924,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.0034935,0.23859,0.28882,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0019699,0.23712,0.30603,1,1
4,GO NUCLEOSOME ORGANIZATION,0.00057531,0.2366,0.27707,1,1
4,GO REGULATION OF BEHAVIOR,0.00332,0.23622,0.22057,1,1
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.014457,0.23583,0.27871,1,1
4,GO NON RECOMBINATIONAL REPAIR,0.0011418,0.23583,0.23718,1,1
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0003797,0.23578,0.24163,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.00064645,0.23536,0.26033,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0027019,0.23496,0.25156,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00040321,0.23496,0.27025,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00057531,0.23475,0.27471,1,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.010572,0.23444,0.28595,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.00057531,0.23423,0.29776,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0029965,0.2339,0.27638,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0023095,0.2337,0.25394,1,1
4,GO DNA REPLICATION,0.00064645,0.23364,0.26841,1,1
4,GO LOCOMOTORY BEHAVIOR,0.00091199,0.23226,0.30879,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0052065,0.2321,0.27008,1,1
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.015776,0.23198,0.31519,1,1
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0012758,0.23193,0.27176,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00021879,0.23189,0.29094,1,1
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.045233,0.23182,0.16315,1,1
4,GO SPINDLE LOCALIZATION,0.0031545,0.23181,0.24368,1,1
4,GO PALLIUM DEVELOPMENT,0.00031664,0.23181,0.28666,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0015041,0.23061,0.26377,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00072571,0.23033,0.33673,1,1
4,GO INCLUSION BODY ASSEMBLY,0.0054671,0.23009,0.25918,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0016767,0.22952,0.29219,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.22936,0.23313,1,1
4,GO SPERM MOTILITY,0.0049572,0.22929,0.19725,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.0038653,0.22918,0.26941,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0066311,0.22909,0.27042,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0080134,0.22905,0.21104,1,1
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0020776,0.22897,0.27359,1,1
4,GO REGULATION OF MRNA 3 END PROCESSING,0.0018673,0.22838,0.23955,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0020776,0.22831,0.25823,1,1
4,GO HISTONE H4 DEACETYLATION,0.0076456,0.22767,0.19898,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0016767,0.22654,0.2751,1,1
4,GO DNA CONFORMATION CHANGE,0.00081392,0.2254,0.27446,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.020391,0.22488,0.22642,1,1
4,GO REGULATION OF APPETITE,0.043559,0.22392,0.17449,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00051151,0.22343,0.2902,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.00096503,0.22311,0.27851,1,1
4,GO DNA REPLICATION INITIATION,0.0052065,0.22304,0.2335,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0024341,0.223,0.29901,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0076456,0.22279,0.26391,1,1
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00332,0.22256,0.24898,1,1
4,GO TORC1 SIGNALING,0.0015882,0.22207,0.28478,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.0021907,0.22199,0.27017,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0017696,0.22148,0.2295,1,1
4,GO CILIUM MOVEMENT,0.014457,0.22102,0.19729,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.024086,0.22087,0.24455,1,1
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.0092139,0.22066,0.26513,1,1
4,GO NUCLEOSOME ASSEMBLY,0.0011418,0.21929,0.30024,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.038848,0.21831,0.15521,1,1
4,GO MIDGUT DEVELOPMENT,0.046961,0.21804,0.18829,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.052482,0.21726,0.20639,1,1
4,GO REGULATION OF CHROMOSOME SEPARATION,0.00011593,0.21675,0.28403,1,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0013481,0.21659,0.27029,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0019699,0.21658,0.2543,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0052065,0.21597,0.20277,1,1
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00096503,0.21583,0.21659,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0015041,0.21561,0.23423,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.022172,0.2156,0.2245,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.010572,0.21555,0.21865,1,1
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00096503,0.21377,0.22077,1,1
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0021907,0.21309,0.23415,1,1
4,GO GOLGI RIBBON FORMATION,0.0025648,0.21278,0.30808,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.013235,0.21225,0.25839,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.21224,0.23927,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.0029965,0.21213,0.24297,1,1
4,GO DNA PACKAGING,0.00054254,0.21178,0.29377,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0011418,0.21155,0.24873,1,1
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0060238,0.21121,0.19198,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0040644,0.21083,0.28762,1,1
4,GO METANEPHROS MORPHOGENESIS,0.025096,0.21034,0.22118,1,1
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0044907,0.21029,0.16074,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.028348,0.21014,0.19418,1,1
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.02951,0.21001,0.26274,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00086166,0.20985,0.27462,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0049572,0.20958,0.24881,1,1
4,GO NEGATIVE CHEMOTAXIS,0.028348,0.20928,0.23815,1,1
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0016767,0.20862,0.2252,1,1
4,GO DNA GEOMETRIC CHANGE,0.0014241,0.20862,0.26159,1,1
4,GO TELENCEPHALON DEVELOPMENT,0.0003797,0.20854,0.27866,1,1
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00031664,0.20806,0.26084,1,1
4,GO MEMBRANE DOCKING,0.0038653,0.20784,0.22346,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.013235,0.20738,0.23523,1,1
4,GO MOTOR NEURON AXON GUIDANCE,0.0080134,0.20712,0.26192,1,1
4,GO DOUBLE STRAND BREAK REPAIR,0.0014241,0.2069,0.24777,1,1
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00015974,0.20605,0.27782,1,1
4,GO ONE CARBON METABOLIC PROCESS,0.033245,0.20579,0.15175,1,1
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0023095,0.20524,0.28687,1,1
4,GO POSITIVE REGULATION OF RNA SPLICING,0.0036751,0.20469,0.22867,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0027019,0.20436,0.18666,1,1
4,GO RNA POLYADENYLATION,0.0052065,0.20334,0.22034,1,1
4,GO ACTIN FILAMENT BASED TRANSPORT,0.045233,0.20319,0.22579,1,1
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0010798,0.20293,0.20857,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0029965,0.20284,0.19481,1,1
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0014241,0.20275,0.21402,1,1
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.026142,0.20249,0.18743,1,1
4,GO HISTONE MONOUBIQUITINATION,0.011574,0.20202,0.19975,1,1
4,GO LOCALIZATION WITHIN MEMBRANE,0.019548,0.20172,0.21748,1,1
4,GO REGULATION OF OOGENESIS,0.035953,0.20059,0.15127,1,1
4,GO ASSOCIATIVE LEARNING,0.00068502,0.20046,0.26233,1,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.013834,0.20007,0.19905,1,1
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00086166,0.19995,0.22874,1,1
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0031545,0.19846,0.24605,1,1
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.0028457,0.19835,0.22765,1,1
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0018673,0.19827,0.24639,1,1
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0010798,0.1979,0.26525,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.012106,0.1975,0.21626,1,1
4,GO FOREBRAIN DEVELOPMENT,0.00035748,0.19679,0.28001,1,1
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0096484,0.19608,0.18181,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.028348,0.196,0.19731,1,1
4,GO HISTONE UBIQUITINATION,0.0057394,0.19584,0.2142,1,1
4,GO FUCOSYLATION,0.024086,0.19507,0.18522,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00332,0.19486,0.25119,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0044907,0.19418,0.29342,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.046961,0.19394,0.146,1,1
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0036751,0.19354,0.2151,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.022172,0.19229,0.19482,1,1
4,GO LIMBIC SYSTEM DEVELOPMENT,0.00064645,0.1911,0.2513,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.016475,0.19102,0.22133,1,1
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.02951,0.19029,0.22976,1,1
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.011063,0.19007,0.21476,1,1
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0080134,0.18999,0.16194,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.046961,0.18975,0.28597,1,1
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.017954,0.18944,0.22679,1,1
4,GO NUCLEAR PORE ORGANIZATION,0.011574,0.18898,0.25804,1,1
4,GO PROTEIN MONOUBIQUITINATION,0.0044907,0.18808,0.20917,1,1
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0012758,0.18742,0.23323,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0060238,0.18702,0.23617,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.024086,0.1856,0.18013,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.028348,0.18552,0.19141,1,1
4,GO PITUITARY GLAND DEVELOPMENT,0.011574,0.1852,0.28364,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.0014241,0.18483,0.16439,1,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0044907,0.18396,0.23148,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00096503,0.1836,0.22244,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0042727,0.1834,0.20463,1,1
4,GO METHYLATION,0.0016767,0.18316,0.19978,1,1
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0049572,0.18305,0.19127,1,1
4,GO ATP TRANSPORT,0.031957,0.18275,0.1588,1,1
4,GO CARNITINE METABOLIC PROCESS,0.033245,0.18226,0.15822,1,1
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.0013481,0.18179,0.19786,1,1
4,GO FATTY ACID BETA OXIDATION,0.037377,0.18168,0.12614,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0017696,0.1812,0.23432,1,1
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00332,0.18051,0.22814,1,1
4,GO REGULATION OF DNA REPLICATION,0.0013481,0.18016,0.23747,1,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.037377,0.17923,0.18293,1,1
4,GO DNA METABOLIC PROCESS,0.0042727,0.17884,0.1779,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0036751,0.17723,0.21632,1,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.007293,0.17697,0.2612,1,1
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.027226,0.1767,0.2502,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.007293,0.17643,0.22992,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.013235,0.17581,0.20369,1,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.0034935,0.17537,0.23508,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.050584,0.17489,0.17127,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0019699,0.17443,0.22081,1,1
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0018673,0.1743,0.23425,1,1
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0044907,0.17386,0.21043,1,1
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0057394,0.17374,0.2004,1,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0054671,0.1731,0.20266,1,1
4,GO NCRNA TRANSCRIPTION,0.0025648,0.17273,0.17507,1,1
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.048745,0.17226,0.13785,1,1
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.012106,0.17207,0.20182,1,1
4,GO REGULATION OF CELL CYCLE PROCESS,0.0012758,0.17014,0.20746,1,1
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0038653,0.1698,0.16033,1,1
4,GO NUCLEAR BODY ORGANIZATION,0.0057394,0.1688,0.18938,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0034935,0.16879,0.29643,1,1
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.018736,0.16766,0.19165,1,1
4,GO ORGANELLE LOCALIZATION,0.010101,0.16726,0.17777,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.031957,0.16692,0.15472,1,1
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.024086,0.16677,0.17495,1,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0066311,0.16554,0.23542,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.023112,0.16542,0.24905,1,1
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0080134,0.16489,0.13107,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0028457,0.16403,0.20987,1,1
4,GO NEGATIVE REGULATION OF CELL AGING,0.0052065,0.16402,0.23249,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.023112,0.1634,0.20628,1,1
4,GO PROTEIN SUMOYLATION,0.0031545,0.16312,0.21261,1,1
4,GO REGULATION OF RNA BINDING,0.011063,0.16279,0.16221,1,1
4,GO RNA SURVEILLANCE,0.020391,0.16243,0.12057,1,1
4,GO DEMETHYLATION,0.00332,0.16218,0.22227,1,1
4,GO RRNA TRANSCRIPTION,0.0031545,0.16213,0.18292,1,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.052482,0.16207,0.18411,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.021265,0.16143,0.1745,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0172,0.16143,0.18209,1,1
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.024086,0.16135,0.2242,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.0092139,0.16089,0.24439,1,1
4,GO REGULATION OF PROTEIN SUMOYLATION,0.026142,0.16064,0.18174,1,1
4,GO FOREBRAIN GENERATION OF NEURONS,0.024086,0.15963,0.19632,1,1
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0034935,0.15899,0.17021,1,1
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0096484,0.15893,0.20445,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.031957,0.1582,0.19293,1,1
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.020391,0.15777,0.21344,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.035953,0.15718,0.25274,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.033245,0.15697,0.22188,1,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.0076456,0.15528,0.16964,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0063209,0.15474,0.14418,1,1
4,GO OVULATION CYCLE PROCESS,0.052482,0.15351,0.16327,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0054671,0.15321,0.16213,1,1
4,GO RHYTHMIC BEHAVIOR,0.021265,0.15276,0.18637,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.040368,0.15174,0.097996,1,1
4,GO DNA METHYLATION,0.010572,0.15149,0.17274,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0044907,0.15145,0.20708,1,1
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0029965,0.15114,0.18459,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0060238,0.1508,0.24211,1,1
4,GO NCRNA EXPORT FROM NUCLEUS,0.0080134,0.1505,0.20666,1,1
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0040644,0.15042,0.15843,1,1
4,GO RNA DESTABILIZATION,0.035953,0.14909,0.19579,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.046961,0.14903,0.1185,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.006955,0.14815,0.1232,1,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.020391,0.14787,0.17186,1,1
4,GO TRNA TRANSPORT,0.010101,0.14713,0.18688,1,1
4,GO LYSOSOMAL TRANSPORT,0.046961,0.14709,0.17179,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.031957,0.14643,0.20799,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0080134,0.14588,0.21762,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0083971,0.1456,0.15354,1,1
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.034576,0.14523,0.16578,1,1
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.013834,0.14411,0.22808,1,1
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0018673,0.1441,0.23822,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.027226,0.14352,0.18621,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.020391,0.14351,0.10861,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.033245,0.14244,0.14211,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.007293,0.14175,0.1751,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.015776,0.14148,0.14515,1,1
4,GO SNRNA PROCESSING,0.045233,0.14116,0.10012,1,1
4,GO REGULATION OF HISTONE UBIQUITINATION,0.0029965,0.13989,0.21064,1,1
4,GO RESPONSE TO AMINO ACID STARVATION,0.007293,0.13968,0.19952,1,1
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.007293,0.13948,0.15621,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0031545,0.13915,0.14051,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.015104,0.13889,0.22224,1,1
4,GO APOPTOTIC DNA FRAGMENTATION,0.012106,0.13847,0.16847,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.0063209,0.13798,0.12778,1,1
4,GO MRNA CLEAVAGE,0.016475,0.13774,0.19899,1,1
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021265,0.13759,0.27784,1,1
4,GO MAINTENANCE OF CELL NUMBER,0.013834,0.13571,0.17277,1,1
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.0057394,0.13571,0.16744,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.01266,0.13463,0.16257,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.011063,0.13335,0.19916,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.012106,0.13318,0.14931,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.023112,0.13223,0.14153,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0049572,0.13192,0.17211,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.011063,0.1311,0.12167,1,1
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.031957,0.13099,0.11446,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.033245,0.12975,0.1321,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.052482,0.12915,0.12925,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.023112,0.12783,0.13588,1,1
4,GO PHOTOTRANSDUCTION,0.01266,0.1277,0.10656,1,1
4,GO TRANSLESION SYNTHESIS,0.012106,0.12564,0.14726,1,1
4,GO INTRACELLULAR MRNA LOCALIZATION,0.021265,0.12431,0.17459,1,1
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.043559,0.12351,0.1411,1,1
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.011063,0.12092,0.13524,1,1
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.015776,0.1209,0.16385,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.034576,0.1205,0.10532,1,1
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0044907,0.12043,0.1796,1,1
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.0096484,0.1191,0.16315,1,1
4,GO DNA MODIFICATION,0.0172,0.1181,0.1406,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.007293,0.1177,0.12578,1,1
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.018736,0.11331,0.098429,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.034576,0.11322,0.13734,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.052482,0.11026,0.11456,1,1
4,GO MULTI ORGANISM LOCALIZATION,0.040368,0.10948,0.12097,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.025096,0.10946,0.16034,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.045233,0.10629,0.099641,1,1
4,GO IMPORT INTO NUCLEUS,0.028348,0.10585,0.14062,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.027226,0.10277,0.18784,1,1
4,GO HISTONE MRNA METABOLIC PROCESS,0.007293,0.10102,0.13372,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.017954,0.099082,0.14197,1,1
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.054439,0.098208,0.10904,1,1
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026142,0.093265,0.17142,1,1
4,GO RESPONSE TO STARVATION,0.050584,0.091299,0.14611,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041938,0.068612,0.0871,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,0.0042727,0.72927,0.55721,1,1
5,GO LOOP OF HENLE DEVELOPMENT,0.00010866,0.65891,0.58751,1,1
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00086166,0.62543,0.62029,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0036751,0.62443,0.49293,1,1
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00068502,0.62205,0.70374,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0018673,0.58271,0.50879,1,1
5,GO INNER DYNEIN ARM ASSEMBLY,0.0092139,0.57842,0.46801,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0047188,0.57552,0.48063,1,1
5,GO DISTAL TUBULE DEVELOPMENT,0.007293,0.56769,0.42324,1,1
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0054671,0.56534,0.43859,1,1
5,GO DENSE CORE GRANULE TRANSPORT,0.00019306,0.55827,0.61589,1,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00064645,0.55692,0.56118,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.4805e-05,0.54966,0.77858,1,1
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0015882,0.54636,0.54885,1,1
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00051151,0.54355,0.4966,1,1
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00051151,0.53949,0.51005,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00029789,0.53284,0.65425,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,5.2428e-05,0.52838,0.6408,1,1
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0014241,0.5246,0.47168,1,1
5,GO PONS DEVELOPMENT,8.9327e-05,0.51956,0.61447,1,1
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00033648,0.50673,0.6922,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.011574,0.50612,0.45454,1,1
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00040321,0.50422,0.50611,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0023095,0.49926,0.5192,1,1
5,GO SYNAPTIC VESICLE DOCKING,0.00048214,0.4991,0.65805,1,1
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00028019,0.49538,0.53641,1,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0014241,0.49116,0.43881,1,1
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00010866,0.48856,0.65877,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0057394,0.48659,0.37692,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,4.8997e-05,0.48406,0.51759,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00010866,0.48173,0.42606,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.012106,0.48149,0.35686,1,1
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00076864,0.47692,0.51556,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00024771,0.47665,0.49735,1,1
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0018673,0.47566,0.41286,1,1
5,GO AXONEME ASSEMBLY,0.0018673,0.47422,0.43104,1,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0015882,0.47317,0.46473,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0013481,0.47171,0.43961,1,1
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012071,0.46652,0.50278,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00060992,0.46629,0.43672,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.00023283,0.46491,0.37878,1,1
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00010866,0.45689,0.61409,1,1
5,GO EXTRACELLULAR TRANSPORT,0.00091199,0.45244,0.42976,1,1
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00076864,0.44991,0.40718,1,1
5,GO DETECTION OF CALCIUM ION,0.00031664,0.44883,0.4309,1,1
5,GO MOTILE CILIUM ASSEMBLY,0.0042727,0.44865,0.36018,1,1
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00042807,0.44793,0.40456,1,1
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00024771,0.44568,0.51603,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,8.9327e-05,0.44381,0.52318,1,1
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,9.5377e-05,0.44301,0.59358,1,1
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0010798,0.4427,0.4463,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0012758,0.44107,0.46912,1,1
5,GO CELL JUNCTION MAINTENANCE,0.00023283,0.44008,0.40313,1,1
5,GO MICROTUBULE BUNDLE FORMATION,0.00076864,0.43937,0.40023,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,3.248e-05,0.43717,0.68607,1,1
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0025648,0.43439,0.39709,1,1
5,GO SECRETORY GRANULE LOCALIZATION,0.00076864,0.43179,0.45268,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.3279e-05,0.42911,0.4312,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.9936e-05,0.42887,0.56986,1,1
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0092139,0.42661,0.45343,1,1
5,GO LIPID DIGESTION,0.00020554,0.42629,0.48049,1,1
5,GO DENDRITIC TRANSPORT,0.008797,0.4259,0.34954,1,1
5,GO CENTRIOLE CENTRIOLE COHESION,0.014457,0.4255,0.32776,1,1
5,GO RESPONSE TO FORSKOLIN,0.00014989,0.42501,0.48962,1,1
5,GO NEURON REMODELING,0.00026348,0.42272,0.47612,1,1
5,GO INTESTINAL LIPID ABSORPTION,0.00010181,0.42125,0.50741,1,1
5,GO VOCALIZATION BEHAVIOR,0.0010798,0.41997,0.41953,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00013188,0.41988,0.56169,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00054254,0.41895,0.50663,1,1
5,GO IRON COORDINATION ENTITY TRANSPORT,0.00048214,0.41659,0.40266,1,1
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.018736,0.41647,0.34116,1,1
5,GO STARTLE RESPONSE,0.00091199,0.41521,0.39074,1,1
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014989,0.4148,0.44946,1,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00048214,0.4134,0.67439,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.5377e-05,0.41325,0.51404,1,1
5,GO COLLECTING DUCT DEVELOPMENT,0.0003797,0.40933,0.45297,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0049572,0.40892,0.43333,1,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.1347e-05,0.40627,0.60794,1,1
5,GO NEURON MATURATION,0.00018128,0.40525,0.38112,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0031545,0.40383,0.36548,1,1
5,GO PREPULSE INHIBITION,0.00332,0.40379,0.45112,1,1
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0003797,0.40341,0.40113,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0040644,0.40278,0.41352,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00051151,0.40206,0.43007,1,1
5,GO MEMBRANE DEPOLARIZATION,2.8267e-05,0.40087,0.44025,1,1
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00042807,0.39815,0.62174,1,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00033648,0.3975,0.41047,1,1
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0018673,0.3961,0.39208,1,1
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00020554,0.3952,0.52081,1,1
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0060238,0.39425,0.37889,1,1
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00010866,0.39227,0.45755,1,1
5,GO PROTEIN POLYGLUTAMYLATION,0.00019306,0.39094,0.39725,1,1
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00081392,0.3906,0.46276,1,1
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0010798,0.39032,0.41106,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00021879,0.39007,0.38341,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0034935,0.38933,0.37647,1,1
5,GO SEGMENT SPECIFICATION,0.0054671,0.3887,0.33741,1,1
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00021879,0.38696,0.39201,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0054671,0.38668,0.37008,1,1
5,GO REFLEX,0.00013188,0.38451,0.47279,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00040321,0.38443,0.44622,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.018736,0.38369,0.33166,1,1
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.024086,0.38343,0.33364,1,1
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00013188,0.38295,0.46662,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,6.8565e-05,0.38288,0.41465,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,3.4805e-05,0.38272,0.56671,1,1
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0016767,0.37992,0.39696,1,1
5,GO NEURONAL ACTION POTENTIAL,0.00012367,0.37887,0.46567,1,1
5,GO LUTEINIZATION,0.0034935,0.37876,0.40257,1,1
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0013481,0.37805,0.42804,1,1
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00057531,0.37796,0.43593,1,1
5,GO LIPOXYGENASE PATHWAY,0.028348,0.37795,0.24651,1,1
5,GO POSTSYNAPSE ASSEMBLY,0.0044907,0.37788,0.4211,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0018673,0.3776,0.39973,1,1
5,GO MICROTUBULE DEPOLYMERIZATION,0.0076456,0.37755,0.32986,1,1
5,GO FEAR RESPONSE,0.0031545,0.37717,0.27011,1,1
5,GO REGULATION OF CILIUM ASSEMBLY,0.0014241,0.37638,0.32125,1,1
5,GO LEYDIG CELL DIFFERENTIATION,0.00040321,0.37372,0.48252,1,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0080134,0.37347,0.35698,1,1
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00054254,0.37325,0.35261,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00076864,0.37323,0.33601,1,1
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045436,0.37308,0.42303,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.0052065,0.37269,0.38493,1,1
5,GO MICROTUBULE ANCHORING,0.0015882,0.37238,0.36332,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00040321,0.37131,0.32579,1,1
5,GO NEURON CELLULAR HOMEOSTASIS,0.013834,0.37081,0.29065,1,1
5,GO NEPHRIC DUCT DEVELOPMENT,0.0076456,0.37031,0.31065,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00014989,0.3696,0.39641,1,1
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00024771,0.36938,0.45557,1,1
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0011418,0.36937,0.35218,1,1
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.00028019,0.36923,0.48532,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0029965,0.36865,0.30388,1,1
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00054254,0.36835,0.34248,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0025648,0.36715,0.3445,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019306,0.36604,0.38124,1,1
5,GO HISTONE H3 K27 METHYLATION,0.0024341,0.36582,0.38235,1,1
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0013481,0.36568,0.37488,1,1
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00096503,0.36485,0.38612,1,1
5,GO RETINA LAYER FORMATION,0.0034935,0.36464,0.41461,1,1
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00015974,0.36453,0.32435,1,1
5,GO MEMBRANE HYPERPOLARIZATION,0.0034935,0.36395,0.30603,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0015041,0.36358,0.39781,1,1
5,GO ADRENAL GLAND DEVELOPMENT,0.00048214,0.36316,0.39071,1,1
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.010101,0.36313,0.34703,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00091199,0.36132,0.40073,1,1
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00051151,0.36042,0.39385,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,9.5377e-05,0.36003,0.40955,1,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00086166,0.35952,0.37828,1,1
5,GO SYNAPTIC VESICLE BUDDING,0.00010181,0.35843,0.39793,1,1
5,GO SYNAPTIC VESICLE CLUSTERING,0.0010209,0.3581,0.49213,1,1
5,GO GLUTAMATE SECRETION,0.00068502,0.35757,0.36494,1,1
5,GO SYNAPSE MATURATION,0.015776,0.35721,0.32432,1,1
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.0016767,0.35716,0.42559,1,1
5,GO NEUROTRANSMITTER SECRETION,0.00017019,0.3555,0.43084,1,1
5,GO NODAL SIGNALING PATHWAY,0.0012758,0.35492,0.33059,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.022172,0.35443,0.34658,1,1
5,GO SYNAPTIC VESICLE PRIMING,0.00028019,0.3538,0.53532,1,1
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0014241,0.35303,0.35967,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00021879,0.35294,0.43907,1,1
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.7287e-05,0.35259,0.38831,1,1
5,GO HISTONE H3 K9 DEMETHYLATION,0.0028457,0.35237,0.33507,1,1
5,GO SYNAPTIC VESICLE LOCALIZATION,8.9327e-05,0.35199,0.4044,1,1
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00014062,0.35179,0.46283,1,1
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00031664,0.35132,0.41663,1,1
5,GO SYNAPTIC VESICLE MATURATION,0.00028019,0.35107,0.52246,1,1
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0019699,0.34977,0.31052,1,1
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0013481,0.34876,0.34877,1,1
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0047188,0.34725,0.379,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0012758,0.34688,0.36859,1,1
5,GO LONG TERM SYNAPTIC DEPRESSION,0.0012758,0.34665,0.3602,1,1
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,9.5377e-05,0.34634,0.42152,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00076864,0.34621,0.46579,1,1
5,GO ATRIAL SEPTUM DEVELOPMENT,0.0028457,0.34573,0.34345,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,0.0021907,0.34489,0.3463,1,1
5,GO CILIUM MOVEMENT,0.00086166,0.34348,0.36477,1,1
5,GO SKELETAL MUSCLE ADAPTATION,0.00033648,0.34306,0.37157,1,1
5,GO REGULATION OF DOPAMINE SECRETION,4.5779e-05,0.3425,0.52154,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00021879,0.34236,0.3572,1,1
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0047188,0.3419,0.31857,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0018673,0.34095,0.39477,1,1
5,GO MRNA SPLICE SITE SELECTION,0.014457,0.3405,0.27404,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0013481,0.34039,0.38851,1,1
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0034935,0.33979,0.28756,1,1
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0015882,0.33934,0.35554,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0057394,0.33908,0.29776,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00033648,0.33847,0.39141,1,1
5,GO COLLATERAL SPROUTING,0.00057531,0.33838,0.40331,1,1
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0023095,0.33753,0.3201,1,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0029965,0.33713,0.38497,1,1
5,GO ADULT BEHAVIOR,0.00057531,0.33672,0.33433,1,1
5,GO RECEPTOR CLUSTERING,0.0015882,0.33661,0.34381,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.33645,0.37873,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.012106,0.3358,0.32493,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.0023095,0.33374,0.37647,1,1
5,GO LEARNING,0.0010798,0.33369,0.31692,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.00014062,0.33266,0.32553,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00035748,0.33208,0.33198,1,1
5,GO DOPAMINE TRANSPORT,9.5377e-05,0.3312,0.46268,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00045436,0.33063,0.38192,1,1
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00018128,0.33047,0.33552,1,1
5,GO SYNAPSE ASSEMBLY,0.00019306,0.33038,0.41719,1,1
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00028019,0.33016,0.40789,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00054254,0.32817,0.39957,1,1
5,GO O GLYCAN PROCESSING,0.00051151,0.32729,0.33487,1,1
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00035748,0.32723,0.35798,1,1
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00068502,0.32714,0.39175,1,1
5,GO NEUROTRANSMITTER TRANSPORT,0.00014989,0.32714,0.40406,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0015882,0.32703,0.37957,1,1
5,GO MICROTUBULE POLYMERIZATION,0.00033648,0.32668,0.33742,1,1
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00021879,0.32644,0.42236,1,1
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00068502,0.32593,0.39985,1,1
5,GO REGULATION OF VESICLE FUSION,0.00015974,0.32567,0.41437,1,1
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0012071,0.32564,0.38907,1,1
5,GO RETROGRADE AXONAL TRANSPORT,0.0034935,0.32525,0.36588,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.00023283,0.32509,0.36678,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0031545,0.32489,0.28663,1,1
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00081392,0.32482,0.34813,1,1
5,GO SHORT TERM MEMORY,0.008797,0.32473,0.32972,1,1
5,GO REGULATION OF NEURON MIGRATION,0.006955,0.32438,0.34981,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.0028457,0.32428,0.36617,1,1
5,GO PROTEIN DEMETHYLATION,0.0012071,0.32424,0.37176,1,1
5,GO DENDRITIC SPINE MORPHOGENESIS,0.00072571,0.32409,0.36158,1,1
5,GO MICROTUBULE SEVERING,0.0066311,0.32325,0.28989,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.010572,0.3222,0.33959,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00086166,0.32178,0.34221,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00023283,0.32115,0.38971,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0012758,0.32089,0.38618,1,1
5,GO LOCOMOTOR RHYTHM,0.00014989,0.3204,0.42697,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.025096,0.32002,0.31563,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025648,0.31963,0.27952,1,1
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0011418,0.31882,0.42447,1,1
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00011593,0.31871,0.40065,1,1
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.00081392,0.31865,0.37828,1,1
5,GO RESPONSE TO GLUCAGON,0.0018673,0.3183,0.27615,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0010798,0.31767,0.39838,1,1
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0031545,0.31762,0.42622,1,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,8.3641e-05,0.3176,0.33982,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00054254,0.31707,0.37611,1,1
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0020776,0.31682,0.31162,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0020776,0.31674,0.31958,1,1
5,GO AXO DENDRITIC TRANSPORT,0.00028019,0.31657,0.33946,1,1
5,GO DOPAMINE METABOLIC PROCESS,0.00068502,0.31651,0.32856,1,1
5,GO PANCREATIC JUICE SECRETION,0.01266,0.31646,0.26056,1,1
5,GO RESPONSE TO MAGNESIUM ION,0.01266,0.31607,0.30611,1,1
5,GO FOREBRAIN NEURON DEVELOPMENT,0.0044907,0.31599,0.30179,1,1
5,GO CEREBRAL CORTEX CELL MIGRATION,0.0010798,0.31549,0.34399,1,1
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0003797,0.31547,0.41517,1,1
5,GO BRAIN MORPHOGENESIS,0.00033648,0.31546,0.34309,1,1
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.040368,0.31544,0.27649,1,1
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00086166,0.31541,0.29909,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0012071,0.31537,0.29929,1,1
5,GO REGULATION OF MICROTUBULE BINDING,0.00054254,0.31507,0.35668,1,1
5,GO DRUG CATABOLIC PROCESS,0.021265,0.31499,0.23716,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,4.5779e-05,0.31493,0.35199,1,1
5,GO TUBULIN DEACETYLATION,0.0016767,0.31378,0.36591,1,1
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0013481,0.31341,0.33585,1,1
5,GO CGMP MEDIATED SIGNALING,0.0013481,0.31275,0.35086,1,1
5,GO SYNAPTIC VESICLE TRANSPORT,3.7287e-05,0.31257,0.38051,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00024771,0.31247,0.42192,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.033245,0.31235,0.26637,1,1
5,GO DENDRITE MORPHOGENESIS,0.00086166,0.31219,0.33641,1,1
5,GO CILIUM ORGANIZATION,0.00096503,0.31218,0.29885,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00332,0.31206,0.27458,1,1
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0020776,0.31183,0.41171,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0014241,0.31163,0.31703,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00091199,0.31145,0.41749,1,1
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.023112,0.31122,0.29027,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,8.9327e-05,0.3112,0.46168,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00018128,0.31118,0.35236,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0038653,0.31109,0.29059,1,1
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0018673,0.31101,0.35554,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,3.9936e-05,0.31071,0.34855,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0047188,0.3102,0.33683,1,1
5,GO DIVALENT METAL ION EXPORT,0.0076456,0.31012,0.287,1,1
5,GO ACTION POTENTIAL,0.00017019,0.30982,0.37611,1,1
5,GO ASSOCIATIVE LEARNING,0.0027019,0.30977,0.30773,1,1
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0015041,0.30975,0.35139,1,1
5,GO TRANSCYTOSIS,0.0049572,0.30944,0.30416,1,1
5,GO NEURON PROJECTION ORGANIZATION,0.00045436,0.30912,0.33593,1,1
5,GO LONG TERM MEMORY,0.0015882,0.30874,0.34454,1,1
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0042727,0.30853,0.28738,1,1
5,GO RESPONSE TO REDOX STATE,0.00018128,0.30837,0.39,1,1
5,GO SECONDARY HEART FIELD SPECIFICATION,0.0038653,0.30837,0.37782,1,1
5,GO NEURON PROJECTION EXTENSION,0.00011593,0.30835,0.36496,1,1
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00057531,0.30825,0.29482,1,1
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0054671,0.30782,0.27438,1,1
5,GO SYNAPTIC SIGNALING,0.00014989,0.30755,0.36234,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0021907,0.30745,0.34806,1,1
5,GO POSTSYNAPSE ORGANIZATION,0.00086166,0.30744,0.31605,1,1
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,3.248e-05,0.30743,0.36536,1,1
5,GO REGULATION OF GOLGI ORGANIZATION,0.00033648,0.30702,0.35963,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00076864,0.30641,0.33273,1,1
5,GO ADHERENS JUNCTION ORGANIZATION,0.00020554,0.30631,0.34643,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,3.9936e-05,0.30629,0.38098,1,1
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0003797,0.30624,0.39412,1,1
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,3.9936e-05,0.30618,0.36231,1,1
5,GO WATER HOMEOSTASIS,0.00035748,0.30613,0.31303,1,1
5,GO AXONAL TRANSPORT,0.00054254,0.30612,0.32788,1,1
5,GO CHEMOSENSORY BEHAVIOR,0.00029789,0.30608,0.3921,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.033245,0.30584,0.33884,1,1
5,GO ANTEROGRADE AXONAL TRANSPORT,0.00091199,0.30582,0.32794,1,1
5,GO RESPONSE TO DIETARY EXCESS,0.0029965,0.30573,0.32057,1,1
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0028457,0.30567,0.2696,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.017954,0.30537,0.283,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0066311,0.30499,0.3251,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00057531,0.30489,0.30949,1,1
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.023112,0.30468,0.25656,1,1
5,GO CAMP METABOLIC PROCESS,0.00048214,0.3034,0.36953,1,1
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.011574,0.30308,0.27196,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00033648,0.30306,0.37028,1,1
5,GO ALANINE TRANSPORT,0.012106,0.30258,0.30674,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00060992,0.30244,0.35443,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00017019,0.30223,0.41691,1,1
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081392,0.30222,0.35916,1,1
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.007293,0.30204,0.23152,1,1
5,GO MICROTUBULE BASED MOVEMENT,0.0003797,0.30182,0.31109,1,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00023283,0.3012,0.37316,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0029965,0.30111,0.30917,1,1
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.010101,0.3011,0.27338,1,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.00051151,0.30042,0.32988,1,1
5,GO LIPID TRANSLOCATION,0.00035748,0.30042,0.35357,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0015041,0.3001,0.39036,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00051151,0.29991,0.36169,1,1
5,GO RESPONSE TO ACETYLCHOLINE,0.0029965,0.29989,0.32871,1,1
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00010181,0.29963,0.51675,1,1
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0044907,0.29933,0.33354,1,1
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0054671,0.2993,0.36858,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00031664,0.29922,0.38707,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0023095,0.29921,0.34597,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.014457,0.29919,0.27269,1,1
5,GO SYNAPTIC VESICLE RECYCLING,3.4805e-05,0.29899,0.41665,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0024341,0.29889,0.29288,1,1
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0014241,0.29887,0.32964,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00026348,0.29854,0.38003,1,1
5,GO UV DAMAGE EXCISION REPAIR,0.0054671,0.29839,0.26327,1,1
5,GO GOLGI RIBBON FORMATION,0.0063209,0.29833,0.31961,1,1
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0049572,0.29824,0.28561,1,1
5,GO CHOLESTEROL EFFLUX,0.014457,0.29808,0.22869,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.014457,0.29778,0.27219,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00014062,0.29674,0.36243,1,1
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.00042807,0.29636,0.35215,1,1
5,GO LATERAL VENTRICLE DEVELOPMENT,0.0042727,0.29628,0.3362,1,1
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0014241,0.2961,0.31564,1,1
5,GO PRESYNAPTIC ENDOCYTOSIS,6.8565e-05,0.29597,0.4088,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0015882,0.29596,0.29744,1,1
5,GO DIOL METABOLIC PROCESS,7.8298e-05,0.2959,0.3342,1,1
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0047188,0.29577,0.30102,1,1
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0017696,0.29571,0.26463,1,1
5,GO NEURON CELL CELL ADHESION,0.00091199,0.29557,0.47305,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0012071,0.29557,0.38943,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013834,0.29552,0.26185,1,1
5,GO INTRACILIARY TRANSPORT,0.0049572,0.29539,0.26256,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014241,0.29513,0.38848,1,1
5,GO SYNAPSE ORGANIZATION,0.00042807,0.29508,0.35239,1,1
5,GO AXON EXTENSION,0.0003797,0.29437,0.35245,1,1
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00048214,0.29421,0.32258,1,1
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00057531,0.29411,0.31698,1,1
5,GO FAT CELL PROLIFERATION,0.0040644,0.29392,0.26005,1,1
5,GO MEMORY,0.00026348,0.29374,0.33834,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0011418,0.2937,0.30782,1,1
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.006955,0.29345,0.29234,1,1
5,GO GENETIC IMPRINTING,0.00045436,0.29341,0.33963,1,1
5,GO DENDRITE DEVELOPMENT,0.00060992,0.29338,0.30855,1,1
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0031545,0.29327,0.39154,1,1
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0080134,0.29312,0.28873,1,1
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00010866,0.29293,0.31706,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0023095,0.29205,0.34011,1,1
5,GO PIGMENT ACCUMULATION,0.0080134,0.29166,0.27553,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0076456,0.29158,0.33098,1,1
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00020554,0.29143,0.41552,1,1
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0010209,0.29132,0.3779,1,1
5,GO GOLGI TO VACUOLE TRANSPORT,0.00020554,0.29131,0.3644,1,1
5,GO ACROSOME REACTION,0.00011593,0.29127,0.29611,1,1
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.035953,0.29124,0.26031,1,1
5,GO POTASSIUM ION TRANSPORT,7.3279e-05,0.29097,0.34915,1,1
5,GO NEURON PROJECTION ARBORIZATION,0.0017696,0.29084,0.33371,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0028457,0.2904,0.34257,1,1
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.0060238,0.29039,0.31327,1,1
5,GO NEURAL RETINA DEVELOPMENT,0.011574,0.29035,0.21908,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00017019,0.2899,0.3713,1,1
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0021907,0.28974,0.34032,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,5.2428e-05,0.28973,0.35205,1,1
5,GO DIET INDUCED THERMOGENESIS,0.013834,0.28944,0.26057,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00068502,0.28942,0.28699,1,1
5,GO SPERM MOTILITY,0.0010798,0.2893,0.29987,1,1
5,GO HISTONE METHYLATION,0.0024341,0.2886,0.28008,1,1
5,GO GROWTH HORMONE SECRETION,0.0096484,0.28852,0.33453,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0010798,0.28764,0.35235,1,1
5,GO POTASSIUM ION HOMEOSTASIS,0.00028019,0.28753,0.32117,1,1
5,GO REGULATION OF TELOMERE CAPPING,0.0027019,0.28752,0.27115,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,7.8298e-05,0.28705,0.33557,1,1
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0015041,0.28667,0.29891,1,1
5,GO CELL PART MORPHOGENESIS,0.00033648,0.28643,0.31225,1,1
5,GO CELLULAR COMPONENT MAINTENANCE,0.00031664,0.28641,0.31549,1,1
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.0172,0.28622,0.27556,1,1
5,GO LYSINE METABOLIC PROCESS,0.0012071,0.28608,0.31132,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00031664,0.28605,0.33664,1,1
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0040644,0.286,0.31829,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00021879,0.28569,0.32549,1,1
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0034935,0.28554,0.33451,1,1
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.00048214,0.2855,0.31243,1,1
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.013235,0.28542,0.31874,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.0016767,0.28488,0.30587,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0028457,0.28477,0.32037,1,1
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.011063,0.28474,0.26147,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.0076456,0.28423,0.22599,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00035748,0.28395,0.31956,1,1
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.00028019,0.28389,0.30843,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00051151,0.28382,0.31087,1,1
5,GO PROTEIN LOCALIZATION TO CILIUM,0.0031545,0.28373,0.29402,1,1
5,GO HAIR CELL DIFFERENTIATION,5.9985e-05,0.28362,0.35941,1,1
5,GO PEPTIDYL ARGININE METHYLATION,4.5779e-05,0.28355,0.32664,1,1
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00086166,0.28352,0.31228,1,1
5,GO CARDIAC ATRIUM DEVELOPMENT,0.0083971,0.28296,0.28613,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.015104,0.28286,0.27661,1,1
5,GO REGULATION OF MITOPHAGY,6.8565e-05,0.28263,0.41043,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00035748,0.28261,0.29414,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.00064645,0.28255,0.29301,1,1
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0036751,0.28254,0.31067,1,1
5,GO PEPTIDYL LYSINE METHYLATION,0.00332,0.28238,0.27926,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00060992,0.28216,0.31388,1,1
5,GO HISTONE H4 K5 ACETYLATION,0.00086166,0.28208,0.29235,1,1
5,GO NEURON RECOGNITION,0.0031545,0.28197,0.33748,1,1
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0092139,0.28162,0.25711,1,1
5,GO HISTONE H3 K9 MODIFICATION,0.008797,0.28145,0.27158,1,1
5,GO MEMBRANE DOCKING,0.00031664,0.28133,0.27468,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00096503,0.28103,0.32187,1,1
5,GO NEURON PROJECTION GUIDANCE,0.00086166,0.28066,0.32002,1,1
5,GO NEUROMUSCULAR PROCESS,0.00096503,0.28005,0.31087,1,1
5,GO TRANSPORT ALONG MICROTUBULE,0.00064645,0.27988,0.27668,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0063209,0.27949,0.27759,1,1
5,GO MICROTUBULE BASED TRANSPORT,0.00042807,0.27948,0.30031,1,1
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00096503,0.27878,0.30581,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0034935,0.27868,0.30761,1,1
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0044907,0.27862,0.25074,1,1
5,GO REGULATION OF ACTION POTENTIAL,0.00068502,0.27827,0.36318,1,1
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0013481,0.2781,0.3146,1,1
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0080134,0.27789,0.29304,1,1
5,GO MONOAMINE TRANSPORT,0.00026348,0.27778,0.35796,1,1
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.017954,0.2776,0.30334,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0038653,0.27759,0.35378,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0040644,0.27754,0.35197,1,1
5,GO EXPLORATION BEHAVIOR,0.0052065,0.27734,0.3059,1,1
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0014241,0.27703,0.29972,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0049572,0.27647,0.26589,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00033648,0.2764,0.34293,1,1
5,GO CHROMATIN SILENCING AT TELOMERE,0.014457,0.27637,0.2288,1,1
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0057394,0.27634,0.23271,1,1
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0038653,0.27621,0.28292,1,1
5,GO FUCOSYLATION,0.00010866,0.27619,0.35191,1,1
5,GO BASEMENT MEMBRANE ASSEMBLY,0.00051151,0.27609,0.46015,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.00010866,0.27549,0.33621,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0020776,0.27547,0.30575,1,1
5,GO DENDRITE EXTENSION,6.4139e-05,0.27543,0.44921,1,1
5,GO DOSAGE COMPENSATION,0.006955,0.2754,0.28114,1,1
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.00054254,0.27535,0.33525,1,1
5,GO CELL PROJECTION ORGANIZATION,0.00031664,0.27509,0.28594,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.0028457,0.27502,0.32516,1,1
5,GO POSITIVE REGULATION OF ACROSOME REACTION,0.00040321,0.27484,0.27851,1,1
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0038653,0.27465,0.27744,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00072571,0.27445,0.32913,1,1
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.043559,0.27441,0.2506,1,1
5,GO NEURON DEVELOPMENT,0.00029789,0.27413,0.30255,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.050584,0.2739,0.25126,1,1
5,GO SPHINGOMYELIN METABOLIC PROCESS,6.4139e-05,0.2735,0.33352,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,7.8298e-05,0.27306,0.31219,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.00060992,0.273,0.35621,1,1
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0083971,0.2729,0.29968,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00040321,0.27283,0.35366,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00072571,0.27274,0.43002,1,1
5,GO NOTCH RECEPTOR PROCESSING,0.00096503,0.27271,0.38229,1,1
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0020776,0.27271,0.34701,1,1
5,GO THYROID GLAND DEVELOPMENT,0.0019699,0.27259,0.26579,1,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0049572,0.27248,0.27072,1,1
5,GO MICROTUBULE BASED PROCESS,0.0013481,0.27238,0.25325,1,1
5,GO RESPONSE TO COCAINE,0.0025648,0.27228,0.28438,1,1
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010209,0.27216,0.4272,1,1
5,GO NEUROTRANSMITTER REUPTAKE,0.00096503,0.27193,0.31842,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,0.00096503,0.27188,0.34204,1,1
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0003797,0.27171,0.2877,1,1
5,GO POSITIVE REGULATION OF MITOPHAGY,0.00033648,0.27166,0.42648,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.0016767,0.27163,0.33936,1,1
5,GO HINDBRAIN DEVELOPMENT,0.0021907,0.27151,0.24822,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0054671,0.27139,0.30739,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0014241,0.27125,0.32046,1,1
5,GO NEGATIVE CHEMOTAXIS,0.00068502,0.27119,0.37823,1,1
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.046961,0.27113,0.20845,1,1
5,GO MITOCHONDRION LOCALIZATION,0.0012758,0.27108,0.29225,1,1
5,GO VISUAL BEHAVIOR,0.00010181,0.27105,0.33028,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0172,0.2709,0.24451,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00048214,0.27084,0.31513,1,1
5,GO REGULATION OF AXON GUIDANCE,0.0013481,0.27075,0.36588,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00042807,0.27053,0.31731,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.00057531,0.27053,0.3657,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0012758,0.2704,0.39229,1,1
5,GO REGULATION OF DENDRITE EXTENSION,5.9985e-05,0.27035,0.53516,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0012758,0.26986,0.33656,1,1
5,GO REGULATION OF AMINO ACID TRANSPORT,0.0083971,0.26976,0.25013,1,1
5,GO SPECIFICATION OF SYMMETRY,0.0010209,0.26931,0.27966,1,1
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.012106,0.26886,0.29132,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0060238,0.26868,0.29508,1,1
5,GO BEHAVIOR,0.0010209,0.26827,0.2748,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.00048214,0.26815,0.31248,1,1
5,GO REPRODUCTIVE BEHAVIOR,0.035953,0.26807,0.20129,1,1
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0018673,0.26792,0.24092,1,1
5,GO REGULATION OF MRNA POLYADENYLATION,0.0016767,0.26786,0.30056,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00028019,0.26785,0.31341,1,1
5,GO REGULATION OF APPETITE,0.0049572,0.26754,0.33882,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00018128,0.26729,0.33749,1,1
5,GO MICROTUBULE NUCLEATION,0.0029965,0.26601,0.29938,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.3641e-05,0.266,0.36839,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,3.248e-05,0.26565,0.27798,1,1
5,GO HEART FIELD SPECIFICATION,0.0023095,0.26561,0.31009,1,1
5,GO ACIDIC AMINO ACID TRANSPORT,0.0003797,0.2653,0.315,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00033648,0.26514,0.29641,1,1
5,GO CATECHOLAMINE SECRETION,0.00010181,0.26354,0.41713,1,1
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0012071,0.26332,0.30208,1,1
5,GO HISTONE H3 K9 TRIMETHYLATION,0.0047188,0.26311,0.29133,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,0.00010866,0.26302,0.29332,1,1
5,GO REGULATION OF AXONOGENESIS,0.0014241,0.26257,0.32942,1,1
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0066311,0.26233,0.28772,1,1
5,GO CATECHOLAMINE METABOLIC PROCESS,0.00040321,0.26228,0.31259,1,1
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0028457,0.26224,0.33061,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00020554,0.26175,0.38854,1,1
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.00026348,0.26127,0.373,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0015882,0.26123,0.27242,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00014989,0.26117,0.33507,1,1
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0096484,0.26114,0.26146,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.006955,0.26109,0.29036,1,1
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,6.8565e-05,0.26076,0.31227,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.012106,0.26057,0.28268,1,1
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0019699,0.26039,0.27876,1,1
5,GO AXON DEVELOPMENT,0.00054254,0.26027,0.30347,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0015041,0.2599,0.29879,1,1
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00064645,0.25982,0.36602,1,1
5,GO RESPONSE TO INACTIVITY,0.012106,0.25973,0.24444,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00081392,0.25968,0.31941,1,1
5,GO CLATHRIN COAT ASSEMBLY,0.00332,0.25966,0.32534,1,1
5,GO HISTONE H3 K9 METHYLATION,0.011063,0.25965,0.28607,1,1
5,GO SOMITOGENESIS,0.006955,0.25945,0.2323,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00028019,0.25938,0.32924,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,0.0015882,0.25921,0.25076,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.00019306,0.25903,0.33221,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0018673,0.25897,0.36158,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.041938,0.25894,0.2353,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00012367,0.25891,0.28532,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,4.5779e-05,0.25889,0.31196,1,1
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0044907,0.25886,0.30215,1,1
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.0011418,0.25876,0.33086,1,1
5,GO SODIUM ION TRANSPORT,4.8997e-05,0.25876,0.35032,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,0.0031545,0.25864,0.28961,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0024341,0.25862,0.29264,1,1
5,GO LOCOMOTORY BEHAVIOR,0.00091199,0.25854,0.30651,1,1
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00033648,0.25834,0.31552,1,1
5,GO HISTONE DEUBIQUITINATION,0.0047188,0.25829,0.27258,1,1
5,GO SUBPALLIUM DEVELOPMENT,0.0036751,0.25812,0.30108,1,1
5,GO NEURON DIFFERENTIATION,0.00040321,0.25798,0.28186,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0047188,0.25758,0.28476,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.2763e-05,0.2575,0.35891,1,1
5,GO FIBROBLAST ACTIVATION,0.0031545,0.25743,0.26278,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013834,0.25741,0.26919,1,1
5,GO CARDIAC CONDUCTION,0.00035748,0.25733,0.3412,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00086166,0.25733,0.35521,1,1
5,GO PROTEIN METHYLATION,0.0044907,0.25726,0.25148,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.0044907,0.25726,0.31783,1,1
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0021907,0.2571,0.33354,1,1
5,GO RESPONSE TO PAIN,0.00054254,0.257,0.36562,1,1
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0044907,0.25698,0.36167,1,1
5,GO TELOMERE CAPPING,0.0016767,0.25692,0.2578,1,1
5,GO DENDRITIC SPINE DEVELOPMENT,0.0015041,0.25689,0.30923,1,1
5,GO SPHINGOID METABOLIC PROCESS,0.00019306,0.25675,0.3393,1,1
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00040321,0.25662,0.35326,1,1
5,GO THALAMUS DEVELOPMENT,0.015776,0.2562,0.25066,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0027019,0.25594,0.33164,1,1
5,GO REGULATION OF MRNA PROCESSING,0.013834,0.2557,0.20282,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00018128,0.25535,0.36519,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00028019,0.25528,0.39709,1,1
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00051151,0.25527,0.36037,1,1
5,GO OSTEOCLAST DEVELOPMENT,0.034576,0.25482,0.25784,1,1
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0028457,0.2548,0.31622,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,5.9985e-05,0.25471,0.30425,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.030713,0.25466,0.21729,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0013481,0.25456,0.27616,1,1
5,GO POLYOL CATABOLIC PROCESS,0.00064645,0.25424,0.30411,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,3.9936e-05,0.25392,0.33925,1,1
5,GO SMOOTHENED SIGNALING PATHWAY,0.0027019,0.2539,0.24822,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0034935,0.25376,0.24643,1,1
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0024341,0.25375,0.34063,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.026142,0.25358,0.20057,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00014062,0.25326,0.32445,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.01266,0.25317,0.23196,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00028019,0.25316,0.31233,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0044907,0.25308,0.31225,1,1
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0034935,0.25306,0.33489,1,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0092139,0.25295,0.23045,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00033648,0.25269,0.34732,1,1
5,GO RESPONSE TO LEAD ION,0.00024771,0.25266,0.29906,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0020776,0.25259,0.28957,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0076456,0.2525,0.2208,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.00029789,0.2522,0.24147,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.01266,0.25203,0.27746,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,0.0044907,0.25188,0.31286,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0019699,0.25154,0.29142,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0027019,0.25128,0.26031,1,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0029965,0.25125,0.3742,1,1
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.017954,0.25109,0.28166,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00042807,0.25101,0.32499,1,1
5,GO REGULATION OF LYASE ACTIVITY,0.0029965,0.25083,0.23044,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.046961,0.25071,0.17721,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.033245,0.25054,0.24755,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.0040644,0.25034,0.32779,1,1
5,GO NEURON MIGRATION,0.0076456,0.25034,0.263,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,9.5377e-05,0.25026,0.26857,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00068502,0.25024,0.3458,1,1
5,GO PROTEIN HETEROOLIGOMERIZATION,0.00068502,0.24991,0.27463,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0038653,0.24979,0.27043,1,1
5,GO TORC1 SIGNALING,0.0017696,0.24963,0.29934,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0012071,0.24957,0.27803,1,1
5,GO MAINTENANCE OF CELL POLARITY,0.0044907,0.24953,0.27403,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0028457,0.24945,0.2812,1,1
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.010572,0.24943,0.36152,1,1
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0036751,0.24928,0.25249,1,1
5,GO BODY MORPHOGENESIS,0.0021907,0.24926,0.30652,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0015041,0.24921,0.31013,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00072571,0.24917,0.30144,1,1
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0018673,0.24903,0.23741,1,1
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.014457,0.24896,0.30249,1,1
5,GO REGULATION OF HORMONE SECRETION,0.00031664,0.24879,0.26526,1,1
5,GO HISTONE H3 K4 METHYLATION,0.0063209,0.24875,0.24612,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0019699,0.24825,0.23327,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.00054254,0.24819,0.29097,1,1
5,GO PHOSPHATE ION TRANSPORT,0.006955,0.24793,0.24872,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00054254,0.24788,0.31058,1,1
5,GO MICROVILLUS ORGANIZATION,0.0092139,0.24776,0.22437,1,1
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00076864,0.24751,0.31521,1,1
5,GO PEPTIDE HORMONE SECRETION,0.00011593,0.24749,0.29939,1,1
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0012758,0.24738,0.26625,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.033245,0.24725,0.24131,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00086166,0.24709,0.36873,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00033648,0.24701,0.36496,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.0057394,0.24678,0.26125,1,1
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0083971,0.24654,0.28744,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.0034935,0.24643,0.23066,1,1
5,GO NEUROGENESIS,0.00045436,0.24623,0.26877,1,1
5,GO SPERM AXONEME ASSEMBLY,0.007293,0.24606,0.23609,1,1
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.006955,0.24596,0.36493,1,1
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,5.9985e-05,0.24589,0.33959,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.041938,0.24555,0.20873,1,1
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.0066311,0.24554,0.31378,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0013481,0.24532,0.29648,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00064645,0.24529,0.33384,1,1
5,GO CELL CELL JUNCTION MAINTENANCE,0.0080134,0.245,0.30703,1,1
5,GO CELL PROJECTION ASSEMBLY,0.00096503,0.24474,0.26298,1,1
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00045436,0.24469,0.39303,1,1
5,GO PROTEIN DEPOLYMERIZATION,0.00060992,0.24453,0.29809,1,1
5,GO DEVELOPMENTAL MATURATION,0.00040321,0.24441,0.28317,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,0.0010798,0.24438,0.35123,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00033648,0.24364,0.33702,1,1
5,GO MEMBRANE BIOGENESIS,0.00045436,0.24363,0.34765,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.00045436,0.24362,0.31605,1,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.037377,0.24355,0.22869,1,1
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0024341,0.24354,0.23874,1,1
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0076456,0.24346,0.24623,1,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0042727,0.2434,0.35516,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0060238,0.2433,0.37071,1,1
5,GO REGULATION OF HEART RATE,0.00048214,0.24311,0.31595,1,1
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0029965,0.24309,0.23372,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00029789,0.24306,0.31012,1,1
5,GO RESPONSE TO ALKALOID,0.0015041,0.24292,0.2326,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00015974,0.24271,0.30338,1,1
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0011418,0.24268,0.28717,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0060238,0.24253,0.23809,1,1
5,GO REGULATION OF RNA SPLICING,0.0092139,0.24252,0.20665,1,1
5,GO REGULATION OF CYCLASE ACTIVITY,0.00332,0.24235,0.23788,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00028019,0.24228,0.30672,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0066311,0.24206,0.2665,1,1
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00023283,0.24187,0.37141,1,1
5,GO PARTURITION,0.0020776,0.24185,0.28165,1,1
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.037377,0.24163,0.21758,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00012367,0.24159,0.31671,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.00086166,0.24141,0.27782,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0023095,0.24139,0.24142,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0025648,0.24136,0.29393,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0049572,0.24132,0.26194,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.00011593,0.24121,0.30956,1,1
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0080134,0.24099,0.23276,1,1
5,GO CELL JUNCTION ORGANIZATION,0.00023283,0.24086,0.31686,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,0.0038653,0.24067,0.22725,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.006955,0.24052,0.28485,1,1
5,GO MEMBRANE REPOLARIZATION,0.00045436,0.24028,0.35711,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00035748,0.24025,0.33136,1,1
5,GO PANCREAS DEVELOPMENT,0.0029965,0.24016,0.26862,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0038653,0.24004,0.23915,1,1
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00014989,0.23993,0.31626,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.01266,0.23992,0.23898,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.025096,0.23988,0.26046,1,1
5,GO MITOCHONDRION DISTRIBUTION,0.0028457,0.23975,0.30653,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0010798,0.23969,0.25407,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0010798,0.23968,0.28335,1,1
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0017696,0.23931,0.26075,1,1
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.00091199,0.23927,0.25975,1,1
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0092139,0.23926,0.23149,1,1
5,GO METENCEPHALON DEVELOPMENT,0.0040644,0.2392,0.25213,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00040321,0.23904,0.31241,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0052065,0.239,0.26092,1,1
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0024341,0.23898,0.32655,1,1
5,GO NEUROTRANSMITTER UPTAKE,0.0016767,0.23891,0.25853,1,1
5,GO COGNITION,0.0012758,0.23879,0.27321,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0057394,0.23874,0.23993,1,1
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0016767,0.23862,0.24611,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.00010866,0.23858,0.33646,1,1
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.0019699,0.23852,0.32797,1,1
5,GO REGULATION OF ACTIN NUCLEATION,0.00028019,0.2382,0.27857,1,1
5,GO REGULATION OF TORC1 SIGNALING,0.0028457,0.23818,0.27509,1,1
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,9.5377e-05,0.23803,0.41053,1,1
5,GO RENAL WATER HOMEOSTASIS,0.0015882,0.23775,0.29078,1,1
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.024086,0.23761,0.19167,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00033648,0.23748,0.33782,1,1
5,GO INSULIN SECRETION,0.00010181,0.23743,0.30088,1,1
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00019306,0.2374,0.3119,1,1
5,GO NERVOUS SYSTEM PROCESS,0.00019306,0.23738,0.26884,1,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00086166,0.2373,0.30061,1,1
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0015882,0.23729,0.29081,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00081392,0.23724,0.27511,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00332,0.23711,0.28187,1,1
5,GO RESPONSE TO DOPAMINE,0.00019306,0.23708,0.26905,1,1
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00010181,0.23702,0.35243,1,1
5,GO ORGANELLE LOCALIZATION,0.00026348,0.23699,0.2437,1,1
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.043559,0.23694,0.24137,1,1
5,GO HISTONE H3 K36 METHYLATION,0.015776,0.23688,0.2998,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.00028019,0.23685,0.27606,1,1
5,GO FOREBRAIN CELL MIGRATION,0.00332,0.2367,0.26816,1,1
5,GO MITOPHAGY,0.00023283,0.23667,0.31671,1,1
5,GO MIRNA METABOLIC PROCESS,0.00029789,0.23645,0.28575,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.031957,0.23637,0.27048,1,1
5,GO WALKING BEHAVIOR,0.0092139,0.23634,0.25818,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.0010798,0.23627,0.29851,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0015882,0.23626,0.28,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0036751,0.2362,0.30716,1,1
5,GO OLFACTORY LOBE DEVELOPMENT,0.031957,0.23619,0.2351,1,1
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0019699,0.23607,0.33065,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0015882,0.23605,0.27786,1,1
5,GO MYELIN ASSEMBLY,0.0011418,0.23602,0.34462,1,1
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00031664,0.2358,0.29633,1,1
5,GO REGULATION OF EXOCYTOSIS,0.00026348,0.23567,0.3182,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,0.00068502,0.23564,0.3192,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00096503,0.23553,0.35778,1,1
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.022172,0.23553,0.2168,1,1
5,GO LENS FIBER CELL DEVELOPMENT,0.0080134,0.23539,0.23258,1,1
5,GO PLASMA MEMBRANE TUBULATION,0.0015041,0.23527,0.29726,1,1
5,GO PRESYNAPSE ORGANIZATION,0.0016767,0.23504,0.344,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,0.0031545,0.23487,0.23314,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045436,0.23486,0.28947,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0066311,0.23479,0.25354,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00064645,0.23427,0.25819,1,1
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.011574,0.23419,0.26588,1,1
5,GO MACROMOLECULE DEACYLATION,0.0019699,0.23419,0.25312,1,1
5,GO SOMITE DEVELOPMENT,0.0047188,0.23415,0.23035,1,1
5,GO MEGAKARYOCYTE DEVELOPMENT,0.0034935,0.2341,0.2981,1,1
5,GO HEART INDUCTION,0.027226,0.23363,0.24749,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0034935,0.23357,0.24004,1,1
5,GO ACTIN FILAMENT NETWORK FORMATION,0.0020776,0.23355,0.31413,1,1
5,GO ENDOCYTIC RECYCLING,0.00051151,0.23351,0.30607,1,1
5,GO HORMONE TRANSPORT,0.00020554,0.23344,0.26959,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0024341,0.23342,0.29077,1,1
5,GO HYPEROSMOTIC RESPONSE,0.0066311,0.23337,0.2556,1,1
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0054671,0.23337,0.25733,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00091199,0.23316,0.25859,1,1
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.041938,0.23282,0.21992,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.00086166,0.2327,0.28452,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.013834,0.23265,0.23636,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.016475,0.23263,0.24017,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0016767,0.23263,0.26544,1,1
5,GO PLATELET MORPHOGENESIS,0.0040644,0.23244,0.28999,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00064645,0.23238,0.28627,1,1
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.024086,0.23226,0.21581,1,1
5,GO PROTEIN O LINKED MANNOSYLATION,0.00021879,0.2321,0.28793,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0044907,0.23208,0.29589,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0003797,0.23208,0.29938,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.00012367,0.23198,0.28532,1,1
5,GO FOREGUT MORPHOGENESIS,0.052482,0.23184,0.19601,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0038653,0.23182,0.2705,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.011063,0.23173,0.20442,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0012071,0.23163,0.26502,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00042807,0.23155,0.28466,1,1
5,GO SEXUAL REPRODUCTION,0.00332,0.23144,0.2007,1,1
5,GO SPERMATID DIFFERENTIATION,0.0016767,0.23127,0.22435,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0052065,0.23124,0.24914,1,1
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.023112,0.23124,0.18921,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.00040321,0.23115,0.26728,1,1
5,GO IMPORT INTO CELL,0.00042807,0.23104,0.27046,1,1
5,GO PROTEIN MANNOSYLATION,0.0034935,0.23094,0.22801,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0025648,0.23092,0.25941,1,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.012106,0.23091,0.19831,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.0049572,0.23088,0.25697,1,1
5,GO METHYLATION,0.0066311,0.23084,0.19521,1,1
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0096484,0.23075,0.27798,1,1
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.040368,0.23074,0.17777,1,1
5,GO SPERM CAPACITATION,0.0038653,0.23073,0.25129,1,1
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0013481,0.23069,0.3055,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.0012758,0.23067,0.25495,1,1
5,GO MITOTIC RECOMBINATION,0.0172,0.23064,0.22472,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0003797,0.2304,0.31917,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.006955,0.23031,0.26116,1,1
5,GO REGULATION OF TUBE SIZE,0.0044907,0.23018,0.22145,1,1
5,GO HISTONE H4 DEACETYLATION,0.019548,0.23012,0.17821,1,1
5,GO HISTONE DEACETYLATION,0.0034935,0.23006,0.25619,1,1
5,GO SPINDLE LOCALIZATION,0.0027019,0.22995,0.24278,1,1
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0044907,0.22995,0.30817,1,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.0044907,0.2299,0.25536,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0017696,0.22986,0.24935,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00051151,0.22964,0.29596,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0047188,0.2294,0.24342,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00068502,0.22927,0.27202,1,1
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0047188,0.22924,0.25523,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.052482,0.22919,0.21948,1,1
5,GO CHROMATIN DISASSEMBLY,0.012106,0.22912,0.23956,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0034935,0.22906,0.21828,1,1
5,GO BONE CELL DEVELOPMENT,0.0057394,0.22884,0.27679,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00051151,0.22865,0.2519,1,1
5,GO COVALENT CHROMATIN MODIFICATION,0.0066311,0.22852,0.2385,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0010798,0.2285,0.27713,1,1
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0042727,0.22845,0.29128,1,1
5,GO AMINE TRANSPORT,0.00060992,0.2284,0.31705,1,1
5,GO REGULATION OF ACROSOME REACTION,0.0014241,0.2284,0.23904,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00024771,0.22825,0.27354,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.0018673,0.22811,0.21525,1,1
5,GO PROTEIN ACYLATION,0.0017696,0.22797,0.23828,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.0012071,0.22783,0.30246,1,1
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.0029965,0.22766,0.21762,1,1
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.011063,0.22745,0.23819,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0029965,0.22736,0.24052,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047188,0.22717,0.23338,1,1
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00076864,0.22694,0.34083,1,1
5,GO CELLULAR RESPONSE TO PH,0.0020776,0.22675,0.26707,1,1
5,GO PEPTIDYL THREONINE MODIFICATION,0.00018128,0.2267,0.30015,1,1
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0042727,0.22656,0.22768,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00054254,0.22649,0.31342,1,1
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0028457,0.22637,0.33211,1,1
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.025096,0.22636,0.22219,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0017696,0.22627,0.21207,1,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0042727,0.22613,0.17551,1,1
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.006955,0.226,0.24536,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00332,0.22589,0.29751,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0021907,0.22583,0.26036,1,1
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00017019,0.2258,0.21966,1,1
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.019548,0.2258,0.26711,1,1
5,GO MELANOCYTE DIFFERENTIATION,0.0054671,0.2257,0.24886,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0020776,0.22566,0.22974,1,1
5,GO REGULATION OF CELL SIZE,0.00045436,0.22564,0.30439,1,1
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.00033648,0.22557,0.31378,1,1
5,GO PURINE NUCLEOTIDE TRANSPORT,0.00026348,0.22547,0.24113,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00096503,0.22542,0.2944,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00028019,0.2251,0.2358,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0029965,0.22497,0.2563,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.00096503,0.22487,0.24604,1,1
5,GO EXOCYTIC PROCESS,7.8298e-05,0.22485,0.33994,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.00096503,0.2248,0.29613,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.035953,0.2247,0.22807,1,1
5,GO ACTIN CROSSLINK FORMATION,0.025096,0.2245,0.23793,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00017019,0.22446,0.29794,1,1
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.015104,0.22431,0.23556,1,1
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0027019,0.22413,0.24913,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.026142,0.22408,0.20909,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00017019,0.22405,0.31878,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0040644,0.22375,0.22964,1,1
5,GO HEAD DEVELOPMENT,0.00072571,0.22366,0.24869,1,1
5,GO CELL MATURATION,0.0003797,0.22363,0.24589,1,1
5,GO METANEPHROS MORPHOGENESIS,0.0080134,0.22352,0.25179,1,1
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0034935,0.2235,0.24314,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0057394,0.2235,0.23429,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00076864,0.22347,0.31657,1,1
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.045233,0.22328,0.19689,1,1
5,GO REGULATION OF INSULIN SECRETION,0.00011593,0.2232,0.29869,1,1
5,GO DETECTION OF VISIBLE LIGHT,0.00048214,0.2231,0.20802,1,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0015882,0.22306,0.25073,1,1
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0011418,0.22301,0.30363,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00033648,0.22289,0.26712,1,1
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.038848,0.22247,0.19691,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0014241,0.22245,0.29904,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.00091199,0.22232,0.3093,1,1
5,GO MUSCLE FIBER DEVELOPMENT,0.010101,0.22221,0.22904,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00064645,0.2222,0.28916,1,1
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00096503,0.2222,0.29674,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00042807,0.22218,0.28548,1,1
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.0012071,0.22205,0.27957,1,1
5,GO HISTONE H3 DEACETYLATION,0.0028457,0.22203,0.27813,1,1
5,GO RESPONSE TO ISCHEMIA,0.038848,0.22187,0.20011,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00029789,0.22186,0.31175,1,1
5,GO RNA POLYADENYLATION,0.0042727,0.22176,0.24301,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00086166,0.2217,0.25365,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0080134,0.22166,0.24268,1,1
5,GO HISTONE H3 K14 ACETYLATION,0.0031545,0.22165,0.30661,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00033648,0.22165,0.37434,1,1
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0036751,0.22159,0.254,1,1
5,GO SEGMENTATION,0.010101,0.22155,0.20084,1,1
5,GO TRANSFERRIN TRANSPORT,7.8298e-05,0.22132,0.28506,1,1
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.021265,0.22122,0.26141,1,1
5,GO REGULATION OF BLOOD CIRCULATION,0.00057531,0.22117,0.28494,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.024086,0.22117,0.29197,1,1
5,GO RESPONSE TO IRON ION,0.012106,0.22109,0.21972,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.031957,0.22101,0.20804,1,1
5,GO SENSORY PERCEPTION,0.00023283,0.22099,0.233,1,1
5,GO CELL MORPHOGENESIS,0.00054254,0.22092,0.28146,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.0024341,0.2208,0.27992,1,1
5,GO SECRETORY GRANULE ORGANIZATION,0.0054671,0.22055,0.24813,1,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.0076456,0.22047,0.21778,1,1
5,GO REGULATION OF GTP BINDING,0.020391,0.22046,0.21846,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.00332,0.22035,0.21254,1,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.052482,0.22034,0.19539,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.0023095,0.22021,0.28062,1,1
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0042727,0.22015,0.22836,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00042807,0.22008,0.27903,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.028348,0.22001,0.27999,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0083971,0.21986,0.21176,1,1
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.015104,0.21976,0.20614,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.030713,0.21965,0.19274,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,0.013235,0.21951,0.28009,1,1
5,GO HISTONE H3 ACETYLATION,0.008797,0.21934,0.19999,1,1
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0014241,0.2193,0.28685,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00017019,0.21928,0.25881,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0024341,0.2191,0.28809,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0038653,0.219,0.22731,1,1
5,GO SPLEEN DEVELOPMENT,0.0042727,0.21888,0.24307,1,1
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00019306,0.21886,0.25209,1,1
5,GO REGULATION OF PINOCYTOSIS,0.030713,0.21876,0.2622,1,1
5,GO POSITIVE REGULATION OF RNA SPLICING,0.011574,0.21874,0.18638,1,1
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0015882,0.21867,0.38745,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.0042727,0.21863,0.23912,1,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.019548,0.21859,0.23032,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0052065,0.21849,0.24449,1,1
5,GO HISTONE H4 ACETYLATION,0.0023095,0.21847,0.2523,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0096484,0.21846,0.22472,1,1
5,GO RNA DESTABILIZATION,0.012106,0.21844,0.2505,1,1
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.015776,0.21837,0.19592,1,1
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0052065,0.21833,0.24103,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.015104,0.21824,0.25328,1,1
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0019699,0.21819,0.25797,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00332,0.21815,0.25016,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0024341,0.21813,0.32874,1,1
5,GO PROTEIN KINASE A SIGNALING,0.0057394,0.21805,0.2294,1,1
5,GO ERYTHROCYTE MATURATION,0.023112,0.21799,0.25487,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.019548,0.21793,0.24007,1,1
5,GO RESPONSE TO AMPHETAMINE,0.012106,0.21782,0.21721,1,1
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0025648,0.21755,0.22042,1,1
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.012106,0.21738,0.35449,1,1
5,GO REGULATION OF GLUCONEOGENESIS,0.0029965,0.21723,0.2808,1,1
5,GO HEAD MORPHOGENESIS,0.008797,0.2172,0.30384,1,1
5,GO PROTEIN ACETYLATION,0.0036751,0.21719,0.22107,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00017019,0.21714,0.22974,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.028348,0.21702,0.19888,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.046961,0.21684,0.17591,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0036751,0.21678,0.27114,1,1
5,GO MYOTUBE DIFFERENTIATION,0.013235,0.21657,0.22303,1,1
5,GO REGULATION OF HISTONE METHYLATION,0.0038653,0.21648,0.25115,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0040644,0.21645,0.22802,1,1
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.022172,0.21629,0.24164,1,1
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.00091199,0.21618,0.20672,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.0013481,0.21597,0.25471,1,1
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00086166,0.21582,0.21682,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0044907,0.21579,0.23438,1,1
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0011418,0.21561,0.27105,1,1
5,GO GAMETE GENERATION,0.0036751,0.21548,0.20215,1,1
5,GO NUCLEOTIDE TRANSPORT,0.00051151,0.21547,0.22143,1,1
5,GO DETECTION OF LIGHT STIMULUS,0.00045436,0.21546,0.20599,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00045436,0.21544,0.26727,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00045436,0.21543,0.31046,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00096503,0.21542,0.26203,1,1
5,GO OXIDATIVE DEMETHYLATION,0.00072571,0.21539,0.33928,1,1
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.017954,0.21538,0.25489,1,1
5,GO SECONDARY METABOLIC PROCESS,7.3279e-05,0.21533,0.26322,1,1
5,GO AXIS SPECIFICATION,0.00096503,0.21532,0.21567,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,0.0012758,0.21526,0.24926,1,1
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.01266,0.21522,0.18137,1,1
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.0096484,0.21522,0.26229,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,0.0016767,0.2152,0.30932,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.031957,0.2152,0.21953,1,1
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00057531,0.215,0.28011,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.007293,0.21484,0.27467,1,1
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.00014062,0.21483,0.27213,1,1
5,GO PHOSPHOLIPID TRANSPORT,0.0031545,0.21467,0.2398,1,1
5,GO REGULATION OF HISTONE MODIFICATION,0.0042727,0.21458,0.22075,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.019548,0.21454,0.24477,1,1
5,GO SIGNAL RELEASE,0.00048214,0.21436,0.26604,1,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0020776,0.21435,0.28797,1,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0096484,0.21428,0.26674,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.007293,0.21408,0.29244,1,1
5,GO LYSOSOME LOCALIZATION,0.041938,0.21399,0.1971,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00013188,0.21391,0.26579,1,1
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.014457,0.21377,0.25673,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,0.0024341,0.21374,0.23849,1,1
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0096484,0.21367,0.26142,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00060992,0.21352,0.24667,1,1
5,GO RESPIRATORY SYSTEM PROCESS,0.0019699,0.21343,0.31289,1,1
5,GO HINDLIMB MORPHOGENESIS,0.0096484,0.21332,0.24223,1,1
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00026348,0.21324,0.30606,1,1
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00020554,0.21319,0.27858,1,1
5,GO ENERGY HOMEOSTASIS,0.00081392,0.21317,0.29429,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00023283,0.21305,0.29862,1,1
5,GO ADAPTATION OF SIGNALING PATHWAY,0.0076456,0.21291,0.30531,1,1
5,GO REGULATION OF FEEDING BEHAVIOR,0.007293,0.21276,0.21801,1,1
5,GO NERVE DEVELOPMENT,0.024086,0.21276,0.23075,1,1
5,GO AROMATIC AMINO ACID TRANSPORT,0.045233,0.21242,0.23881,1,1
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.006955,0.21222,0.21216,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00060992,0.21217,0.27925,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0017696,0.21201,0.30089,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.00086166,0.21191,0.23979,1,1
5,GO SULFATE TRANSPORT,0.0096484,0.21185,0.21441,1,1
5,GO AMINO ACID TRANSPORT,0.00028019,0.21171,0.26771,1,1
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.007293,0.21164,0.27116,1,1
5,GO CHLORIDE TRANSPORT,0.00051151,0.21147,0.29784,1,1
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0017696,0.2113,0.27559,1,1
5,GO GOLGI VESICLE BUDDING,0.00033648,0.211,0.24573,1,1
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00068502,0.21083,0.20919,1,1
5,GO ORGANELLE ASSEMBLY,0.00091199,0.21081,0.2208,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.031957,0.21078,0.29435,1,1
5,GO LIPID GLYCOSYLATION,0.0057394,0.21075,0.27983,1,1
5,GO PROTEIN KINASE C SIGNALING,0.015104,0.21074,0.28046,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.006955,0.21059,0.31731,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013481,0.21051,0.24929,1,1
5,GO DEVELOPMENTAL PIGMENTATION,0.0019699,0.21047,0.24858,1,1
5,GO RESPONSE TO LITHIUM ION,0.0018673,0.21016,0.27021,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0013481,0.21014,0.25226,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.010101,0.2101,0.20176,1,1
5,GO CELLULAR PIGMENTATION,0.00028019,0.21001,0.25503,1,1
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.027226,0.21001,0.20536,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.20992,0.24501,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.0057394,0.2099,0.23543,1,1
5,GO NUCLEAR BODY ORGANIZATION,0.0024341,0.20989,0.24659,1,1
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0054671,0.20981,0.30419,1,1
5,GO DICARBOXYLIC ACID TRANSPORT,0.00029789,0.20947,0.2736,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.0172,0.20941,0.20659,1,1
5,GO COPII COATED VESICLE BUDDING,0.00033648,0.20941,0.2454,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0016767,0.20937,0.35742,1,1
5,GO PEPTIDE CATABOLIC PROCESS,0.006955,0.20935,0.24904,1,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0011418,0.20934,0.26684,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.0011418,0.20934,0.2359,1,1
5,GO RESPONSE TO FOOD,0.0172,0.20914,0.1918,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.043559,0.20913,0.181,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0031545,0.20888,0.27743,1,1
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.038848,0.20885,0.18787,1,1
5,GO REGULATION OF PROTEIN TARGETING,0.00029789,0.20879,0.24392,1,1
5,GO DEMETHYLATION,0.00031664,0.20876,0.28673,1,1
5,GO RECEPTOR RECYCLING,0.023112,0.20857,0.1999,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0172,0.20811,0.18336,1,1
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0049572,0.20793,0.26665,1,1
5,GO FATTY ACID BETA OXIDATION,0.0010209,0.20791,0.24096,1,1
5,GO ALCOHOL CATABOLIC PROCESS,0.0020776,0.20783,0.20931,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00040321,0.20761,0.32589,1,1
5,GO CALCIUM ION IMPORT,0.0015041,0.20733,0.30666,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.035953,0.20694,0.17626,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00332,0.20688,0.22922,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.010101,0.20681,0.28977,1,1
5,GO PHOTOTRANSDUCTION,0.00072571,0.20675,0.17825,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0031545,0.20672,0.34901,1,1
5,GO FEEDING BEHAVIOR,0.0057394,0.2067,0.22465,1,1
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.006955,0.20649,0.21358,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00076864,0.20647,0.23394,1,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0042727,0.20639,0.26692,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,0.00033648,0.20628,0.30046,1,1
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.006955,0.20627,0.2492,1,1
5,GO HEART PROCESS,0.00091199,0.20622,0.27079,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.013834,0.20613,0.25526,1,1
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.022172,0.20602,0.29306,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0019699,0.20594,0.19594,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00076864,0.20578,0.25725,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.052482,0.20564,0.1776,1,1
5,GO PALLIUM DEVELOPMENT,0.007293,0.20552,0.21267,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.0012758,0.20552,0.27296,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0076456,0.20541,0.20162,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0015041,0.20536,0.24203,1,1
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0060238,0.20526,0.22091,1,1
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.021265,0.2052,0.20047,1,1
5,GO NOTCH SIGNALING PATHWAY,0.00018128,0.2051,0.29318,1,1
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0042727,0.20498,0.30696,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0038653,0.20494,0.26512,1,1
5,GO ORGANIC CATION TRANSPORT,0.017954,0.20493,0.21286,1,1
5,GO EMBRYONIC AXIS SPECIFICATION,0.0016767,0.20489,0.22526,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0013481,0.20461,0.26596,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0028457,0.2046,0.20451,1,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.00045436,0.20459,0.30893,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0066311,0.20457,0.26658,1,1
5,GO BONE MATURATION,0.025096,0.20439,0.2265,1,1
5,GO FEMALE GAMETE GENERATION,0.0076456,0.20435,0.1905,1,1
5,GO REGULATION OF ION TRANSPORT,0.00051151,0.20426,0.27054,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00028019,0.20418,0.27715,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.020391,0.20414,0.21999,1,1
5,GO REGULATION OF CELL DEVELOPMENT,0.00091199,0.20411,0.2451,1,1
5,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.012106,0.20409,0.27654,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0015882,0.20401,0.19383,1,1
5,GO FILOPODIUM ASSEMBLY,0.0042727,0.20389,0.24378,1,1
5,GO LIPID PHOSPHORYLATION,0.0060238,0.20377,0.2265,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,0.00086166,0.20371,0.24645,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.011574,0.20365,0.27177,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0029965,0.20359,0.2752,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00019306,0.20356,0.27208,1,1
5,GO INTESTINAL ABSORPTION,0.028348,0.20351,0.23868,1,1
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.007293,0.2035,0.31172,1,1
5,GO CARDIAC CHAMBER DEVELOPMENT,0.00332,0.20346,0.25168,1,1
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0076456,0.20344,0.22087,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0042727,0.2034,0.33452,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.0012071,0.2032,0.2891,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0054671,0.2032,0.26971,1,1
5,GO RESPONSE TO MUSCLE STRETCH,0.019548,0.20288,0.32006,1,1
5,GO REGULATION OF TOR SIGNALING,0.00072571,0.20288,0.24102,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0042727,0.20283,0.22392,1,1
5,GO MALE GAMETE GENERATION,0.0036751,0.2028,0.19711,1,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00060992,0.20279,0.34468,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,0.0021907,0.20264,0.22814,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00054254,0.20262,0.2931,1,1
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.048745,0.20252,0.16511,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0028457,0.20252,0.21618,1,1
5,GO CRISTAE FORMATION,0.00048214,0.20247,0.23696,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00051151,0.20241,0.25182,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.20215,0.19378,1,1
5,GO REGULATION OF HORMONE LEVELS,0.00021879,0.20211,0.24226,1,1
5,GO RESPONSE TO CALCIUM ION,0.00014062,0.20205,0.29852,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0023095,0.20197,0.25141,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.0015041,0.20193,0.19897,1,1
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.015104,0.20177,0.2252,1,1
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.0047188,0.20117,0.22235,1,1
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0060238,0.20104,0.27191,1,1
5,GO PIGMENTATION,0.00035748,0.20097,0.26899,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0042727,0.20084,0.20483,1,1
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0036751,0.20083,0.23753,1,1
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0016767,0.20082,0.24351,1,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.0016767,0.20066,0.23331,1,1
5,GO ORGANELLE MEMBRANE FUSION,0.00021879,0.20044,0.29042,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00064645,0.19999,0.30425,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.015104,0.19997,0.24197,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.054439,0.1999,0.17219,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.00017019,0.19986,0.2617,1,1
5,GO GERM CELL DEVELOPMENT,0.0036751,0.19986,0.20636,1,1
5,GO KERATINIZATION,0.0038653,0.19967,0.2142,1,1
5,GO PHOTOPERIODISM,0.0010798,0.19966,0.23227,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.012106,0.19939,0.18993,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0054671,0.19933,0.24102,1,1
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.00086166,0.1991,0.25934,1,1
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,6.8565e-05,0.19908,0.30652,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0011418,0.19907,0.24066,1,1
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00057531,0.19897,0.3121,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00033648,0.19885,0.2787,1,1
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.026142,0.19861,0.2183,1,1
5,GO SCHWANN CELL DIFFERENTIATION,0.011574,0.19855,0.23307,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00012367,0.19847,0.26771,1,1
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0031545,0.19842,0.26346,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0040644,0.1983,0.20287,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.011574,0.19828,0.20897,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.008797,0.19812,0.27249,1,1
5,GO XENOBIOTIC TRANSPORT,0.011063,0.19811,0.25861,1,1
5,GO CELL SUBSTRATE ADHESION,0.022172,0.19806,0.25073,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00072571,0.19792,0.28041,1,1
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.021265,0.19792,0.21656,1,1
5,GO ACTIN FILAMENT SEVERING,0.035953,0.19779,0.27088,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0010209,0.19779,0.24195,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0011418,0.19773,0.29711,1,1
5,GO SEQUESTERING OF CALCIUM ION,0.038848,0.19771,0.20986,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.007293,0.1977,0.30466,1,1
5,GO POSITIVE REGULATION OF HEART RATE,0.0096484,0.19764,0.24261,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0024341,0.1976,0.2207,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0047188,0.19757,0.2185,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.00081392,0.19735,0.24072,1,1
5,GO RESPONSE TO AMINE,0.014457,0.19728,0.20524,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00033648,0.19724,0.24359,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0003797,0.19722,0.2404,1,1
5,GO REGULATION OF SYSTEM PROCESS,0.00057531,0.19717,0.25611,1,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.007293,0.19711,0.19688,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00064645,0.19706,0.25111,1,1
5,GO VESICLE LOCALIZATION,4.5779e-05,0.19699,0.29539,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0092139,0.19696,0.30618,1,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0011418,0.19676,0.25581,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.008797,0.19669,0.23654,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0076456,0.19654,0.19519,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.0014241,0.19651,0.26239,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.027226,0.1965,0.19082,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0092139,0.19649,0.2024,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0014241,0.19637,0.24956,1,1
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00068502,0.19632,0.29469,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0014241,0.1963,0.23424,1,1
5,GO CHROMATIN ORGANIZATION,0.0083971,0.19629,0.22356,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00013188,0.19621,0.28075,1,1
5,GO PROGESTERONE METABOLIC PROCESS,0.02951,0.19609,0.18872,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.016475,0.19608,0.24,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.006955,0.19582,0.31626,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,0.00012367,0.19579,0.23311,1,1
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00019306,0.19561,0.25005,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0016767,0.19551,0.25275,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.00011593,0.1955,0.27136,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.030713,0.19543,0.19272,1,1
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.010101,0.19537,0.20608,1,1
5,GO RESPONSE TO LIGHT STIMULUS,0.0010798,0.19537,0.21322,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015104,0.19524,0.26441,1,1
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0063209,0.19515,0.1784,1,1
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0010798,0.19507,0.19472,1,1
5,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0023095,0.19506,0.22317,1,1
5,GO MYOFIBRIL ASSEMBLY,0.0018673,0.19505,0.26193,1,1
5,GO NEUTRAL AMINO ACID TRANSPORT,0.0034935,0.19504,0.23012,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.0020776,0.19495,0.21731,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0060238,0.19491,0.22872,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,0.00017019,0.19462,0.2798,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.0010798,0.19457,0.21806,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.011574,0.19429,0.25533,1,1
5,GO CELLULAR RESPONSE TO SALT STRESS,0.014457,0.19422,0.22288,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.022172,0.19415,0.20759,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.0063209,0.19414,0.25311,1,1
5,GO POST EMBRYONIC DEVELOPMENT,0.0010798,0.19404,0.26437,1,1
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.030713,0.1939,0.18874,1,1
5,GO NEURON PROJECTION REGENERATION,0.00076864,0.19389,0.28392,1,1
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00091199,0.19376,0.3228,1,1
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0016767,0.19374,0.18803,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0036751,0.19373,0.29548,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,4.8997e-05,0.19358,0.23898,1,1
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0015041,0.19355,0.27442,1,1
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0015882,0.19341,0.27494,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.00064645,0.19335,0.23618,1,1
5,GO CELL CELL SIGNALING,0.00051151,0.19329,0.25421,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0092139,0.19311,0.25921,1,1
5,GO RECEPTOR CATABOLIC PROCESS,0.0014241,0.19299,0.24881,1,1
5,GO POSITIVE REGULATION OF SECRETION,0.0040644,0.19285,0.217,1,1
5,GO BIOLOGICAL ADHESION,0.015776,0.19276,0.22938,1,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0024341,0.19273,0.21954,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.00072571,0.1926,0.25055,1,1
5,GO REGULATION OF NEURON MATURATION,0.015776,0.19259,0.2466,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,0.00091199,0.19247,0.2677,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0015882,0.19245,0.22089,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,0.031957,0.19225,0.17998,1,1
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0015041,0.19216,0.2663,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.00015974,0.19199,0.27198,1,1
5,GO CYTOSKELETON ORGANIZATION,0.0010798,0.19193,0.24164,1,1
5,GO DEVELOPMENTAL GROWTH,0.00086166,0.19179,0.2532,1,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.030713,0.19166,0.24119,1,1
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.00048214,0.19159,0.24323,1,1
5,GO REGULATION OF FERTILIZATION,0.00086166,0.19156,0.2017,1,1
5,GO STRIATUM DEVELOPMENT,0.0029965,0.19155,0.27857,1,1
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0028457,0.19143,0.27205,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0034935,0.19143,0.22654,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.0018673,0.19142,0.21049,1,1
5,GO TOXIN TRANSPORT,0.0021907,0.19124,0.24646,1,1
5,GO ORGANELLE FUSION,0.00014062,0.19112,0.26975,1,1
5,GO SALIVARY GLAND DEVELOPMENT,0.020391,0.19102,0.25294,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.033245,0.19099,0.18473,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00029789,0.19097,0.27177,1,1
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.015776,0.19094,0.23417,1,1
5,GO PIGMENT CELL DIFFERENTIATION,0.0038653,0.19088,0.24587,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0066311,0.19082,0.31615,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0019699,0.19068,0.25214,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0054671,0.19067,0.20672,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0034935,0.19056,0.23856,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0021907,0.19051,0.25598,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00060992,0.19048,0.31761,1,1
5,GO ATP TRANSPORT,0.0021907,0.19032,0.20742,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00060992,0.19029,0.27791,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00096503,0.19028,0.24823,1,1
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.045233,0.19028,0.2476,1,1
5,GO WOUND HEALING,0.054439,0.19027,0.20404,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0018673,0.19026,0.25236,1,1
5,GO REGULATION OF CILIUM MOVEMENT,0.024086,0.19022,0.20125,1,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0054671,0.19016,0.28315,1,1
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.016475,0.19015,0.24232,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.017954,0.19003,0.19858,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.0017696,0.18998,0.26742,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.018736,0.18998,0.22856,1,1
5,GO ENDODERM DEVELOPMENT,0.025096,0.18988,0.24331,1,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.0012758,0.18977,0.21247,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00068502,0.18975,0.21661,1,1
5,GO LUNG CELL DIFFERENTIATION,0.045233,0.18968,0.23893,1,1
5,GO DNA MODIFICATION,0.0021907,0.18961,0.18941,1,1
5,GO MEMBRANE FUSION,0.00014989,0.18937,0.26583,1,1
5,GO PULMONARY VALVE MORPHOGENESIS,0.052482,0.18936,0.24574,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0003797,0.18932,0.23474,1,1
5,GO VESICLE DOCKING,0.00011593,0.18909,0.33097,1,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0083971,0.18904,0.20597,1,1
5,GO SELECTIVE AUTOPHAGY,0.0011418,0.189,0.25317,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0024341,0.18897,0.21522,1,1
5,GO SNARE COMPLEX ASSEMBLY,0.007293,0.18896,0.30185,1,1
5,GO STRESS FIBER ASSEMBLY,0.00086166,0.18883,0.2755,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0052065,0.18878,0.25011,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0040644,0.1887,0.25188,1,1
5,GO TISSUE MIGRATION,0.037377,0.18858,0.21214,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.0027019,0.18857,0.25581,1,1
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0044907,0.18855,0.2193,1,1
5,GO GLUTATHIONE METABOLIC PROCESS,0.0076456,0.18841,0.17265,1,1
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0066311,0.18841,0.21253,1,1
5,GO PATTERN SPECIFICATION PROCESS,0.0060238,0.18837,0.20202,1,1
5,GO EMBRYO DEVELOPMENT,0.0029965,0.18833,0.2115,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00042807,0.18817,0.25739,1,1
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0044907,0.18806,0.23075,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0049572,0.18799,0.23397,1,1
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0092139,0.18791,0.23521,1,1
5,GO CELL MATRIX ADHESION,0.020391,0.1879,0.2586,1,1
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0010209,0.18788,0.25345,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.027226,0.18785,0.2192,1,1
5,GO GLIAL CELL DEVELOPMENT,0.013834,0.18773,0.19173,1,1
5,GO MANNOSYLATION,0.0044907,0.18772,0.18813,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.0049572,0.18765,0.27075,1,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0172,0.18763,0.23065,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00017019,0.18756,0.25145,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.0013481,0.18745,0.26234,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0040644,0.18732,0.27869,1,1
5,GO REGULATION OF PROTEIN BINDING,0.0023095,0.18723,0.21779,1,1
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0020776,0.1871,0.27999,1,1
5,GO NADH METABOLIC PROCESS,0.0057394,0.1871,0.20676,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.0019699,0.187,0.31093,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0015041,0.18697,0.25171,1,1
5,GO GLUCOSE METABOLIC PROCESS,0.00051151,0.18688,0.21631,1,1
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0012758,0.18633,0.26947,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.014457,0.18632,0.26599,1,1
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015041,0.18629,0.21958,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00045436,0.18624,0.28013,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,8.3641e-05,0.18621,0.23923,1,1
5,GO JNK CASCADE,0.0083971,0.18618,0.22844,1,1
5,GO POSITIVE REGULATION OF MYELINATION,0.040368,0.18617,0.2395,1,1
5,GO KERATINOCYTE MIGRATION,0.013235,0.18612,0.24439,1,1
5,GO RESPONSE TO AXON INJURY,0.00051151,0.18608,0.25083,1,1
5,GO ERBB SIGNALING PATHWAY,0.0057394,0.18602,0.22605,1,1
5,GO TOOTH MINERALIZATION,0.0027019,0.18595,0.35839,1,1
5,GO SENSORY ORGAN DEVELOPMENT,0.0047188,0.18585,0.21327,1,1
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.010101,0.18585,0.21754,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.020391,0.18582,0.21399,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0029965,0.18575,0.27691,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.013235,0.18574,0.22913,1,1
5,GO REGULATION OF DNA REPAIR,0.0096484,0.18572,0.19909,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0010798,0.18567,0.23382,1,1
5,GO PEPTIDE SECRETION,0.0066311,0.18567,0.21327,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0015882,0.18566,0.23137,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0003797,0.18561,0.27599,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00024771,0.18556,0.29624,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0052065,0.18551,0.22907,1,1
5,GO MULTI ORGANISM PROCESS,0.0025648,0.18546,0.19002,1,1
5,GO APICAL JUNCTION ASSEMBLY,0.0017696,0.18533,0.23628,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.00015974,0.18517,0.24015,1,1
5,GO DEPHOSPHORYLATION,0.00064645,0.18514,0.2411,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0015041,0.18506,0.28149,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0020776,0.18489,0.33192,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0066311,0.18488,0.23882,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0012758,0.18487,0.25634,1,1
5,GO GOLGI ORGANIZATION,0.0012071,0.18483,0.273,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0042727,0.18482,0.30292,1,1
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.033245,0.18475,0.26484,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.019548,0.18474,0.21398,1,1
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.006955,0.18455,0.19512,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,0.0063209,0.1845,0.22719,1,1
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00332,0.18448,0.17492,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0014241,0.18428,0.28254,1,1
5,GO EYE MORPHOGENESIS,0.0015041,0.18426,0.2697,1,1
5,GO CERAMIDE METABOLIC PROCESS,0.00015974,0.18404,0.25194,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.031957,0.18385,0.23929,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,0.00010181,0.1836,0.24725,1,1
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0015041,0.18355,0.24606,1,1
5,GO RESPONSE TO LEPTIN,0.00072571,0.18345,0.29761,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0049572,0.18335,0.23565,1,1
5,GO HISTONE UBIQUITINATION,0.0080134,0.1833,0.21908,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.014457,0.18321,0.30591,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00033648,0.18316,0.25829,1,1
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.012106,0.18314,0.2277,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.0092139,0.18312,0.27954,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.015104,0.18309,0.19549,1,1
5,GO RESPONSE TO MISFOLDED PROTEIN,0.00051151,0.18301,0.27449,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0023095,0.18298,0.23928,1,1
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00024771,0.18297,0.22311,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.006955,0.18297,0.20961,1,1
5,GO HISTONE MONOUBIQUITINATION,0.0092139,0.18288,0.22556,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00086166,0.18274,0.32002,1,1
5,GO RESPONSE TO WOUNDING,0.043559,0.18271,0.20131,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.00019306,0.18254,0.24189,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.010101,0.1825,0.19174,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010101,0.18248,0.25533,1,1
5,GO RESPONSE TO GONADOTROPIN,0.010101,0.18246,0.19811,1,1
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.01266,0.18233,0.22273,1,1
5,GO RESPONSE TO UV,0.017954,0.1823,0.16449,1,1
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0021907,0.18225,0.25191,1,1
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00029789,0.18223,0.27957,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00010181,0.18196,0.22508,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.025096,0.1819,0.20733,1,1
5,GO ERYTHROCYTE DEVELOPMENT,0.021265,0.18185,0.20992,1,1
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.027226,0.18182,0.18939,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.00076864,0.1817,0.22545,1,1
5,GO PEPTIDYL ARGININE MODIFICATION,0.0076456,0.18167,0.14651,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.00091199,0.1816,0.21374,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.017954,0.18158,0.20476,1,1
5,GO VESICLE TARGETING,0.00014989,0.1815,0.24979,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,7.3279e-05,0.18148,0.24099,1,1
5,GO POSITIVE REGULATION OF GROWTH,0.00060992,0.1814,0.26289,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.00064645,0.18139,0.23577,1,1
5,GO GONADOTROPIN SECRETION,0.0029965,0.18136,0.23655,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.0015041,0.18133,0.27429,1,1
5,GO CATION TRANSPORT,0.00026348,0.18132,0.25462,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.1813,0.19239,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0172,0.18128,0.17372,1,1
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.008797,0.18127,0.22938,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.0040644,0.1812,0.24341,1,1
5,GO LIPID DROPLET ORGANIZATION,0.00042807,0.18102,0.22445,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0021907,0.18092,0.26973,1,1
5,GO TOR SIGNALING,0.00064645,0.18083,0.22791,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.00018128,0.18074,0.24487,1,1
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0013481,0.18074,0.23082,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.021265,0.18072,0.23049,1,1
5,GO RHYTHMIC PROCESS,0.0021907,0.18069,0.21396,1,1
5,GO ACID SECRETION,0.00040321,0.18046,0.24178,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0096484,0.18028,0.23269,1,1
5,GO MEMBRANE FISSION,0.0029965,0.1802,0.2956,1,1
5,GO ORGANIC ACID TRANSPORT,0.00051151,0.18,0.22531,1,1
5,GO DIGESTION,0.0076456,0.17994,0.1854,1,1
5,GO NEPHRON DEVELOPMENT,0.017954,0.17993,0.23099,1,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0012758,0.17991,0.22476,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0044907,0.17985,0.20997,1,1
5,GO NEURAL TUBE FORMATION,0.0076456,0.1798,0.22318,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0015882,0.1796,0.27267,1,1
5,GO AORTA MORPHOGENESIS,0.012106,0.17929,0.30789,1,1
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.00060992,0.17913,0.2813,1,1
5,GO COCHLEA DEVELOPMENT,0.010572,0.179,0.20175,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00054254,0.17886,0.24407,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0010209,0.17879,0.25111,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0172,0.17857,0.18913,1,1
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.019548,0.17855,0.15676,1,1
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.019548,0.17844,0.16248,1,1
5,GO REGULATION OF CELLULAR PH,0.0020776,0.17841,0.20714,1,1
5,GO ION HOMEOSTASIS,0.0172,0.17834,0.18571,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.045233,0.17828,0.21706,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.034576,0.17811,0.22825,1,1
5,GO HEART FORMATION,0.008797,0.17811,0.22674,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.00024771,0.17803,0.2683,1,1
5,GO MUSCLE CONTRACTION,0.0027019,0.17791,0.23795,1,1
5,GO OUTFLOW TRACT MORPHOGENESIS,0.037377,0.17783,0.19462,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.033245,0.17774,0.17064,1,1
5,GO POLYOL METABOLIC PROCESS,0.00010866,0.17772,0.24826,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.00014989,0.17768,0.29912,1,1
5,GO ENDOCYTOSIS,0.0060238,0.17766,0.23186,1,1
5,GO REGULATION OF HAIR CYCLE,0.011574,0.17762,0.22342,1,1
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.020391,0.17759,0.185,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0020776,0.17746,0.33551,1,1
5,GO GLIAL CELL DIFFERENTIATION,0.0076456,0.1772,0.19288,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0049572,0.17713,0.28021,1,1
5,GO SODIUM ION HOMEOSTASIS,0.015104,0.17703,0.23181,1,1
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0092139,0.1769,0.20805,1,1
5,GO PROTEIN POLYMERIZATION,0.00035748,0.17679,0.24445,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.01266,0.17676,0.23493,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0066311,0.1767,0.19743,1,1
5,GO RESPONSE TO AMYLOID BETA,0.050584,0.17667,0.23413,1,1
5,GO TRNA WOBBLE BASE MODIFICATION,0.013834,0.17662,0.16028,1,1
5,GO LIPID MODIFICATION,0.0015041,0.17659,0.2368,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.008797,0.17655,0.19185,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.0047188,0.17651,0.19608,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00015974,0.17641,0.25392,1,1
5,GO LYSOSOMAL TRANSPORT,0.00031664,0.17625,0.30288,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0016767,0.17615,0.20706,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.0020776,0.17605,0.23762,1,1
5,GO CIRCADIAN RHYTHM,0.00096503,0.17574,0.21886,1,1
5,GO METAL ION TRANSPORT,0.00042807,0.17573,0.25963,1,1
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.016475,0.17572,0.22499,1,1
5,GO REGULATION OF PEPTIDE SECRETION,0.008797,0.1757,0.20196,1,1
5,GO INORGANIC ANION TRANSPORT,0.00040321,0.17568,0.26528,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0038653,0.17556,0.21198,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0052065,0.17535,0.20983,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00064645,0.17532,0.27315,1,1
5,GO FACE DEVELOPMENT,0.011063,0.1751,0.27063,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.0040644,0.17504,0.21271,1,1
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.030713,0.17485,0.18677,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE,0.016475,0.17479,0.18927,1,1
5,GO EXCRETION,0.0066311,0.17467,0.23868,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0003797,0.17464,0.23189,1,1
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0052065,0.17454,0.18036,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00033648,0.17452,0.26656,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.17446,0.2281,1,1
5,GO RENAL SYSTEM PROCESS,0.0092139,0.17445,0.23013,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.018736,0.17445,0.18614,1,1
5,GO CERAMIDE TRANSPORT,0.019548,0.17443,0.284,1,1
5,GO HIPPOCAMPUS DEVELOPMENT,0.0172,0.17431,0.18002,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0021907,0.17415,0.19246,1,1
5,GO GLYCOSYLATION,0.00015974,0.17415,0.24868,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0044907,0.17406,0.21993,1,1
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0028457,0.17405,0.18691,1,1
5,GO LIPID OXIDATION,0.0028457,0.17375,0.21114,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00064645,0.1737,0.27574,1,1
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0092139,0.17352,0.26927,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.023112,0.1735,0.17802,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.021265,0.1734,0.22902,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,0.0038653,0.17326,0.21768,1,1
5,GO BARBED END ACTIN FILAMENT CAPPING,0.023112,0.17302,0.22072,1,1
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0023095,0.17293,0.19572,1,1
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0066311,0.17289,0.19508,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.024086,0.17276,0.17435,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017696,0.17266,0.25478,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00040321,0.17264,0.23743,1,1
5,GO CIRCULATORY SYSTEM PROCESS,0.0017696,0.17262,0.24705,1,1
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0036751,0.17261,0.18875,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,0.00019306,0.17253,0.30741,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0020776,0.17246,0.22168,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013834,0.17243,0.18756,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.00035748,0.17242,0.224,1,1
5,GO METAL ION HOMEOSTASIS,0.026142,0.17236,0.17706,1,1
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.027226,0.17232,0.18645,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00017019,0.17231,0.23933,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.014457,0.1723,0.20465,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.046961,0.1722,0.18002,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00076864,0.17215,0.27913,1,1
5,GO HEART MORPHOGENESIS,0.0092139,0.17212,0.21926,1,1
5,GO REGULATION OF SECRETION,0.0024341,0.17212,0.22554,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00091199,0.17205,0.22139,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.024086,0.17204,0.15422,1,1
5,GO CELL GROWTH,0.00026348,0.172,0.25362,1,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0080134,0.17195,0.21072,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.045233,0.17192,0.18891,1,1
5,GO RESPONSE TO PH,0.0042727,0.17189,0.2597,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.041938,0.17189,0.23564,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.019548,0.17176,0.21567,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.01266,0.17174,0.18806,1,1
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.011063,0.17172,0.25267,1,1
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0027019,0.17167,0.25015,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.010572,0.17165,0.23526,1,1
5,GO REGULATION OF LIPID STORAGE,0.026142,0.17162,0.21372,1,1
5,GO CARBOHYDRATE PHOSPHORYLATION,0.0066311,0.17156,0.21241,1,1
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.016475,0.17148,0.23324,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0083971,0.17143,0.21852,1,1
5,GO PROTEIN TARGETING TO VACUOLE,0.0010209,0.1714,0.25146,1,1
5,GO MIDBRAIN DEVELOPMENT,0.00057531,0.17138,0.19222,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00096503,0.1712,0.27201,1,1
5,GO VASODILATION,0.018736,0.1711,0.20278,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00332,0.17096,0.22651,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.021265,0.17094,0.18752,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.006955,0.17091,0.22803,1,1
5,GO CHEMICAL HOMEOSTASIS,0.0038653,0.17089,0.20231,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.010572,0.17067,0.21983,1,1
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0010209,0.17061,0.17253,1,1
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.030713,0.17045,0.25295,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.0015041,0.17013,0.19979,1,1
5,GO UV PROTECTION,0.010101,0.17012,0.23276,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.02951,0.17006,0.18677,1,1
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.010572,0.17004,0.2256,1,1
5,GO REPRODUCTION,0.0020776,0.17002,0.19357,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.00057531,0.16976,0.24488,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.048745,0.16972,0.22261,1,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.026142,0.16971,0.20909,1,1
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0027019,0.16962,0.21731,1,1
5,GO INNER EAR MORPHOGENESIS,0.013834,0.1696,0.18898,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.010101,0.16958,0.25214,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.0031545,0.16943,0.21915,1,1
5,GO VACUOLAR TRANSPORT,0.00018128,0.16941,0.27823,1,1
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00086166,0.16937,0.36087,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00096503,0.16936,0.26497,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.011574,0.16933,0.20087,1,1
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.006955,0.16931,0.26063,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012758,0.16929,0.33663,1,1
5,GO REGULATION OF TRANSPORT,0.0015041,0.16919,0.2281,1,1
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.007293,0.16917,0.17342,1,1
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.008797,0.16899,0.19631,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0047188,0.16899,0.1879,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00021879,0.16886,0.24857,1,1
5,GO CEREBELLAR CORTEX FORMATION,0.0052065,0.16885,0.27605,1,1
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.006955,0.16876,0.18316,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0049572,0.16849,0.2276,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.007293,0.16848,0.20359,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.043559,0.16833,0.21257,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025096,0.16824,0.15836,1,1
5,GO EPITHELIAL TUBE FORMATION,0.0096484,0.16823,0.20557,1,1
5,GO RESPONSE TO WATER,0.0036751,0.16816,0.23251,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0092139,0.16809,0.19898,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0015882,0.16806,0.19087,1,1
5,GO REGULATION OF PH,0.0029965,0.16797,0.19779,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.0036751,0.16795,0.23646,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0038653,0.16792,0.27658,1,1
5,GO HEMOGLOBIN METABOLIC PROCESS,0.0018673,0.16789,0.22407,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.0010209,0.16774,0.2871,1,1
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00026348,0.16772,0.23412,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0076456,0.16766,0.28057,1,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0025648,0.16764,0.31153,1,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0028457,0.16735,0.27123,1,1
5,GO CELL CELL ADHESION,0.046961,0.16728,0.19593,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00014062,0.16725,0.21721,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.010101,0.16719,0.21796,1,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.01266,0.16704,0.1905,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0034935,0.16694,0.24944,1,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.022172,0.16676,0.13956,1,1
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0031545,0.16662,0.18587,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00091199,0.16658,0.19048,1,1
5,GO MUSCLE SYSTEM PROCESS,0.0042727,0.16658,0.22232,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0012071,0.16647,0.21823,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0023095,0.16638,0.22027,1,1
5,GO EMBRYONIC PATTERN SPECIFICATION,0.0063209,0.16637,0.2213,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0040644,0.16637,0.25412,1,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.030713,0.16634,0.18932,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00096503,0.16629,0.18997,1,1
5,GO L AMINO ACID TRANSPORT,0.02951,0.16615,0.16964,1,1
5,GO DETECTION OF STIMULUS,0.00020554,0.1661,0.19605,1,1
5,GO ACTIN NUCLEATION,0.00057531,0.16598,0.22945,1,1
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0015041,0.16588,0.23377,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.024086,0.16579,0.24033,1,1
5,GO ION TRANSPORT,0.00026348,0.16561,0.24888,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.0011418,0.1656,0.22826,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0024341,0.16549,0.20792,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.024086,0.16547,0.20196,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.00023283,0.16542,0.24979,1,1
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.013834,0.16541,0.18114,1,1
5,GO IRON ION TRANSPORT,0.0017696,0.16538,0.20798,1,1
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.0047188,0.16534,0.18916,1,1
5,GO LIPID HOMEOSTASIS,0.022172,0.16521,0.17461,1,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0172,0.1651,0.1731,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.0012071,0.16497,0.21008,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016475,0.16469,0.2009,1,1
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.00023283,0.16468,0.20953,1,1
5,GO LACTATION,0.013235,0.16465,0.22612,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00048214,0.16464,0.19051,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.012106,0.16447,0.20193,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00045436,0.16447,0.2236,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0047188,0.16436,0.22924,1,1
5,GO REGULATION OF CATABOLIC PROCESS,0.0016767,0.16427,0.19204,1,1
5,GO FATTY ACID CATABOLIC PROCESS,0.00076864,0.16414,0.22693,1,1
5,GO MUSCLE HYPERTROPHY,0.0047188,0.16413,0.23237,1,1
5,GO GROWTH,0.00076864,0.16402,0.22115,1,1
5,GO ANION TRANSPORT,0.00020554,0.16397,0.23876,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.025096,0.16387,0.27444,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0054671,0.16386,0.32272,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.00072571,0.16362,0.19594,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0014241,0.16343,0.20097,1,1
5,GO NON RECOMBINATIONAL REPAIR,0.017954,0.16331,0.17185,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.014457,0.1633,0.19135,1,1
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00023283,0.16326,0.21521,1,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.0044907,0.163,0.19667,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0027019,0.163,0.21978,1,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0066311,0.16277,0.16199,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.017954,0.16266,0.2128,1,1
5,GO DEVELOPMENTAL INDUCTION,0.016475,0.16234,0.19828,1,1
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0011418,0.16233,0.2092,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0063209,0.16226,0.24028,1,1
5,GO RESPONSE TO BMP,0.014457,0.16196,0.23109,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00024771,0.16187,0.21656,1,1
5,GO ORGANIC ANION TRANSPORT,0.00040321,0.16185,0.22113,1,1
5,GO NUCLEUS ORGANIZATION,0.0027019,0.16182,0.19828,1,1
5,GO CARBOHYDRATE TRANSPORT,0.0013481,0.16174,0.23135,1,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00042807,0.16172,0.21604,1,1
5,GO OVULATION CYCLE,0.041938,0.16169,0.22219,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.033245,0.16159,0.22239,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.019548,0.16155,0.19766,1,1
5,GO SARCOMERE ORGANIZATION,0.0029965,0.16144,0.20559,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00045436,0.16136,0.25899,1,1
5,GO STEROL METABOLIC PROCESS,0.00332,0.16136,0.19514,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.014457,0.16122,0.20815,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00040321,0.16115,0.19761,1,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0015882,0.1611,0.20867,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0023095,0.16093,0.22281,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.0063209,0.16092,0.23083,1,1
5,GO RECEPTOR INTERNALIZATION,0.017954,0.1609,0.20446,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0076456,0.16078,0.234,1,1
5,GO MOLTING CYCLE,0.010101,0.16074,0.2098,1,1
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.013834,0.16072,0.2682,1,1
5,GO TELENCEPHALON DEVELOPMENT,0.0092139,0.16063,0.20837,1,1
5,GO FERTILIZATION,0.00057531,0.16059,0.18769,1,1
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0019699,0.16055,0.18436,1,1
5,GO KETONE BODY METABOLIC PROCESS,0.0052065,0.16052,0.225,1,1
5,GO AUTOPHAGOSOME MATURATION,0.0025648,0.16052,0.25843,1,1
5,GO HORMONE METABOLIC PROCESS,0.0034935,0.16034,0.18488,1,1
5,GO MAGNESIUM ION TRANSPORT,0.0076456,0.16033,0.27935,1,1
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0029965,0.16007,0.2683,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0023095,0.15979,0.2082,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.006955,0.15974,0.19145,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.025096,0.15963,0.16672,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.00081392,0.15954,0.19298,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010798,0.15952,0.22573,1,1
5,GO LIPID CATABOLIC PROCESS,0.0020776,0.15934,0.19183,1,1
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.014457,0.15933,0.17699,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0023095,0.15932,0.22957,1,1
5,GO LIPID LOCALIZATION,0.0038653,0.15931,0.21231,1,1
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0028457,0.15925,0.21856,1,1
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0172,0.15908,0.22458,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.034576,0.15904,0.17684,1,1
5,GO ANIMAL ORGAN MATURATION,0.041938,0.15902,0.21181,1,1
5,GO TUBE FORMATION,0.013834,0.15883,0.19857,1,1
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00057531,0.15876,0.19905,1,1
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0038653,0.15875,0.22273,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.018736,0.15873,0.25702,1,1
5,GO RESPONSE TO EPINEPHRINE,0.045233,0.15865,0.27159,1,1
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0060238,0.15859,0.18451,1,1
5,GO CYTOKINESIS,0.0038653,0.15841,0.20466,1,1
5,GO SECRETION,0.016475,0.15824,0.17954,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0040644,0.15822,0.23891,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.006955,0.15817,0.18241,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.0028457,0.15817,0.22383,1,1
5,GO RESPONSE TO CAMP,0.020391,0.15813,0.17698,1,1
5,GO ERAD PATHWAY,0.0024341,0.15795,0.21694,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0042727,0.15794,0.25116,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0013481,0.15791,0.2627,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.01266,0.15789,0.20135,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,0.0076456,0.15769,0.19711,1,1
5,GO VESICLE ORGANIZATION,0.00021879,0.15763,0.24912,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.023112,0.15753,0.17639,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.020391,0.15747,0.21613,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0040644,0.15739,0.18696,1,1
5,GO MESENCHYME DEVELOPMENT,0.0076456,0.15636,0.21636,1,1
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0031545,0.15634,0.25852,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0010209,0.15631,0.2141,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00086166,0.1562,0.23222,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,0.019548,0.15618,0.20334,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.0020776,0.15617,0.24624,1,1
5,GO RESPONSE TO METAL ION,0.00060992,0.15609,0.20981,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.026142,0.15608,0.15703,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.022172,0.15606,0.20852,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00096503,0.15598,0.18722,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0096484,0.15585,0.2219,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.037377,0.15584,0.14547,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.015776,0.15572,0.21531,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.00012367,0.15563,0.23208,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.017954,0.15559,0.19673,1,1
5,GO HAIR FOLLICLE MATURATION,0.025096,0.15558,0.23353,1,1
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.023112,0.15554,0.27058,1,1
5,GO GOLGI VESICLE TRANSPORT,0.00024771,0.15542,0.24536,1,1
5,GO RESPONSE TO RADIATION,0.0029965,0.15537,0.17808,1,1
5,GO ESCRT COMPLEX DISASSEMBLY,0.011574,0.1553,0.17631,1,1
5,GO SPERM EGG RECOGNITION,0.00051151,0.15526,0.16047,1,1
5,GO MUSCLE CELL DIFFERENTIATION,0.0034935,0.15518,0.2286,1,1
5,GO REGULATION OF GTPASE ACTIVITY,0.007293,0.15516,0.24526,1,1
5,GO HORMONE BIOSYNTHETIC PROCESS,0.0019699,0.15515,0.18819,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0047188,0.15508,0.21959,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0011418,0.15473,0.20491,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.015776,0.15466,0.22604,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0054671,0.15464,0.21102,1,1
5,GO EMBRYONIC MORPHOGENESIS,0.014457,0.15463,0.20197,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00096503,0.15463,0.20177,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0096484,0.15459,0.24173,1,1
5,GO AUTOPHAGY OF MITOCHONDRION,0.00051151,0.15446,0.23754,1,1
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0044907,0.15446,0.18003,1,1
5,GO ENDOSOMAL TRANSPORT,0.00033648,0.1544,0.24692,1,1
5,GO REGULATION OF GROWTH,0.00051151,0.15413,0.21972,1,1
5,GO EPITHELIUM DEVELOPMENT,0.0020776,0.15409,0.20946,1,1
5,GO RESPONSE TO STEROID HORMONE,0.019548,0.15402,0.18186,1,1
5,GO LIMBIC SYSTEM DEVELOPMENT,0.010572,0.15394,0.18897,1,1
5,GO CARDIOLIPIN METABOLIC PROCESS,0.054439,0.15386,0.12453,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.025096,0.15383,0.20371,1,1
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0044907,0.15383,0.23076,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0017696,0.15381,0.22858,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0012071,0.1536,0.19888,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00045436,0.15351,0.23359,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.0036751,0.15335,0.20546,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0036751,0.15335,0.22917,1,1
5,GO HEART DEVELOPMENT,0.0034935,0.15325,0.22595,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0042727,0.15318,0.2318,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0049572,0.15299,0.24461,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0057394,0.1529,0.24042,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.013235,0.15289,0.192,1,1
5,GO RESPONSE TO HORMONE,0.0092139,0.15285,0.18766,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.016475,0.15271,0.20873,1,1
5,GO STEROL TRANSPORT,0.008797,0.15262,0.22713,1,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.019548,0.15247,0.21437,1,1
5,GO NEGATIVE REGULATION OF GROWTH,0.0031545,0.15241,0.1997,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.0052065,0.15214,0.21543,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.0092139,0.15212,0.21293,1,1
5,GO LYTIC VACUOLE ORGANIZATION,0.0021907,0.15205,0.23394,1,1
5,GO FAT CELL DIFFERENTIATION,0.017954,0.15203,0.18942,1,1
5,GO REGULATION OF ANION TRANSPORT,0.015104,0.15197,0.18514,1,1
5,GO REGULATION OF MESODERM DEVELOPMENT,0.013834,0.15194,0.20061,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0083971,0.15192,0.19406,1,1
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0063209,0.15164,0.17884,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.00096503,0.15163,0.23064,1,1
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.00081392,0.15162,0.21789,1,1
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.028348,0.15159,0.24276,1,1
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0018673,0.15157,0.1977,1,1
5,GO REGULATION OF MACROAUTOPHAGY,0.00068502,0.15157,0.22876,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0017696,0.15155,0.22345,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0052065,0.15149,0.1847,1,1
5,GO STRESS GRANULE ASSEMBLY,0.014457,0.15148,0.21111,1,1
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00019306,0.15135,0.20723,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0027019,0.15124,0.21122,1,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.0042727,0.15109,0.17064,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.050584,0.15104,0.19452,1,1
5,GO MACROMOLECULE DEPALMITOYLATION,0.0042727,0.15095,0.16818,1,1
5,GO PHAGOSOME ACIDIFICATION,0.0019699,0.15094,0.2066,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0036751,0.15083,0.20868,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.0063209,0.15072,0.20145,1,1
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00086166,0.15059,0.21132,1,1
5,GO PLASMA MEMBRANE FUSION,0.035953,0.15054,0.21852,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.019548,0.15049,0.23804,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.017954,0.15046,0.19565,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.031957,0.15046,0.1625,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.018736,0.15031,0.1653,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.00081392,0.15013,0.24443,1,1
5,GO ORGANELLE DISASSEMBLY,0.00076864,0.15009,0.21811,1,1
5,GO TOXIN METABOLIC PROCESS,0.038848,0.15007,0.19037,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.0049572,0.15005,0.19433,1,1
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0076456,0.15,0.18399,1,1
5,GO RESPONSE TO ESTRADIOL,0.026142,0.15,0.16584,1,1
5,GO MEMBRANE ORGANIZATION,0.0010798,0.14969,0.21649,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.028348,0.14965,0.20424,1,1
5,GO BODY FLUID SECRETION,0.0063209,0.14956,0.19414,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0080134,0.14954,0.21725,1,1
5,GO PHAGOSOME MATURATION,0.0029965,0.1494,0.23604,1,1
5,GO RETINA HOMEOSTASIS,0.00068502,0.14931,0.2318,1,1
5,GO MACROAUTOPHAGY,0.0010798,0.14929,0.21218,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00064645,0.14924,0.19323,1,1
5,GO RESPONSE TO AMINO ACID STARVATION,0.0021907,0.1492,0.20177,1,1
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.007293,0.14912,0.15251,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0172,0.14911,0.24622,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.0023095,0.14905,0.23101,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY,0.00057531,0.14891,0.1821,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.027226,0.14869,0.20366,1,1
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0028457,0.14861,0.18629,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0092139,0.14858,0.24204,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.050584,0.14851,0.20684,1,1
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.052482,0.14848,0.21404,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.006955,0.14836,0.19058,1,1
5,GO REGULATION OF CELL MATURATION,0.01266,0.14835,0.17247,1,1
5,GO CELL MOTILITY,0.027226,0.14833,0.19614,1,1
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0080134,0.14824,0.18018,1,1
5,GO HISTONE H2A ACETYLATION,0.0096484,0.14809,0.22421,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.0038653,0.1478,0.18157,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0020776,0.14759,0.2321,1,1
5,GO TUBE DEVELOPMENT,0.026142,0.14757,0.20065,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0040644,0.14757,0.23874,1,1
5,GO ORGANELLE INHERITANCE,0.0042727,0.14728,0.17531,1,1
5,GO MUSCLE ADAPTATION,0.011574,0.14719,0.2039,1,1
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0066311,0.14719,0.16639,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.01266,0.14706,0.20326,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.043559,0.14704,0.19865,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.050584,0.14704,0.14653,1,1
5,GO HEART GROWTH,0.0049572,0.14696,0.21482,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0076456,0.1469,0.1986,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.048745,0.14679,0.13718,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.010572,0.14679,0.18182,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,0.0016767,0.14677,0.20062,1,1
5,GO RESPONSE TO INSULIN,0.0042727,0.14665,0.19632,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.027226,0.14659,0.2145,1,1
5,GO REGULATION OF MRNA 3 END PROCESSING,0.017954,0.14652,0.19901,1,1
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.037377,0.14647,0.23553,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.0028457,0.14642,0.19608,1,1
5,GO INTRACELLULAR TRANSPORT,0.00051151,0.14641,0.1875,1,1
5,GO NEURON DEATH,0.0057394,0.14639,0.20231,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0044907,0.14638,0.17066,1,1
5,GO ENDOCRINE HORMONE SECRETION,0.035953,0.14632,0.16402,1,1
5,GO RRNA TRANSCRIPTION,0.021265,0.1463,0.17187,1,1
5,GO OVULATION CYCLE PROCESS,0.043559,0.14621,0.22754,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.0014241,0.14598,0.20601,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.026142,0.14589,0.21054,1,1
5,GO NUCLEOTIDE PHOSPHORYLATION,0.0047188,0.14582,0.18008,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.010101,0.14579,0.19354,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.054439,0.14571,0.20452,1,1
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00033648,0.14544,0.22043,1,1
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.00096503,0.14543,0.23638,1,1
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0017696,0.14538,0.16801,1,1
5,GO ADAPTIVE THERMOGENESIS,0.016475,0.14535,0.18018,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0014241,0.14533,0.21425,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0092139,0.14508,0.21512,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.018736,0.14494,0.2101,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0044907,0.14493,0.22129,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0029965,0.14479,0.19906,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0057394,0.14464,0.21018,1,1
5,GO CARNITINE METABOLIC PROCESS,0.010101,0.14457,0.22037,1,1
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00020554,0.14457,0.24099,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0025648,0.14447,0.18327,1,1
5,GO VIRAL BUDDING,0.0025648,0.14416,0.16141,1,1
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.0054671,0.14414,0.21459,1,1
5,GO HOMEOSTATIC PROCESS,0.0054671,0.14378,0.18438,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00081392,0.14376,0.192,1,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.006955,0.14373,0.16943,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.0083971,0.14372,0.17617,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00096503,0.1436,0.22124,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0063209,0.14357,0.18147,1,1
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00033648,0.14354,0.21459,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.015776,0.14341,0.16642,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0042727,0.14338,0.18885,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.0083971,0.14313,0.20323,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013235,0.14299,0.20457,1,1
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.046961,0.14295,0.14891,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.017954,0.14255,0.16453,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00045436,0.14253,0.20565,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0016767,0.14252,0.20479,1,1
5,GO REGULATION OF CYTOKINESIS,0.016475,0.14229,0.18475,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0036751,0.14204,0.1828,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00021879,0.14203,0.22705,1,1
5,GO HYALURONAN METABOLIC PROCESS,0.031957,0.14199,0.24505,1,1
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0038653,0.14157,0.17391,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.008797,0.14156,0.18215,1,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0066311,0.14155,0.21403,1,1
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.0029965,0.14148,0.2574,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.013834,0.14143,0.20223,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.01266,0.14135,0.19866,1,1
5,GO CELLULAR HOMEOSTASIS,0.013235,0.14117,0.16905,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,0.0049572,0.14116,0.19168,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0052065,0.14115,0.21919,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0034935,0.14103,0.21793,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.048745,0.14093,0.19021,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00332,0.14093,0.19681,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0044907,0.14091,0.20198,1,1
5,GO REGULATION OF PROTEIN FOLDING,0.0060238,0.14079,0.19836,1,1
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0040644,0.14074,0.24622,1,1
5,GO RESPONSE TO PEPTIDE,0.0063209,0.14059,0.19332,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0031545,0.14059,0.15525,1,1
5,GO REGULATION OF CELL CYCLE,0.011063,0.14058,0.16598,1,1
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0023095,0.14058,0.19769,1,1
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.0010209,0.14045,0.15455,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0013481,0.14044,0.19494,1,1
5,GO PROTEIN MATURATION,0.010572,0.14042,0.15679,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.011574,0.14041,0.17018,1,1
5,GO CELL RECOGNITION,0.018736,0.14041,0.18476,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016475,0.14035,0.19835,1,1
5,GO REGULATION OF AUTOPHAGY,0.0010798,0.14019,0.22639,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0015041,0.14002,0.18469,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,0.0080134,0.13982,0.20643,1,1
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00081392,0.13975,0.17853,1,1
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.019548,0.13959,0.1577,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.041938,0.13959,0.14471,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.0040644,0.13933,0.20646,1,1
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.00091199,0.1393,0.17936,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.010572,0.13922,0.19095,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.022172,0.13918,0.19255,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0019699,0.13909,0.21586,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00040321,0.13892,0.20542,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.0025648,0.13874,0.2262,1,1
5,GO OSSIFICATION,0.031957,0.13868,0.18275,1,1
5,GO PROTEIN TETRAMERIZATION,0.017954,0.13839,0.16554,1,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.0066311,0.13814,0.20472,1,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0052065,0.13803,0.19062,1,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.025096,0.13777,0.13747,1,1
5,GO POSITIVE REGULATION OF URINE VOLUME,0.034576,0.13774,0.2315,1,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.022172,0.13765,0.19993,1,1
5,GO C4 DICARBOXYLATE TRANSPORT,0.0063209,0.13765,0.17802,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.020391,0.13744,0.173,1,1
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.01266,0.13741,0.27956,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.013235,0.13738,0.18273,1,1
5,GO GLUCOSE IMPORT,0.0083971,0.13733,0.19172,1,1
5,GO RESPONSE TO MANGANESE ION,0.031957,0.13726,0.18054,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.040368,0.13726,0.14788,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.011574,0.13707,0.13514,1,1
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00068502,0.13699,0.17983,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0054671,0.13679,0.19684,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0057394,0.13674,0.2708,1,1
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0040644,0.1367,0.19123,1,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.021265,0.13665,0.15173,1,1
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.0044907,0.13655,0.12487,1,1
5,GO METANEPHROS DEVELOPMENT,0.048745,0.13653,0.18683,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.020391,0.1365,0.16144,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0013481,0.13631,0.19796,1,1
5,GO CELL FATE DETERMINATION,0.008797,0.13627,0.21809,1,1
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.035953,0.13618,0.16862,1,1
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.006955,0.13607,0.26907,1,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.016475,0.13603,0.16717,1,1
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.0054671,0.13601,0.15408,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.018736,0.13579,0.21401,1,1
5,GO SULFUR COMPOUND TRANSPORT,0.0010209,0.13566,0.23409,1,1
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0015882,0.13557,0.18835,1,1
5,GO ALDEHYDE CATABOLIC PROCESS,0.027226,0.13555,0.11548,1,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00076864,0.13549,0.1804,1,1
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.038848,0.13527,0.15229,1,1
5,GO REGULATION OF BEHAVIOR,0.017954,0.13495,0.16,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00035748,0.13495,0.22111,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0010798,0.13478,0.18673,1,1
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.019548,0.13472,0.2001,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00057531,0.13464,0.2204,1,1
5,GO PROTEOLYSIS,0.0027019,0.13462,0.18904,1,1
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.043559,0.13458,0.16193,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0052065,0.13457,0.21077,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0060238,0.13454,0.18981,1,1
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00076864,0.13445,0.20386,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.008797,0.13442,0.16245,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.008797,0.13437,0.1983,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0083971,0.13431,0.26443,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0023095,0.13419,0.18632,1,1
5,GO COPII COATED VESICLE CARGO LOADING,0.013235,0.13419,0.23302,1,1
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0010798,0.13403,0.19438,1,1
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.046961,0.13399,0.15841,1,1
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0052065,0.13395,0.23802,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.011063,0.13392,0.23048,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.00035748,0.13389,0.20225,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0049572,0.13388,0.20672,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.13382,0.19653,1,1
5,GO NEURON APOPTOTIC PROCESS,0.0044907,0.13377,0.19451,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0031545,0.13369,0.1531,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.037377,0.13369,0.20926,1,1
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0014241,0.13365,0.16315,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.010572,0.13353,0.22577,1,1
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.013834,0.13334,0.14322,1,1
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.028348,0.13333,0.12007,1,1
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.013834,0.13313,0.15704,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.0020776,0.1331,0.16252,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0040644,0.13304,0.18815,1,1
5,GO ENSHEATHMENT OF NEURONS,0.0096484,0.13296,0.20329,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.0054671,0.13288,0.19955,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.043559,0.13275,0.25078,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0021907,0.13275,0.18364,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.045233,0.13266,0.18107,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.010572,0.13255,0.19609,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0028457,0.13253,0.18231,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.024086,0.1324,0.17851,1,1
5,GO RESPONSE TO COLD,0.048745,0.13223,0.19861,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.007293,0.13222,0.15262,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0052065,0.13202,0.23367,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.026142,0.13184,0.23267,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0054671,0.13181,0.20528,1,1
5,GO GASTRIC ACID SECRETION,0.052482,0.13176,0.11343,1,1
5,GO VACUOLE ORGANIZATION,0.00064645,0.1317,0.23653,1,1
5,GO RESPONSE TO ACIDIC PH,0.026142,0.13169,0.2522,1,1
5,GO ENAMEL MINERALIZATION,0.013235,0.13163,0.32203,1,1
5,GO MAINTENANCE OF LOCATION,0.020391,0.13163,0.18351,1,1
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.012106,0.13158,0.16006,1,1
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.012106,0.13156,0.17769,1,1
5,GO GLIOGENESIS,0.025096,0.13148,0.18566,1,1
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.027226,0.13124,0.1838,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0076456,0.13124,0.20493,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00096503,0.13079,0.21624,1,1
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.031957,0.13077,0.11527,1,1
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.011574,0.1307,0.16518,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0020776,0.13061,0.23068,1,1
5,GO EMBRYONIC EYE MORPHOGENESIS,0.01266,0.13057,0.24348,1,1
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0044907,0.13036,0.19816,1,1
5,GO SINGLE FERTILIZATION,0.0010209,0.12998,0.17478,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0172,0.12986,0.18828,1,1
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.02951,0.12972,0.15206,1,1
5,GO FEMALE SEX DIFFERENTIATION,0.031957,0.12965,0.16677,1,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0096484,0.12947,0.21062,1,1
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0172,0.129,0.17146,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.027226,0.12886,0.17622,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023112,0.1288,0.13554,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,0.0076456,0.12873,0.17392,1,1
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0025648,0.12862,0.15638,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.048745,0.12859,0.17118,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0020776,0.12859,0.19221,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.031957,0.12857,0.1649,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.0020776,0.12817,0.16322,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0080134,0.12814,0.19462,1,1
5,GO CARDIOCYTE DIFFERENTIATION,0.013834,0.12802,0.20972,1,1
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.016475,0.128,0.14216,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0038653,0.12792,0.19225,1,1
5,GO MAINTENANCE OF LOCATION IN CELL,0.026142,0.1279,0.17929,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.017954,0.12775,0.16253,1,1
5,GO PHAGOLYSOSOME ASSEMBLY,0.041938,0.12767,0.25598,1,1
5,GO EAR DEVELOPMENT,0.013235,0.12763,0.17761,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.016475,0.1276,0.17863,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.052482,0.12722,0.12779,1,1
5,GO PH REDUCTION,0.019548,0.12714,0.15186,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,0.0040644,0.12701,0.23588,1,1
5,GO INTERMEMBRANE LIPID TRANSFER,0.030713,0.12694,0.18731,1,1
5,GO QUINONE METABOLIC PROCESS,0.020391,0.12664,0.098749,1,1
5,GO MITOCHONDRIAL FUSION,0.0029965,0.12643,0.19293,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0066311,0.12643,0.19535,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00091199,0.12627,0.18555,1,1
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.048745,0.12622,0.14969,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0031545,0.12611,0.23167,1,1
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.027226,0.12605,0.15914,1,1
5,GO NADP METABOLIC PROCESS,0.019548,0.12592,0.14457,1,1
5,GO ORGANIC ACID CATABOLIC PROCESS,0.00076864,0.12564,0.19204,1,1
5,GO RESPONSE TO CAFFEINE,0.026142,0.12561,0.23579,1,1
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.00081392,0.12557,0.16548,1,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.031957,0.12551,0.18611,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.008797,0.12547,0.17214,1,1
5,GO TISSUE MORPHOGENESIS,0.0092139,0.12542,0.19793,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0031545,0.12539,0.19753,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0025648,0.12528,0.15825,1,1
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.0054671,0.12526,0.22811,1,1
5,GO LIPID IMPORT INTO CELL,0.037377,0.1252,0.18074,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.010572,0.12505,0.2189,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0044907,0.12503,0.20562,1,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0060238,0.12486,0.17548,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0172,0.12481,0.16782,1,1
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.011063,0.1248,0.14912,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.024086,0.12473,0.16053,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0027019,0.12448,0.18179,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.046961,0.12443,0.19006,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.010101,0.12437,0.17167,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0028457,0.12423,0.18768,1,1
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.00068502,0.12413,0.18615,1,1
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0024341,0.12404,0.15093,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.021265,0.12403,0.17295,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0052065,0.12379,0.17559,1,1
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0011418,0.12362,0.15884,1,1
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.015104,0.12356,0.13427,1,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0042727,0.12336,0.17701,1,1
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.012106,0.12317,0.14097,1,1
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.013834,0.12315,0.1585,1,1
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.024086,0.123,0.17075,1,1
5,GO PEROXISOME ORGANIZATION,0.0016767,0.12294,0.18001,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.010101,0.12282,0.17722,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.008797,0.1227,0.16738,1,1
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0054671,0.1226,0.14219,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0092139,0.12256,0.17994,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.028348,0.12251,0.18916,1,1
5,GO MACROMOLECULE CATABOLIC PROCESS,0.0029965,0.1225,0.15274,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.043559,0.12249,0.13079,1,1
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00051151,0.12243,0.16562,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.006955,0.12241,0.18074,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.019548,0.1224,0.20099,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,0.041938,0.12234,0.1923,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.024086,0.1223,0.18272,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0172,0.12226,0.16542,1,1
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060238,0.12204,0.21017,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.020391,0.12198,0.19935,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00040321,0.12125,0.23146,1,1
5,GO RETINAL CONE CELL DIFFERENTIATION,0.027226,0.12105,0.17283,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.010101,0.12081,0.18089,1,1
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00086166,0.1207,0.17,1,1
5,GO REGULATION OF ATPASE ACTIVITY,0.0066311,0.12066,0.13514,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.011574,0.12057,0.17254,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.027226,0.12034,0.15891,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.019548,0.12022,0.18559,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0031545,0.1202,0.22892,1,1
5,GO TETRAPYRROLE METABOLIC PROCESS,0.011574,0.12011,0.13736,1,1
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0020776,0.12006,0.16188,1,1
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.01266,0.12,0.12098,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.024086,0.11981,0.14925,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.025096,0.1198,0.17453,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.010572,0.11978,0.18978,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.048745,0.11968,0.16351,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0052065,0.11954,0.19292,1,1
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00332,0.11945,0.14635,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.017954,0.11931,0.1923,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.0027019,0.11926,0.18131,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0063209,0.11914,0.14839,1,1
5,GO ENDOSOME ORGANIZATION,0.0024341,0.11893,0.18597,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,0.0096484,0.11891,0.19783,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0066311,0.11886,0.23386,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.023112,0.11872,0.18612,1,1
5,GO MULTIVESICULAR BODY ORGANIZATION,0.008797,0.11869,0.13852,1,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.025096,0.11866,0.17176,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0047188,0.11841,0.14419,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.038848,0.11821,0.21173,1,1
5,GO MITOCHONDRIAL TRANSPORT,0.00332,0.1181,0.13685,1,1
5,GO STEROID METABOLIC PROCESS,0.0042727,0.11801,0.18046,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.025096,0.11801,0.15554,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.022172,0.11782,0.19502,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.0025648,0.11778,0.17742,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0017696,0.11768,0.18515,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.0028457,0.11721,0.16441,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.0025648,0.11715,0.19664,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.015776,0.11702,0.17541,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.019548,0.11688,0.15746,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.019548,0.11677,0.19592,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.013834,0.11668,0.18744,1,1
5,GO FATTY ACYL COA METABOLIC PROCESS,0.0060238,0.11659,0.16818,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.02951,0.11648,0.24301,1,1
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.013235,0.11633,0.237,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0092139,0.11632,0.17236,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.010572,0.11628,0.22466,1,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.008797,0.11619,0.17686,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.11618,0.19099,1,1
5,GO ANION HOMEOSTASIS,0.0096484,0.11606,0.20175,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.030713,0.11579,0.1461,1,1
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0018673,0.11564,0.16492,1,1
5,GO MITOTIC CYTOKINESIS,0.027226,0.11555,0.16433,1,1
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0011418,0.11546,0.15394,1,1
5,GO REGULATION OF DNA METABOLIC PROCESS,0.030713,0.11545,0.15255,1,1
5,GO NUCLEOTIDE EXCISION REPAIR,0.016475,0.11523,0.13607,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.028348,0.11452,0.20434,1,1
5,GO CELL CYCLE,0.012106,0.1145,0.16714,1,1
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.052482,0.11427,0.16421,1,1
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0036751,0.11427,0.12148,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0052065,0.11402,0.18989,1,1
5,GO CELLULAR RESPONSE TO STARVATION,0.0019699,0.11376,0.19604,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0096484,0.11339,0.18904,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.015776,0.11295,0.18372,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.01266,0.11267,0.18503,1,1
5,GO MITOCHONDRION MORPHOGENESIS,0.0054671,0.11255,0.16655,1,1
5,GO TRICARBOXYLIC ACID CYCLE,0.02951,0.1122,0.11071,1,1
5,GO FATTY ACID TRANSPORT,0.046961,0.11206,0.15188,1,1
5,GO PEROXISOMAL TRANSPORT,0.0012758,0.11202,0.16377,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0019699,0.11171,0.20108,1,1
5,GO RESPONSE TO DRUG,0.010101,0.11136,0.17283,1,1
5,GO REGULATION OF HEART GROWTH,0.023112,0.11133,0.17565,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00060992,0.11096,0.18705,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.02951,0.11074,0.17765,1,1
5,GO MESODERM DEVELOPMENT,0.0172,0.1107,0.16921,1,1
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.017954,0.11059,0.16673,1,1
5,GO VITAMIN TRANSPORT,0.041938,0.11049,0.17007,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.045233,0.10974,0.17252,1,1
5,GO RNA CAPPING,0.015776,0.10964,0.1173,1,1
5,GO PROTEIN STABILIZATION,0.019548,0.10945,0.13805,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.0010798,0.10944,0.19282,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.014457,0.10934,0.19892,1,1
5,GO ORGAN GROWTH,0.01266,0.10901,0.20169,1,1
5,GO PROTEIN DESTABILIZATION,0.0019699,0.109,0.19135,1,1
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0044907,0.10878,0.22152,1,1
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0049572,0.10833,0.17707,1,1
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.02951,0.10823,0.23379,1,1
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0011418,0.10808,0.16566,1,1
5,GO RESPONSE TO STARVATION,0.0019699,0.10808,0.18861,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0080134,0.10785,0.16042,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.016475,0.10773,0.19421,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.018736,0.10741,0.18332,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0080134,0.10682,0.21993,1,1
5,GO MITOCHONDRION ORGANIZATION,0.00086166,0.10643,0.13651,1,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.024086,0.1062,0.14473,1,1
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0092139,0.10614,0.13516,1,1
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.035953,0.10611,0.1336,1,1
5,GO LIPID METABOLIC PROCESS,0.0023095,0.10607,0.19431,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00332,0.10562,0.17838,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.011063,0.10406,0.18168,1,1
5,GO TEMPERATURE HOMEOSTASIS,0.015776,0.10398,0.17342,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.011063,0.10349,0.18902,1,1
5,GO RHYTHMIC BEHAVIOR,0.020391,0.10335,0.16897,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.02951,0.10304,0.17692,1,1
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0066311,0.10239,0.1342,1,1
5,GO REGENERATION,0.025096,0.1019,0.1742,1,1
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024341,0.10121,0.11996,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0021907,0.10109,0.16702,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0036751,0.10074,0.17329,1,1
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.020391,0.10056,0.1405,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION,0.0027019,0.099979,0.17034,1,1
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.022172,0.099428,0.12853,1,1
5,GO MITOCHONDRIAL FISSION,0.0025648,0.099331,0.21542,1,1
5,GO PROTEIN FOLDING,0.0038653,0.099096,0.13787,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00091199,0.098965,0.16651,1,1
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.0172,0.098679,0.09805,1,1
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.037377,0.098408,0.12998,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,0.0029965,0.098219,0.21742,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.028348,0.097749,0.17261,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.097566,0.16293,1,1
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.048745,0.097067,0.21267,1,1
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0044907,0.096519,0.14064,1,1
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.037377,0.096178,0.14602,1,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0096484,0.096137,0.18259,1,1
5,GO GLAND DEVELOPMENT,0.013235,0.095996,0.1946,1,1
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0042727,0.095717,0.1316,1,1
5,GO CYTOKINETIC PROCESS,0.0076456,0.094584,0.174,1,1
5,GO REGULATION OF ORGAN GROWTH,0.017954,0.094495,0.18594,1,1
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0034935,0.094264,0.15034,1,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.011063,0.093783,0.1514,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0015041,0.093762,0.16764,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.017954,0.093458,0.191,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0031545,0.093457,0.14936,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.025096,0.093265,0.16525,1,1
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00072571,0.093208,0.13905,1,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.010572,0.092337,0.21233,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.017954,0.092203,0.18709,1,1
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0027019,0.091126,0.1312,1,1
5,GO MITOTIC CYTOKINETIC PROCESS,0.014457,0.089865,0.12859,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.037377,0.08978,0.14074,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,0.013235,0.089595,0.12877,1,1
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.050584,0.089166,0.22928,1,1
5,GO PIGMENT METABOLIC PROCESS,0.0049572,0.088762,0.14057,1,1
5,GO POLYAMINE METABOLIC PROCESS,0.030713,0.088431,0.12,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.031957,0.087166,0.13689,1,1
5,GO REGULATION OF ERAD PATHWAY,0.041938,0.085793,0.14908,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.052482,0.083969,0.16391,1,1
5,GO OXIDATION REDUCTION PROCESS,0.0018673,0.083907,0.14755,1,1
5,GO VIRION ASSEMBLY,0.0034935,0.081266,0.12591,1,1
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.028348,0.079651,0.18975,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.034576,0.078992,0.14327,1,1
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0027019,0.07596,0.13532,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0080134,0.074723,0.13669,1,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.033245,0.074023,0.16535,1,1
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.027226,0.067969,0.10605,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.033245,0.060573,0.17371,1,1
5,GO PROTEIN TARGETING,0.0047188,0.045098,0.081353,1,1
